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Alkaptonuria (AKU) is a rare autosomal recessive condition which is caused by deficiency of a single 
enzyme on the tyrosine metabolic pathway. The disorder results from the absence of homogentisate 
1,2 dioxygenase (HGD), which breaks down homogentisic acid (HGA). This disorder was the first 
shown to be an inborn error of metabolism. The absence of HGD results in high circulating levels of 
HGA. The disorder shows a triad of clinical features, the first of these is excretion of gram quantities 
of HGA in the urine. Over time or on addition of alkali the urine darkens. The second feature is 
ochronosis, which results from long term exposure of collagenous tissues to HGA. The circulating 
HGA shows high affinity for collagenous tissues and undergoes polymerisation and deposition by a 
currently unknown mechanism to appear as a dark melanin like pigment in collagenous tissues, 
predominantly the load-bearing articular cartilages. The final clinical feature is ochronotic arthropathy 
which results from the ochronosis of the articular cartilages. There is currently no known treatment 
for this disease, the chromosomal location and structure of the missing enzyme is known and the gene 
has been cloned. The aim of this study was to gain an insight into the pathogenesis of the disorder.
Utilising the largest number of in a single study of AKU tissue samples, this study has been able to 
provide insights in to the effects and distribution of ochronosis in patient tissues. The most striking 
feature of the observations was the non-uniform distribution of ochronotic pigment in the patient 
tissues. Consistent with these observations ultrastructural analysis demonstrates that even in tissues 
which ochronosis appears in all regions macroscopically, ultrastrucuturally there are regions of tissue 
that demonstrate no association with ochronotic pigment. This study shows the earliest association of 
ochronotic pigment with collagen fibres in the matrix of patient tissues, furthermore this association 
shows a regular periodicitiy that is possibly associated with the periodic banding that is typical of the 
fibrillar collagens. Analysis of in vitro cultures demonstrates similar association of pigment with 
matrix fibres in culture of osteo and chondrosarcoma cells incubated in HGA.
This study, through meticulous examination by microscopical techniques a novel bone and cartilage 
phenotype has been seen in alkaptonuric joint samples. In the most severely ochronotic samples, there 
is absence of the subchondral bone and calcified cartilage plates. Alongside this observation the 
earliest detectable ochronosis associated with individual chondrocyte has been seen, demonstrating 
that ochronosis commences closest to the subchondral boundary before progressing to the articular 
surface. Alongside the observations of the cartilage phenotype, novel bone structures were observed 
in AKU specimens, and subsequently observed in osteoarthritis (being used as control) samples.
Through macroscopic and microscopic analysis of a murine model of AKU, this study demonstrates 
the first observations of ochronosis in a murine model of AKU. This model demonstrates the earliest 
signs of ochronosis observed around single chondrocytes in the cartilage matrix, identical to those 
observed in human joint tissues.
This thesis also describes novel observation of ochronosis in pathological tissues, both in the presence 
and absence of a collagenous matrix. This raises the question of the role of factors other than the 
presence of HGA in the deposition of ochronotic pigment in patient tissues.
In summary this study represents novel and significant advances in the understanding of the 
pathogenesis of ochronosis and also providing useful tools that can be used in advancing the 
understanding of the disease further but more importantly identifying and utilising therapeutic targets 
to tackle this rare condition.
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11. Introduction
2Alkaptonuria (AKU) is a rare autosomal recessive condition caused by mutation or 
absence of a single enzyme in the tyrosine metabolic pathway; homogentisate 1,2- 
dioxygenase (HGD). The lack of the enzyme results in the inability of the sufferer to fully 
metabolise homogentisic acid (HGA), this results in elevated levels of HGA in the body 
tissues and massive urinary excretion of the HGA. The disorder is characterised by three 
clinical features: darkening of urine on standing due to the presence of HGA, ochronosis 
of collagenous tissues, primarily articular' cartilages of the weight bearing joints and 
subsequent ochronotic arthropathy as a result of the long term deposition of ochronotic 
pigment.
1.1 JOINT TISSUES
1.1.1 Articular Cartilage
In the human body there are three types of cartilage, these are grouped in relation to their 
function and properties. They are distinguished by their compositional constituents which 
are related to their function. The cartilages are elastic, fibrocartilage and hyaline. One of 
the most distinct properties of cartilage is in health is it is avascular, has no nervous 
innervations and is alymphatic. Elastic cartilage is found in the pinna and parts of the 
larynx. Fibrocartilage is present in intevertebral discs and the menisci of the knees. 
Hyaline cartilage is the most predominant cartilage in the body and is seen on the ends of 
the long bones and is significant in joint function. It is also seen in the nasal septum, 
tracheal cartilages and the respiratory cartilages. Articular cartilage is a complex highly 
specialised tissue with numerous functions; shock absorption from locomotion, load 
distribution of the initial load through to the underlying bone and to provide a smooth and
3low friction surface for efficient movement. The complexity of this tissue is further 
increased as in contrast to parenchymal organs such as liver, brain and kidney the 
connective tissues of the joints do not function directly via their cells but via their 
extracellular matrices.
The cartilage matrix consists of collagens, proteoglycans and non-collagen proteins. 
Within this matrix a single cell type; chondrocytes maintain turnover of certain matrix 
components within their vicinity. (Goldring, 2009). The cartilage matrix can be 
subdivided into 4 distinct layers, (uppermost to deepest) superficial, middle, deep and 
calcified. To date there is no real classification for dividing these compartments up. For 
many years cartilage had been considered an unresponsive or inert tissue, but it is now 
clear that the chondrocytes also respond to many of the same types of stimuli which 
cause responses in bone, such as cytokines, mechanical stimuli and genetic factors 
(Goldring 2007). The cartilage matrix consists of water, collagen and proteoglycans. Of 
this between 60-80% is usually water which is held in place by being bound to the 
proteoglycans in the matrix.
1.1.2 Structure, function and composition of cartilage
The composition of articular cartilage is directly related to its biomechanical function. 
Within the articular cartilage located on the long bones, there are four distinct layers, 
each one has its extracellular components organised to meet its biomechanical function. 
These layers have differing cell densities and matrix organisation related to their structure 
and function. Throughout these layers, there are also different compartments,
4distinguished by their proximity to the cellular components of the cartilage. Immediately 
around the chondrocytes is the pericellular matrix. The regions furthest from the 
chondrocytes, is deemed the interterritorial matrix, which constitutes the majority of 
cartilage given the sparse distribution of cells in this tissue. Between these two 
compartments is the territorial matrix. Synonymic with this organisational distinction 
there are also compositional differences of the matrix components. The majority of the 
articular cartilage is made up of water (60-80%), collagen fibres (10-30%) and 
proteoglycans (5-10%). Articular cartilage also contains non-collagenous proteins and a 
single cell type, chondrocytes. Chondrocytes are sparsely located within the matrix and 
are responsible for maintaining their surrounding matrix. The matrix is predominantly 
composed of type II collagen, but other types, including; V, VI, IX, X, XI, XII, and XIV 
are also present in lesser amounts. At the superficial zone collagen fibres are laid down 
parallel to the surface with the chondrocytes flattened. The preservation of this surface 
may prove critical for protection of the underlying layers. Collagen IX is found 
interspersed between the collagen II fibres. The middle layer demonstrates collagen fibres 
arranged in an oblique manner, this aids in the absorption of compressive and shear 
forces being placed on the joint. Chondrocytes in this region are spherical. In the deep 
layer the collagen fibres are arranged perpendicular to the surface along with the 
chondrocytes, this maximises the absorption of compressive forces through the joint.
5Figure 1.2: A schematic showing the arrangement of cells and their relation to the named 
regions of matrix. Chondrocytes are usually seen in small groups or clusters known as 
isogenous groups. The matrix immediately round the cell is the pericellular matrix 
(yellow). The territorial matrix (TM) is around the chondrocytes, often seen as to he 
within the isogenous group (purple). The interterritorial matrix (ITM) is located amongst 
the clusters of chondrocytes (pink).
1.1.3 Collagen
Collagen fibres play a critical role in the structure and function of extra cellular matrix 
and at the cellular-extra cellular boundary (Kadler, 2008). Collagen exhibits a triple 
helical structure, with distinct periodicities at 67nm, giving it an unmistakable banding
6pattern. The most abundant collagen in cartilage is type II. The collagen fibres are 
fundamental in maintaining the tensile properties of cartilage. This is facilitated by the 
crosslinking of collagen fibres, with collagen monomers demonstrating binding sites to 
mediate fibril formation (Prockop, 1998). Whilst collagen monomers will readily form 
fibres in vitro, this appears not to be synonymic in vivo, with other binding factors 
appearing to play an important role in the process and ensuring that diversity of fibre 
types, probably related to location and function, is maintained (Di Lullo, 2002 & Kadler, 
2008). The collagen molecules themselves are formed from a repeat structure which sees 
the amino acid glycine located as every 3rd amino acid, to give the motif; Gly - X - Y, 
whereby X is usually pro line and Y is hydroxyproline (Gordon, 2010).
Whilst collagen is the largest solid component of cartilage, other molecules are present 
and play a significant role in the structure and function of the tissue, these are the 
proteoglycans. Aggrecan is the largest part of the proteoglycans found in cartilage. 
Alongside being able to withstand tensile forces, cartilage can absorb compressive forces, 
enabling deformation under compressive load, whilst being able to return to its original 
form. This feature is associated with aggrecan and the aggregates it forms with 
hyaluronic acid and link protein. These aggregates usually consist of <100 aggrecan 
molecules located off a central hyaluronic acid filament (Martel-Pelletier, 2008). 
Aggrecan is important in the retention of water within cartilage under mechanical 
loading.
71.1.4 Chondrocytes
As the sole cell in articular cartilage chondrocytes are responsible for maintaining the 
extracellular matrix. It has been demonstrated that they turnover matrix components in 
their vicinity (pericellular matrix) more rapidly than those at a greater distance from them 
(interterritorial matrix) (Goldring 2008). The longevity of chondrocytes within the matrix 
must be many years given that the rate of cell division is extremely low.
1.2 BONE
1.2.1 Bone structure and function
Bone is a highly specialised tissue which performs numerous functions. The majority are 
associated with mechanical function, such as movement, absorbing load, providing soft 
tissue support and protection. The other function is as a homeostatic store for mineral 
components utilised by the body during daily function and maintenance. There are two 
types of bone, cortical and trabecular. Cortical bone is densely packed and provides the 
external structure of the bone organ. Internally is trabecular bone, which appears as rod 
and plate like elements, and has a much larger surface area. In amongst the trabecular is 
the bone marrow, which has haemopoetic potential. Bone is composed of type I collagen 
fibres which are laid down as osteoid and then mineralised. It is this mineralisation that 
acts as the homeostatic store of calcium within the body. The structure and function of 
bone sees it modelled and remodelled during life to ensure the tissue can withstand the 
necessary load of supporting the body, while minimising the energy costs associated with 
locomotion of the bone organ. During life the remodelling of bone sees the internal shape
8constantly alter in response to the mechanical load that is place on it and also to meet the 
mineral needs of the body.
The structure of bone is predominantly hydroxyapatite (mineral) with collagenous and 
non collagenous proteins. The collagen is type I and can become mineralised. The 
collagen fibres consist of two al chains and one a2 chain, coded for by separate genes 
and wound together in a triple helix. The fibres are the finished product of procollagen 
which is secreted from the cells with an N and C terminal domains which are cleaved 
extracellularly. Alongside the collagen there are non collagenous proteins found in bone 
which are instrumental to its maintenance and turnover. These proteins include 
osteocalcin, matrix Gla protein, osteonectin, proteoglycans, bone sialoprotein and serum 
proteins (Roach, 1994).
1.2.2 Cells within bone
The turnover and remodelling of the bone organ is a highly ordered process. This process 
is undertaken by the cells which reside within the bone organ. Collagen is synthesised, 
secreted and laid down by osteoblasts as osteoid. Once this deposition has occurred the 
osteoblast either entombs itself into a cavity within the mineralised matrix, becoming an 
osteocyte, or alters it shape to become flattened and reside on the surface of the bone, 
becoming a bone lining cell. Removal of mineralised matrix requires a highly specialised 
cell; osteoclasts. These cells are multinucleated and arise from the fusion of mononuclear 
haemopoetic precursors. The osteoclasts move to the bone surface and undertake the 
process of bone resorption.
91.2.3 Bone turnover
Bone is a highly dynamic tissue, altering in response to mechanical, biochemical and 
genetic stimuli. It repairs constantly at the site of micro-fractures and repeats this feat on 
a larger scale at sites of fracture associated with trauma. It can also adapt to new or 
altered loading applied to it over time. Although there are two distinctly different types of 
bone, the remodelling process is the same. There is a highly ordered process of bone 
turnover which sees packets of bone only being removed if there is going to be adequate 
deposition to replace it. This process is mediated by the cells, originally thought only to 
involve the osteoblasts and osteoclasts, it is now evident that osteocytes are also 
influential in the remodelling process (Bonewald, 2008). The process is initiated by the 
bone lining cells moving away from the bone surface to expose the underlying bone 
matrix. Then osteoclast precursors migrate to the area, fuse to form mature osteoclasts 
and resorb the bone. The process of resorption ceases prior to the recruitment of 
osteoblasts to the active surface to fill in the resorption lacunae.
Bone turnover is a general phenomenon which occurs in all regions of all bones. Any 
deviation from this finely balanced process results in pathological conditions, such as 
osteoporosis or subchondral bone sclerosis in osteoarthritis (OA).
1.2.4 Subchondral bone
Subchondral bone or the subchondral bone plate lies immediately beneath the layer of 
calcified articular cartilage at the ends of the long bones. This plate provides a rigid 
structure to which the cartilage is attached. The two tissues, whilst compositionally and 
functional distinct share a closely balanced relationship. The subchondral bone and its
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continual remodelling shows interdigitations into the calcified cartilage plate. 
Subchondral bone pathology is extremely important in the initiation and progression of 
osteoarthritis and has recently been suggested as a possible target for treatment of the 
disease (Kwan Tat, 2010). Even with this suggestion there is still no clear’ evidence as to 
whether the subchondral bone pathology in joint diseases such as OA follows or precedes 
changes in the overlying articular cartilage.
1.3 SYNOVIAL AND SOFT TISSUES
Whilst cartilage and bone changes are predominantly associated with joint degeneration, 
the synovial tissues and surrounding musculature cannot be ignored as their functional 
significance is of great importance. The capsule, ligaments and surrounding musculature 
contribute to the mechanical stability of the joints and without their normal function 
cartilage degeneration is often seen, such as in malalignment syndromes resulting from 
abnormal loading across the cartilage surface. It is also evident that the synoviocytes, or 
cells that line the synovial surface are of high functional significance. They produce 
synovial fluid; a filtrate of plasma, but also maintain nutrition flow to the chondrocytes 
and produce high levels of hyaluronic acids to ensure efficient gliding of the joints. These 
cells also remove waste products from the joint space and thus balance homeostasis of the 
joint cavity.
Bone, cartilage and soft tissues are all unique in their matrix and cellular composition in 
health. These tissues rely on normal and healthy function of all the others to maintain the 
healthy and function of the joint organ as a whole. In AKU it is originally thought that the
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cartilage was the only affected tissue, and that the synovial effects were a secondary 
result due to the presence of ochronotic shards of cartilage becoming embedded in the 
synovium. These tissues, whilst each unique all rely on the normal and intact function of 
the others to maintain joint health and function. In AKU it appeal's that the changes in the 
cartilage affect the synovium and to an extent the bone.
1.4 METABOLISM
Metabolism is a complex mechanism of chemical reactions that are inter-related and an 
important part of maintaining homeostasis of an organism. The homeostasis is 
fundamentally important to maintain cellular processes and functionality and converting 
one substance or compound into another that is readily useable by the organism. 
Metabolism can often be divided into two functional components; catabolism and 
anabolism. Catabolism covers processes which see complex molecules broken down to 
give their principal functional components. For example breakdown of large globular 
proteins to polypeptides which can be further broken down to amino acids. Anabolism is 
the opposite and sees these small functional components utilised to build proteins and 
complex structures useful to the body for processes related to growth, energy or repair 
from amino acids. There are many underlying reasons for these reactions but some of the 
most significant are related to the size and cost to the body of moving around large 
molecules to the site where they are needed in the body. These reactions are usually 
regulated by highly specific enzymes which facilitate these reactions. Within the body 
there predicted to be somewhere in the region of 135 metabolic pathways containing over
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2700 enzymes. Many of these pathways are found to be conserved amongst species, both 
complex and simple (Romero, 2005).
1.4.1 Tyrosine Metabolism
Tyrosine is a non-essential amino acid that is synthesised in the liver from phenylalanine. 
Tyrosine is a polar, uncharged (hydrophillic) amino acid which is fundamentally 
important in humans for a number of processes, it is used to synthesis 3 catecholamine 
hormones; adrenalin, noradrenaline and dopamine. It is also the precursor to thyroxin 
which is important in the regulation of cellular metabolism, growth and enhancing the 
effect of other catecholamine effects. It is also used in melanin biosynthesis whereby it 
forms pigment in the melanocytes of the skin. Tyrosine is also involved in other 
metabolic pathways where it is enzymatically degraded through a number of steps to 
fumarate and acetoacetate both products are then used as substrates in the citric acid 
cycle. It is along this specific pathway that a number of genetic diseases occur.
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Figure 1.3:- Diagram showing the phenylalanine and tyrosine metabolic pathway with 
enzymes and defects. A = Tyrosinemia type II. B = Tyrosinemia type III. C = 
Alkaptonuria. D = Tyrosinemia type I.
1.5 ALKAPTONURIA
1.5.1 History
Alkaptonuria (AKU) is a rare autosomal recessive condition resulting from the inability 
to fully metabolise the amino acids tyrosine and phenylalanine. The disorder is renowned 
for being one of the first disorders to be described by Sir Archibold Edward Garrod as
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“an inborn error of metabolism” and to conform to the laws of Mendelian autosomal 
recessive inheritance (Garrod, 1902, Garrod 1908). Prior to the deduction by Garrod that 
AKU is an autosomal recessive condition and is an “inborn error of metabolism” there 
were numerous published observations that described clear features of AKU.
The earliest documented report of AKU relates to the description of a school boy who 
passed urine “as dark as ink,” by Scribonius in 1584 (Scribonius, 1584). This was closely 
followed 25 years later when Schenck described the same phenomena in a Carmelite 
monk (Schenck 1609). Similar reports were documented by Lusitanus in 1649, Singer in 
1775, and Marcet in 1822. In 1859, Boedeker undertook an extensive analysis of urine 
from a 44yr old man with increasing lumbar spine pain and severely compromised 
mobility. He identified a reducing substance present in the urine of this individual that 
reduced alkaline copper solutions consistent with diabetes, however Nylander’s solution 
remained unchanged (A test for glucose in the urine, which produces a black precipitate). 
Boedeker deduced that the reducing substance in the urine was not glucose based on 
these observations and the fact that the individuals urine failed to support yeast 
fermentation. Further analysis demonstrated silver nitrate, chromic acid, osmic acid and 
permanganate were all reduced. He also observed, consistent with previous observations, 
that when left to stand the urine darkened. He further described that this occurred from 
the surface of the solution downwards. Boedeker demonstrated that this darkening was 
rapidly accelerated on addition of alkali substances and quickly took up a large volume of 
oxygen. This finding allowed Boedeker to name the new substance “alkapton” derived 
from the Arabic “Alkali” (meaning alkali) and the Greek word meaning “to suck up
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(oxygen) readily/greedily in alkali. Boedeker was also able to extract his newly named 
compound by a process involving precipitation with lead and extraction in ether. This 
process yielded “alkapton” crystals that were not pure; contaminated with nitrogen 
(Boedeker, 1861). Following Boedeker’s discoveries there was still no knowledge as to 
the actual compound responsible for the disorder and its features. Prior to its discovery 
there were numerous attempts to deduce the compound and its’ structure. The compounds 
suggested in the intermediary included; pyrocatechol, protocatechuic acid, glycosuric 
acid, urrhodinic acid, uroxanthic acid and uroleucic acid (O’Brien, 1963). Eventually, in 
1891 Wolkow and Baumann managed to extract alkapton and its lead salt form (Wolkow, 
1891). They also obtained prismatic crystals of the free acid, detailing its melting point 
and empirical formula; CeH^O,*.
In parallel, but unrelated to attempts to distinguish the compound responsible for 
darkening of the urine, there were interesting observations being made by Virchow in 
necropsy of a 67yr old man who died from congestive heart failure. He found that the 
articular cartilages, intervertebral discs, menisci, laryngeal and tracheal cartilages were 
all black. The ligaments and synovial tissues displayed pigmentation to a lesser extent of 
the cartilages. Microscopic analysis of these tissues showed that the black pigmentation 
observed macroscopically actually appeared yellow in colour. As a result of this 
appearance Virchow termed the phenomena “Ochronosis” derived from the Greek ochros 
“sallow” and nosos “disease” (Virchow, 1866). It was in 1902 that Albrecht connected 
the ochronosis of tissues, ochronotic arthritis and alkaptonuria. He concluded that long 
term suffering from alkaptonuria resulted in ochronosis (Albrecht, 1902). In 1904 Osier 
was the first person to publish evidence to document the diagnosis of alkaptonuria in
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living individuals. The sufferer in question displayed pigmentation of the ears and the 
sclera. Osier also noted that the sufferer had a brother who displayed similar features, 
both presented arthritis in the spine (Osier 1904). In 1902 Garrod described the disorder 
as the result of an alternative course of metabolism, harmless and usually congenital and 
lifelong (Garrod, 1902). Most famously Garrod presented his work at the Croonian 
lectures in 1908, whereby he demonstrated that albinism, alkaptonuria, cystinuria and 
pentosuria were all resultant of Mendelian inheritance, causing variation in metabolism of 
normal metabolites on normal pathways (Garrod, 1908, Schriver 2008). Garrod 
demonstrated that there was an association between the intake of the amino acids tyrosine 
and phenylalanine and this increased the output of HGA in alkaptonuric individuals 
(Garrod, 1905). Ochronosis has been confirmed in an Egyptian mummy dating back to 
1500 B.C. The confirmation of AKU in Hawm, was verified by performing radiological 
and biochemical analysis of the joints most affected by the disease, the knees, hips and 
intervertebral discs (Stenn, 1977).
1.5.2 Epidemiology
The incidence of alkaptonuria is estimated to be between 1 in 200,000 to 1 in 1,000,000 
births in the developed world (Sahin, 2001, Phornphutkul, 2002, Keller, 2004). In regions 
of Slovakia and the Dominican Republic the prevalence is much higher, around 1 in 
19,000. It has been demonstrated that there are numerous mutations within the Slovakian 
population (Zatkova, 2000), with further independent founder mutations identified in this 
small country (Gehring, 1997, Muller, 1999, Zatkova, 2000). The prevalence of AKU in 
Slovakia is further complicated by the discovery that the M368V mutation, the most
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prevalent AKU mutation in Europe and a relatively frequent AKU mutation in the 
neighboring countries, has not been encountered in the Slovak patients (Zatkova, 2000). 
They also discovered that there are relatively few mutations from the surrounding 
countries that occur in the Slovakian AKU gene pool, and that there are 3 mutations 
which show a high prevalence in the this region and are rarely found outside Slovakia. 
One of the most difficult things in predicting the appearance of AKU in any region is the 
lack of knowledge of how many caniers (HGD mutational heterozygote’s) there are in 
the general population.
1.5.3 Clinical Presentations
Alkaptonuria has three clinical features which present at different stages through life. The 
first and earliest presenting symptom is the excretion of HGA in the urine; this darkens 
on standing or can be darkened rapidly by the addition of alkaline substances. The 
presence of HGA in urine is used as a diagnostic tool for determining AKU. It has been 
trialed on over 135,000 children in Wales as part of a screening study looking for 
inherited metabolic disorders, particularly phenylketonuria (PKU) after the discovery that 
it causes severe mental retardation if not treated with a low phenylalanine diet from birth. 
This trial discovered 2 infants with the disorder (Bradley, 1975). It has been reported that 
darkening of urine in nappies can be seen within 57 hours of birth (Garrod, 1902). This 
would confirm that the excretion of HGA in the urine is high from birth. The excretion of 
HGA in the urine and its subsequent darkening and staining of nappies and/or clothing in 
infants is the only clinical sign of the disorder in the pediatric group (Peker, 2008). 
Whilst darkening of urine is usually an obvious sign of abnormality, it is not unique to
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AKU, it can be caused by accumulation of other tyrosine metabolic compounds such as 
L-DOPA, melanin or melanogen (Slawson, 1980), or by intake of certain foods in large 
quantities (Noll, 1980). To ensure AKU is correctly diagnosed further analyses of the 
urine are usually undertaken in the pediatric age group as the other clinical features, such 
as the ochronosis of ear cartilages only becomes notable around the 4th decade (O’Brien, 
1963) and the ochronotic arthropathy, does not present until the 3rd or 4th decade of life 
(Phornphutkul, 2002). Further analysis of urine is usually undertaken using either 
spectrophotometric analysis (Phornphutkul, 2002), HPLC (Bory, 1989 & 1990) or by 
NMR urinalysis (Yamaguchi, 1986).
Over time levels of HGA accumulate in body tissues and undergo polymerisation by an 
unknown mechanism to deposit as a dark pigment associated with the extracellular matrix 
(Helliwell, 2008 & Taylor, 2010). This deposition is termed ochronosis, as coined by 
Virchow on his microscopic observations (Virchow, 1866). Ochronosis is most 
noticeable in the sclera of the eyes and pinna where the pigmentation of cartilages can be 
seen through the skin, this occurs after the 30th year of life (Phornphutkul, 2002). The 
ochronosis occurs in many other tissues of the body, but in the majority it is not as clear 
as in the pinna or sclera. Other tissues which show ochronosis include the skin (O’Brien, 
1963), not only in the dermis but observations have been described in the sweat glands, 
both intracellularly and in the basement membrane (Friderich, 1951 & Lichenstein, 
1954). Occasionally the ochronosis can be the first point of elucidating the diagnosis of 
AKU in an individual, such as the ochronosis found in the tracheal and bronchial 
cartilages (Parambil, 2005). The majority of other tissues that demonstrate ochronosis are 
usually observed post-mortem or are found due to issues related to the deposition of
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pigment in those tissues which brings about the need for surgical intervention. Post­
mortem macroscopic and microscopic examination of tissues from individuals diagnosed 
with AKU has demonstrated an extremely wide presentation of ochronosis affected 
tissues. Tendon pigmentation is widely reported with the Achilles and quadriceps often 
being ochronotic and this pigmentation is assumed to be the reason for spontaneous 
failure (Manoj Kumar, 2003 & Chua, 2006). There has also been discussion of 
pigmentation in other less frequently affected tendons, such as that of the flexor 
digitorum profundus muscle. Post-mortem pigmentation has been observed in other 
tendons, including that of the sternocleidomastoid (Helliwell, 2008). It has also been 
described that there is a distinct lack of involvement of tendons which possess a synovial 
sheath, except one; the tendon of long head of m biceps brachii (Filippou, 2008).
The cardiac system is often seen to be affected by ochronosis. There are numerous 
reports of valve involvement due to the deposition of ochronotic pigment resulting in the 
need for replacement in alkaptonuria sufferers (Phornphutkul, 2002, Fisher, 2004,) 
Cardiac issues due to the presence of ochronotic pigment in the heart valves can 
sometimes be the initial presentation of alkaptonuria (Ffolkes, 2007). The involvement of 
the heart valves is well described, but there is also deposition associated with the aorta 
and main arteries (Helliwell, 2008), the coronary arteries do not appear to be involved 
before the age of 40, or at least involved to the extent where changes can be detected, 
although by the age of 59, 50% of patients examined showed coronary artery 
involvement in the form of calcification detected by CT scan (Phorphutkul, 2002).
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There are descriptions of ochronosis in the dura mater (Gladston, 1952, Liu, 2001, 
Helliwell, 2008). Whilst HGD expression and HGA metabolism occur in the liver, there 
is no literature to demonstrate that these tissues, along with those of the lymphoreticular, 
pancreas, gastrointestinal or endocrine structures show macro or microscopic ochronosis 
(Helliwell, 2008). There is literature detailing the pigmentation in the islets of 
Langerhans (Helliwell, 2008 & Lichtenstein, 1954), although the significance of this is 
difficult to interpret as the distribution within the cells and tissue is not described.
There have been reports of numerous presentations of ochronosis in different tissues 
presenting as the initial symptom of AKU, however it is most common that the first 
presentation is detected radiographically or clinically as OA~related pain in the joints. 
Ochronosis in the joints occurs over a prolonged period whereby there is gradual 
deterioration in joint function. This is termed ochronotic arthropathy. The earliest and 
most common presentation is often related to the spine, particularly the lower back and is 
often confused with ankylosing spondylitis. In a study of 163 cases of AKU, the spine 
was involved in 159, knee in 62, shoulder in 37 and hip in 33 (O’Brien, 1963, Lagier, 
1980). The difference between the ochronotic arthropathy in the spine and ankylosing 
spondylitis is that the sacro-iliac joints usually remain unaffected in ochronotic 
arthropathy (Perry, 2006), although the presence of ankylosing spondylitis and AKU in 
the same patient has been described (Balaban, 2006). Spinal changes in AKU also differ 
from those of the spine in OA; spinal involvement in AKU seems to preferentially affect 
the thoracolumbar region rather than lumbosacral (Phornphutkul, 2002, Ben Rayana, 
2008). Such is the severity of spinal involvement in AKU, a third of 45 patients examined
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showed a loss in height (Phornphutkul, 2002). The involvement of the spine sees 
narrowing and pigmentation of the intervertebral discs along with calcification; 
osteophytes are usually small or absent. Following spinal involvement in AKU, it is 
usually proximal joints which are the next to be affected, with hips and shoulders being 
described as the next joints to present with ochronotic arthropathy (Perry, 2006). 
Ochronotic arthropathy of the hips presents clinically and radiographically as OA with 
joint space narrowing and subchondral sclerosis often observed (Araki, 2009). The only 
current approach for treating the joint arthropathies is pain management and surgical 
intervention. It is well documented that surgical intervention brings about the diagnosis 
of AKU (Rose, 1957 & Perry 2006), if all other symptoms and features have been missed 
or overlooked. Ochronotic femoral heads have been studied extensively following 
surgical replacement and reveal a wide phenotypic presentation, but what is consistent is 
the presence of ochronotic pigment associated with the cartilage matrix (Melis, 1994, Di 
Franco, 2000, Shimizu, 2007, Kefeli, 2008). Even with all the complications and 
associations of pigment with tissues there is no evidence to correlate a shortened life span 
of patients with AKU (Srsen, 1985). There are numerous reports of misdiagnosis of 
rheumatological conditions which are masquerading as AKU following administration of 
monocycline and tetracycline. This evidence suggests that the most reliable confirmation 
of AKU is urinary excretion of gram quantities of HGA (Vilboux, 2009).
1.5.4 Therapeutic strategies
The treatment of AKU, its clinical features and understanding of the pathogenesis are still 
not completely understood. The majority of therapies have been aimed at preventing
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ochronosis of tissues, brought about by the oxidation of HGA to its intermediate and 
ultimately its pigmented polymer which binds to the connective tissue components.
1.5.4.1 Ascorbic Acid
It has been suggested that treatment of AKU patients with ascorbic acid (ASC) maybe 
one such approach (Sealock, 1940). It had been previously demonstrated that lOmM ASC 
inhibited HGA polyphenol oxidase, an enzyme suggested as specific to the 
polymerisation of HGA (Zannoni 1969). It would be difficult to achieve this 
concentration in vivo. The more significant issue with using ascorbic acid would be the 
danger that it could contribute to the formation of kidney oxalate stones in AKU sufferers 
(Phornphutkul, 2003). The usefulness of ascorbic acid has been shown in rats to decrease 
the binding of homogentisic acid in connective tissues (Lustberg, 1970). It is more 
notable that ASC may have a far more detrimental effect on HGA than any potential 
benefit that is yet to be elucidated. Experiments have shown the ascorbic acid is stable at 
physiological pH and in certain concentrations, however on addition of HGA solution the 
auto-oxidation rate greatly increases along with the rate of oxygen consumption (Martin, 
1987). ASC is a co-factor to 4-hydroxyphenylpyruvate dioxygenase, which may result in 
the vitamin increasing production of HGA in alkaptonuric patients. Experiments have 
demonstrated that there is also no beneficial effect of utilising ascorbic acid as it does not 
lower urinary or plasma HGA levels in adults or 15 month old infants. It also indicated 
that in the cases of young infants it can have a profound increase on urinary levels of 
HGA (Wolff 1989). In 1988, Forslind drew the conclusion that ascorbic acid is not an
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effective therapy for treating symptomatic ochronosis (Forslind, 1988). It may be that a 
more beneficial strategy would be to block the formation of HGA itself. It has recently 
been shown in vitro that administration of ASC in combination with N-Acetylcysteine 
(NAC) to human articular chondrocytes challenged with HGA; decreased apoptosis, 
increased chondrocyte growth and partially restored proteoglycan release all of which 
were detrimentally affected by HGA. The results showed a notable increase in efficacy 
when the antioxidants were used in combination rather than in isolation, the use of NAC 
in combination with ASC is theorised to counteract the increase in HGA production by 
use of ASC alone (Tinti, 2010). It is also now being investigated that there are other anti­
oxidants maybe viable therapeutic agents for AKU (Braconi, 2010). Experimental 
evidence has shown that the minocycline induced pigmentation can be seen in thyroid 
glands of rats. This pigmentation is absent when rats are fed ascorbic acid in tandem with 
minocycline (Bowles, 1998).
1.5.4.2 Nitisinone (NTBC)
One of the main issues with treating AKU is that the HGA and its intermediates seem to 
affect tissues, such as deep in the articular cartilage, where the presence of any gene 
therapy would be unable to have any action. One of the most promising recent 
developments has come in the form of an early triketone which was originally developed 
as a herbicide (Schulz, 1993). This substance is NTBC, or 2-(2-nitro~4- 
trifluoromethylbenzoyl)-l,3-cyclohexanedione, which is already administered orally to 
sufferers of tyrosinaemia type I (Lindstedt, 1992). NTBC is one of a family of triketone 
herbicides, all of which function to inhibit 4-hydroxyphenyIpyruvate dioxygenase
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(HPPD). This enzyme is responsible for the conversion of hydroxyphenylpyruvate to 
HGA. In hereditary tyrosinaemia type I (HTT1), NTBC acts by inhibiting the production 
of HGA, resulting in a partial block to the formation of fumarylacetoacetate. Prevention 
of this product reduces the concentration of any oxidizing metabolites which result in 
often fatal features of the disorder in children; these include severe liver disease, 
hepatocellular carcinoma and kidney tubule dysfunction (Anikster, 1998). The safety and 
functional significance of NTBC in treating HTT1 was demonstrated in a murine model 
of the disease. FAH mutation is normally fatal in neonates with the phenotype. FAH is 
normally produced in the foetal mouse on day 16 of gestation. It was demonstrated that 
subcutaneous injection of NTBC into the mother on day 15 would correct this disorder in 
the pups, they would then be administered a daily oral dose of NTBC following birth 
(Grompe, 1995). Following the verification of safety and use of NTBC for HTT1 in mice 
and humans it was shown that NTBC could be used to treat a murine model of 
alkaptonuria, whereby mice that exhibited urine which darkened on contact with NaOH 
soaked filter paper were maintained on NTBC and their urinary HGA levels analysed 
alongside plasma NTBC levels. These results showed that NTBC caused a dose 
dependant reduction in the urine levels of HGA in these mice, providing initial proof for 
the treatment of AKU by NTBC (Suzuki, 1999). Initial trials of NTBC in humans 
demonstrated that there was at least a 69% reduction in urinary HGA in 2 patients with 
AKU when the drug was administered in low doses. In this study there was significant 
elevation of tyrosine plasma levels which produces the risk of corneal crystal formation, 
corneal epithelial damage, and photophobia (Phornphutkul, 2005). The deposition of 
corneal opacities has been described in individuals taking NTBC for HTT1, believed to
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be due to elevated plasma and serum tyrosine and possibly exacerbated by poor dietary 
compliance (Ahmad 2002). A larger scale study looking at 9 patients with AKU was 
undertaken to investigate the effect of NTBC and its effects on HGA excretions and 
plasma levels (Suwannarat, 2005). Both NTBC and ASC have been used in combination 
with low protein diets to reduce dietary intake of tyrosine and phenylalanine.
1,5.4.3 Low protein diet
There are a small number of reports documenting the use of restricted protein intake as a 
way to reduce the level of HGA in the body of alkaptonuric individuals and investigate 
the effect on pigmentation. The studies show mixed results; one such study shows that 
there is little effect of ASC on urinary excretion of HGA; furthermore there is a 
suggestion that it increases the amount of the speculated causative intermediate, BQA 
(Mayatepek, 1998).
Another study describes protein restriction as lowering urinary HGA excretion levels in 
patients under the age of 12; however this effect is lost beyond this age group. 
Furthermore there are often issues with compliance to a restricted protein diet, 
particularly as age progresses (de Haas, 1999). Questions must also be raised about the 
effect of physical and mental progression in children who have their diet restricted of 
protein during their key developmental stage. Another issue with restricting dietary 
protein is that the majority of HGA is generated from protein breakdown within the body.
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1.5.4.4 Enzyme replacement therapy
Since it is a single enzyme that is deficient in AKU, the ideal treatment would be the 
immediate replacement of HGD in the metabolic pathway to give normal tyrosine 
catabolism. In theory this technique should be feasible, but due to the intracellular 
function of the tyrosine metabolic enzymes there are more lethal complications that could 
arise. Whilst the lack of the HGD gene results in deposition of ochronotic pigment, this 
phenomenon is not fatal. Following the degradation of HGA in the liver and kidneys, the 
production of MAA and subsequent reversible conversion to FAA results in the 
spontaneous formation of succinylacetone; this is toxic and highly mutagenic. For this 
reason any enzyme replacement would have to ensure that the functional HGD is 
delivered to the cellular location of tyrosine metabolism to prevent the buildup of 
succinylacetone occurring around the body and in the bloodstream.
1.6 HOMQGENTISATE 1.2-DIOXYGENASE PRODUCTION. FUNCTION AND
MUTATIONS
AKU results from the mutation in the gene encoding for the enzyme HGD. The normal 
human HGD gene is 54,363bp long and codes a 1715 nucleotide sequence that is divided 
into 14 exons, which vary in lengths of between 35 and 360 bp (Granadino 1997). The 
445 amino acid protein forms a dimer of two trimers which constitutes a functional 
hexamer (Vilboux, 2009). The crystalline protein structure has been resolved. It consists 
of a 280 residue N-terminal domain with a central (3-sandwich structure flanked by a (3- 
sheet that interacts with the 140 residue C-terminal domain of neighboring subunits. The 
active site binds iron in a domain defined by 3 side chains; His335, Glu341, and His371.
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(Vilboux, 2009 & Titus, 2000). The HGD protein is responsible for catalysing the 
breakdown of HGA to MAA. HGA is the last metabolite in Tyrosine metabolism to 
retain the benzene ring, HGD metabolises HGA to form MAA by cleavage of the 
benzene ring between Cl and C2 giving the linear compound (Knox, 1955). The presence 
of HGA in normal individuals is limited to the kidney and liver due to the production of 
the tyrosine metabolic enzymes in these tissues. It is believed that the majority of the 
HGD production and function occurs in the liver and kidneys. Work in rats has shown 
that that the highest functional activity of HGD is in the liver, followed by the kidneys 
and then essentially inactive amounts of enzyme activity are seen in spleen, heart, 
skeletal muscle or small intestine (Crandall, 1954). This is consistent with work of others 
to show that this liver and kidneys demonstrate the majority of HGD functional activity. 
The demonstration of essentially inactive amounts of HGD in other tissues is both in 
confirmation with and contrary to the findings of others who had shown that HGD was 
functionally expressed in non-renal and hepatic tissues (Crandall 1954 & Bernheim 
1944). This work also demonstrated that the tyrosine metabolic pathway proceeds 
intracellularly (Crandall 1954). More recently, HGD expression has been detected in 
small intestine, colon and prostate of humans, alongside the liver and kidneys 
(Fernandez-Canon, 1996). To date at least 91 mutations have been identified covering a 
number of mutation types: 62 missense, 13 splice site, 10 frameshift, 5 nonsense, and 1 
no-stop mutation. It is also suggested that the majority of HGD variants occur in exons 3, 
6, 8 & 13 (Vilboux, 2009). Interestingly attempts have been made to correlate genotype 
and phenotype in AKU, however given that the human liver can produce enough HGD to 
metabolise 1.5kg of HGA/day any mutation must result in at least 99% reduction in
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functional enzyme production in order to present the AKU phenotype (Scriver, 2001 
Vilboux, 2009). To date there is no correlation with type of HGD mutation, the amount of 
HGA in the urine, HGA plasma level or severity of the disease. (Introne, 2003). The 
build up of HGA does not normally happen in normal individuals as once formed it is 
cleaved to MAA and further metabolised to FAA and then fumarate and acetoacetate. In 
alkaptonuric individuals it has been demonstrated that the HGD is the only missing 
enzyme in the metabolic tissues, all subsequent enzymes are present and functional (La 
Du, 1958).
1.7 HOMOGENTISIC ACID
HGA is a small highly water soluble molecule of molecular weight 168.15 and a linear 
formula of (HO^CsHiC^CCLH. The crystals are off-white to tan in colour. It is also 
known as 2,5 dihydroxyphenylacetic acid.
Figure 1.4:- Chemical structure of homogentisic acid.
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It undergoes chemical changes on addition of NaOH or when left to stand in the presence 
of molecular oxygen to form its quinone intermediate; benzoquinone. This intermediate is 
highly unstable and believed to undergo polymerisation to form the pigmented polymer 
observed in patient tissues. It is theorised that this process has many similarities to the 
formation of melanin from tyrosine.
Metabolic Pathway of Ochronotic Pigment Production
DIETARY PROTEIN
ACETOACETIC ACID + FUMARIC ACID
TYROSINE Homogentisic acid oxidase (HGA) deficiency 
BLOCK IN ALKAPTONURIA
POLYMER
(Ochronotic
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BENZOQUINONE 
ACETIC ACID
HOMOGENTISIC ACID HGA
POLYPHENOL
OXIDASE
(CU++)
POLYPHENOL
OXIDASE
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■ PHYSICAL
■ BONDING CHEMICAL
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CONNECTIVE TISSUE MACROMOLECULES
Figure 1.5:- Diagram showing the theorised metabolic pathway of ochronotic pigment
production. (Adapted from Stanbury, 1978).
1.8 AKU IN OTHER ORGANISMS
AKU has been described in other organisms. It has been shown in other primates such as 
the crab-eating macaque which displayed the typical darkened urine associated with the 
disorder but failed to show any signs of ochronosis or joint involvement in this Syr old 
animal (Johnson, 1993). Prior to the discovery of this macaque there have been two 
descriptions of AKU occurring in other primates, much closer to the homo sapien
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lineage. These occurred in the chimpanzee (Watkins, 1970) and the orangutan (Keeling, 
1973). Diagnosis was based in the discolouration of urine but no ochronosis or joint 
involvement was detailed. EGA in urine has also been observed in Dalmatians (Lonsdale, 
1994). There are also early reports of the appearance of ochronosis in cattle, horses and 
dogs and a rabbit which displayed darkened urine (Lewis, 1926, O’Brien, 1963).
1.9 AKU ANIMAL MODELS
Many human disorders benefit from animal models to help progress their understandings 
and to trial therapeutic strategies. It was noted that there was limited research into the 
attempts to induce ochronosis and ochronotic arthropathy as way to study AKU in 
animals (O’Brien, 1963). The earliest attempts at an animal model of AKU were 
undertaken by intraperitoneal or intravenous injection of EGA into rabbits. The 
investigators also injected EGA into the joints of rabbits (Ig, 0.25g, 0.125g, 0.06g/lml of 
saline). Animals which received multiple injections exhibited darkening of urine along 
with ochronosis of joint tissues and surrounding fat, tendon and muscles in a non-specific 
nature. Intraperitoneal and intravenous injections of EGA did not produce ochronosis. 
This study demonstrated the damaging effects of EGA; consistent results were obtained 
when buffered or unbuffered EGA solution was injected into tissues (Moran, 1962). One 
interesting note of the study is the observation of tubular casts in the kidney resulting 
from the excretion of EGA initially injected into the joints or peritoneum suggesting that 
there may be localised damage due to the EGA. The investigators also looked at the 
reaction of injecting ochronotic pigment from a necroscopied case of AKU into the knee 
joints of rabbits. Thickening and swelling of the synovium was noted with the presence
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of macrophages and giant cells around pigment. The significance of this is diluted by the 
fact that a standard immunological response would be expected from the injection of 
human material into a rabbit. The authors also suggested an adaptation of their method 
whereby overloading of the animal with HGA by exposing to a high tyrosine and low 
ascorbic acid diet (Moran, 1962). The first model study was made in rats whereby 
feeding them for a minimum period of 9 months from the age of 1 month on a diet of 8% 
L-tyrosine appeared to induce ochronosis and arthropathy. The induction of AKU was 
confirmed by presence of HGA in the urine (Blivaiss, 1966). A murine model of AKU 
was produced in 1993 by mutagenesis. These mice arose by intraperitoneal injection of 
ehthlynitrosourea (250mg/kg) of eight week old mice from an inbred stock carrying 
seven recessive mutations. Following recovery, these animals were then mated to 129/Sv- 
T/+ mice. Independent micro-pedigrees were achieved by systematic sibling mating for 
more than 10 generations. The AKU mutation was then backcrossed onto both the 
BALB/cByJ (albino) and the C57/BL/6J (pigmented) backgrounds. These animals were 
previously thought not to exhibit ochronosis, despite the mutant phenotype exhibiting 
darkened urine and high levels of urinary and plasma HGA, both of which were absent 
from wild type and heterozygotes. (Montagutelli, 1994). The mice have a truncated 
protein form of the HGD enzyme resulting from a splice mutation (Manning, 1999). 
Macroscopic and microscopic analysis of these animals revealed an absence of 
ochronosis of tissues (Montagutelli, 1994). It is well known that mice endogenously 
produce the anti-oxidant ascorbic acid and this maybe a protective mechanism in the 
mouse (Levine, 1986). As part of the investigation into the murine model, the detection 
of the mutation in the mouse genome was found to be in an area that was highly
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homologous with the human 3q (Montagutelli, 1994). The mode of transmission of the 
murine disorder was demonstrated to be autosomal recessive consistent with the human 
transmission of the disorder. This demonstrated that heterozygote’s, even with 50% of 
wild type production of HGD can sufficiently clear EGA from their systems (La Du 
1989, Montagutelli, 1994). The mapping of the human alkaptonuria gene was based on 
the inter species conservation of genetic linkage groups (Janocha, 1994).
1.10 FUNGAL MODEL
AKU is a metabolic disorder in the same metabolic pathway as the more serious a HTT1. 
In murine HTT1 there is neonatal lethality which makes it a difficult model for studying 
the disorder. Aspergillus nidulans shows an interesting versatility in its metabolic ability, 
it proceeds through two different phenyl compounds for carbon sources that are both 
metabolised to 2,5-dihydroxyphenylacetic acid, or EGA, and then metabolised further to 
maleylacetoacetate and fumarylacetoacetate. The species demonstrates a highly 
conserved amino acid sequence when compared to the human sequence. Loss of the 
FahA results in phenylalanine toxicity and secretion of succinylacetone consistent with 
human ETT1. Furthermore loss of the EGD prevents phenylalanine toxicity and results 
in an alkaptonuric type phenotype; in this culture system induction of the 
phenylalanine/phenylacetate catabolism results in production of EGA which accumulates 
in the media and undergoes oxidation and polymerisation to become dark brown 
(Fernandez-Canon, 1995).
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1.X1 SUMMARY
Alkaptonuria is identified by clinicians as the first disorder to be demonstrated as an 
inborn error of metabolism. HGA is the molecule responsible for deposition as a 
pigmented polymer in joint tissues of sufferers of AKU. The accumulation of this 
molecule is the result of a single enzyme deficiency; HGD, the gene for this enzyme and 
its chromosomal location are known. Whilst these represent large advances in knowledge 
of the disease; the understanding of the pathogenic mechanisms that see HGA converted 
to its pigmented polymer, or other intrinsic and extrinsic factors that may be influential in 
determining the tissues and regions that are affected by the pigment are not fully 
understood. These unknowns represent a large gap in the knowledge of the disease and 
gaining insights into these areas would open up more therapeutic opportunities for 
treatment of this rare and debilitating condition. There are also numerous individual case 
reports in the literature many are descriptive of end-stage ochronosis and arthropathy, 
whilst informative, these describe a stage that is possibly beyond the opportunity for 
treatment. There is evidence to suggest that in these patients that HGA alone is not the 
sole or limiting factor determining pigmentation. Alongside this, due to the rarity of the 
disorder there is little in the way of models and longitudinal data to enable study of the 
disease, which may have limited the advancement into understanding of the disorder. The 
formation of the findAKUre project has allowed access to the numerous AKU specimens 
which will enable the comparison of patient tissues and investigation of unknown factors 
that may elucidate currently unknown mechanisms in the disorder, which will be a large 
advancement in understanding of the pathogenesis of the disease.
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1,12 AIMS OF THE STUDY
Alkaptonuria is a rare autosomal recessive disease with no known cure or treatment. The 
causative molecule, HGA, and missing enzyme has been identified and cloned (HGD). 
Despite this little is known about how or why specific tissues and components of tissues 
are preferred for the deposition of the pigmented polymer. Furthermore there is little 
evidence describing the variation of pigment presentation from one patient to another, 
and within a patient. Therefore the aims of this study were to compare and contrast 
presentations of pigmentation in AKU patient tissue samples and to increase the 
understanding of the biochemical and molecular pathogenesis of the disease in order to 
open up more therapeutic strategies for the treatment of the disease.
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2. Materials and Methods
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2.1 ETHICAL APPROVAL
All human tissue samples used in this project were obtained under ethical approval from 
Liverpool REC (07/Q1505/29). Patients involved signed a fully informed consent form and 
the data was anonymised to protect the patients confidentiality. All joint tissues were 
obtained at time of surgery and dissected as required before either being passed into PBS or 
DMEM for transport back to the laboratory, or fixed in PBFS. Once back in the laboratory, 
unfixed tissues were further dissected and plated out as described in this chapter.
2.2 CELL CULTURE
2.2.1 Reagents
Dulbeco’s modified eagles medium (DMEM) and DMEM with Ham’s F12 1:1 was 
purchased from Gibco and supplemented with 10% foetal calf serum (FCS), purchased from 
Biosera, 1% penicillin/streptomycin (P/S), 1 % L-glutamine purchased from Sigma. 
Trypsin/EDTA (ready to use), hyaluronidase, collagenase, homogentisic acid, L-ascorbic acid 
2-phosphate and dexamethasone were purchased from Sigma. PBS was made up in 
laboratory (PBS: 0.286 M sodium chloride, 5.55 mM potassium chloride, 16.4 mM disodium 
hydrogen phosphate, 2.94 mM potassium dihydrogen orthophosphate distilled water, pH 7.4 
and then autoclaved).
2.2.2 Plasticware
No. 10 Swann Morten disposable scalpels were purchased from Sarstedt. Plasticware was 
purchased from Sarstedt and BD Falcon.
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2.2,3 Culture of human osteosarcoma and chondrosarcoma cells
Human osteosarcoma cells SaOS-2, MG63 & Te-85 were taken from laboratory stocks. C20- 
A4 chondrosarcoma cells were a kind gift from Dr Mary Goldring (Hospital for Special 
Surgery, NY, USA). Cells were maintained in 9 cm petri dishes and passaged every 3 days. 
Cells were cultured to confluence, media removed, washed twice with sterile PBS. 3-5ml of 
trypsin EDTA was then added to cells and incubated for 5-7mins at 37°C. Trypsin action was 
halted by addition of 12mls of fresh DMEM containing 10% PCS. This solution was 
distributed across 3 9cm petri dishes and then had 5mls of fresh DMEM added to each dish 
prior to being replaced in the incubator. Cells were cultured in a humidified incubator at 37°C 
in an atmosphere of 95% air and 5% CO2.
2.2.4 Preparation of HGA stock solution
HGA stock solution was prepared by dissolving 0.102 g of HGA crystals into 6.07 ml of PBS 
to give a IxlO"1 M stock solution. Solution was then aliquoted out and stored at “80°C for 
future use.
2.2.5 Preparation of HGA supplemented cultures
Cells were passaged as described previously and then plated out into 6, 12 or 24 well plates 
depending on the experiment being undertaken. Following passaging one of the dishes of cell 
suspension was pipetted into a 25ml universal and had 20mls of fresh DMEM added to it. 
The cell suspension was then vortexed and distributed evenly across the well plates. 
Following one day to allow cells to become attached to the plasticware HGA medium was
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added at one of the following concentrations; 3.3x1 O'4 M, 3.3x1 O'5 M or 3.3x1 O'6 M. The 
3.3x10 M solution was made by taking 9ml of fresh DMEM and placing into a labelled 
universal, 29.7pl of HGA stock solution was then added to this universal. A serial dilution 
was then made into another universal containing 9ml of fresh DMEM which then had 1ml 
added to it from the universal containing the 3.3x10 4M solution. This gave a concentration of 
3.3xlO'5M. The final concentration was the made by adding 1ml of the 3.3xl0'5M solution to 
another universal containing 9ml of fresh DMEM. Volumes and dilutions were adjusted 
accordingly depending on which size petri dishes or well plates were being used. Medium on 
these cultures was changed every 3 days and the supernatants were stored in labelled 
eppendorfs at -80°C.
2.2.6 Preparation of ASC stock solution
L-Ascorbic acid 2-phosphate was prepared by adding 289mg to 10ml of PBS. The solution 
was aliquoted out and stored at -80°C.
2.2.7 Addition of ASC to culture plates
ASC was added to designated cultures at a concentration of 1 pl/ml of DMEM.
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2.2.8 Preparation of Dexamethosone stock solution
Dexamethosone was prepared by adding 39,3mg to 1ml of 100% ethanol to give a IxlO^M 
solution. This was then made upto 100ml in 100% ethanol and serially diluted to give a final 
concentration of lxl0'5M solution which was stored at -80°C.
2.2.9 Addition of Dexamethasone to culture
Dexamethasone stock was added to designated cultures at a concentration of 1 Op 1/ml of 
DMEM.
2.3 HISTOLOGY
2.3.1 Reagents
Haematoxylin, eosin, potassium ferricyanide, ferric chloride, nuclear fast red and DPX 
microscopy mountant were all purchased from VWR, EDTA, chrome potassium sulphate and 
bovine gelatine were purchased from Sigma. Glass slides and coverslips were purchased from 
BDH.
2.3.2 Fixation
All tissues were fixed in 10% PBFS containing phenol red indicator solution. Following 
fixation tissues were placed into 70% ethanol in preparation for histological processing.
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2.3,3 Decalcification of mineralised tissues
Following fixation mineralised tissues were dissected to the required size and thickness 
(<lcm) and deposited into 10% formalin/12% EDTA solution for decalcifying and left until 
the mineralised tissue was soft enough to bend. Tissues were then passed through three 
changes of distilled water for a minimum time of 12 hours.
2.3.4 Processing of samples for embedding
Pieces of tissue were removed from fixative, placed through changes of increasing grades of 
alcohols up to 100% ethanol before being subject to 2 changes of xylene followed by 2 
changes of wax. Tissues were removed from molten wax and placed into warmed metallic 
boats before being submerged in molten wax and then had a microtome chuck placed on top 
of them. Blocks of tissue were then left to solidify before being removed from their metallic 
mould and trimmed to give a rhomboidal cutting surface for sectioning on the microtome.
2.3.5 Subbing of glass slides
2.3.5.1 Subbing solution
1) 0.2% bovine gelatine (Img in 500ml)
2) 0.2% chromium potassium sulphate
2.3.5.2 Subbing procedure
1) Dissolve gelatine in warm distilled water (do not heat over 50°C)
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2) Add chrome sulphate, use the same day
3) Treat clean slides with 100% ethanol for at least 2mins.
4) Drain for 5mins.
5) Stand in subbing solution for at least Imin.
6) Drain excess. Cover slides to keep out of dust and dry overnight at room temp.
2.3.6 Sectioning of tissues
5pm sections were cut using a microtome. Ribbons of sections were floated out onto 45°C 
water in a water bath before being mounted on subbed glass slides and left in the incubator at 
50°C overnight.
2,3.7 Histological staining of slides
In preparation for staining slides, were deparaffinised placing the slides in the following 
solutions for the following length of time:
1) Xylene for 5mins
2) Xylene for 5mins
3) 100% ethanol for 5mins
4) 100% ethanol for 5mins
5) 90% ethanol for 5mins
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6) 70% ethanol for 5mins
7) dHiO for 5mins
Stains were prepared as described by Bancroft, specifically as follows:- 
2.3.7.1 H&E
1) Sections to water
2) Stain in haematoxylin for 3-5 mins
3) Rinse in 1% HC1 solution for <5 seconds
4) Differentiate in running warm water for 3-5mins, or until slides are “blue”
5) Stain in eosin for 3-5 mins
6) Rinse in tap water for <30 seconds
7) Dehydrate through graded alcohols to xylene
8) Moimt with DPX
23.12 SchmorPs
1) 1% aqueous ferric chloride (or sulphate)
2) 1% aqueous potassium ferricyanide
3) Distilled H20
Add the following together:-
1) 37.5 ml of ferric chloride solution
2) 5 ml of potassimn ferricyanide solution
3) 7.5 ml of dE^O
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2.3.7.3 Method
1) Sections to water
2) Immerse for 5-10mins in SchmorFs reagent
3) Wash well in running H2O to remove any residual ferricyanide
4) Counter stain for 5mins using NFR
5) Dehydrate through graded alcohols and xylene
6) Mount with DPX
2.4 TRANSMISSION ELECTRON MICROSCOPY
2.4.1 Reagents
Gluteraldehyde was purchased from Sigma. Osmium tetroxide solution and Agar 100 resin 
were purchased from Agar Scientific. Reynold’s lead citrate was produced by combining lead 
nitrate (Agar Scientific) and sodium citrate (Sigma) (see below).
2.4.1.1 Preparation of lead citrate solution
1) Boil fresh 18.2 mega Ohm dE^O for 10 minutes to remove any CO2. Cover with Petri dish 
and cool for 30 minutes before use.
2) Make 10 ml of 1M NaOH using the freshly prepared water.
3) Add 30 ml of freshly prepared water to the 1.33g lead nitrate and 1.76g sodium citrate; 
shake/sonicate for 60 minutes to allow conversion of lead nitrate to citrate.
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4) Add 8 ml of 1M NaOH; solution should clear, make up to 50 ml with freshly prepared 
water,
5) Store in foil-lined plastic container at 4°C. The stain is stable for up to 6 months; discard if 
it becomes cloudy.
6) Before use, microfuge aliquot at 5,000 rpm for 5 minutes. (1677g)
2.4.2 Preparation of specimens for transmission electron microscopy
Tissues were obtained from surgery and washed in PBS. Tissues were micro-dissected to give 
pieces less than 1mm3. Tissues were then fixed by immersion in 4% paraformaldehyde with 
2.5% gluteraldehyde in 0.1M sodium cacodylate (pH 7.4) overnight. Samples were then 
washed in 0.1 M sodium cacodylate buffer wash pH 7.4 for 5mins. Samples were immersed in 
1 /o osmium tetioxide in distilled water for 1.5hr in a rotator. Samples were then stained with 
5% alcoholic uranyl acetate for 3 cycles of SOminutes. Samples were then dehydrated through 
graded alcohols and infiltrated with Agar 100 resin as listed below:
2.4.2.1 Dehydration at room temperature
1) 50% ethanol for 5mins
2) 50% ethanol for 5mins
3) 70% ethanol for 5mins
4) 70% ethanol for 5mins
5) 90% ethanol for 5mins
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6) 90% ethanol for 5mins
7) _100% ethanol (High purity) for lOmins
8) 100% ethanol (High purity) for lOmins
9) 100% ethanol (High purity) for lOmins
10) 100% acetone (high purity) for 5mins
11) 100% acetone (high purity) for 5mins
12) 100% acetone (high purity) for 5mins 
2.4.2.2 Resin infiltration
1) 30% resin /100% acetone for 1 hour
2) 70% resin /100% acetone for 1 hour
3) 100% resin for 1 hour’
4) 100% resin for 1 hour
Tissues were then placed into a resin mould, labelled and submerged in fresh resin. Resin 
moulds with tissues were then polymerised overnight in an oven at 60°C overnight.
2.4.3 Sectioning and post staining of tissues in resin blocks
70 run sections were cut using a Reichert Ultracut E microtome and post stained using uranyl 
acetate in 50% ethanol and lead citrate. TEM was performed using an FEI 120kV Tecnai G2 
Spirit BioTWIN, images were obtained using digital image capture using SIS Megaview III
camera.
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2.5 SCANNING ELECTRON MICROSCOPY
2.5.1 Reagents
Tergazyme was purchased from Alconox, Alconox inc, NY, USA. PMMA was purchased 
from Sigma. Hydrogen peroxide was purchased as stock concentrate from Aristar.
2.5.2 Sample processing
Samples were removed from 70% ethanol and cut into 4mm thick slices using an ethanol 
cooled diamond saw. Slices were then embedded in PMMA, the block surfaces trimmed and 
polished, and coated with carbon by evaporation. They were imaged using backscattered 
electrons (BSE) in a Zeiss DSM962 SEM with external computer control. Images were 
recorded at 20kV, 0.5nA probe current and 17mm working distance using halogenated 
dimethacrylate standards to calibrate the electron backscattering (Boyde, 1999). Bone slices 
were macerated for 18 days in 4% Tergazyme, bacterial pronase enzyme detergent, followed 
by 29 days in 5% hydrogen peroxide solution (i.e., 6 fold dilution of the Aristar stock 
concentrate) to remove all cells and normal hyaline cartilage matrix and leave all calcified 
matrices. After washing and drying, these slices were carbon coated from both sides and 
imaged using 3D BSE SEM.
2.5.3 Fluorescence Light Microscopy
Direct view stereoscopic fluorescence microscopy was conducted on unstained histology 
sections and SEM blocks using an Edge 3D microscope fitted with twin Canon digital 
cameras (Greenberg, 1997).
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2.6 MURINE EXPERIMENTS
2.6.1 Reagents
NTBC powder was a kind gift from Swedish Orphan. Sodium bicarbonate (NaHC03) was 
purchased from Sigma. Ultrapure H2O (18 MO filtered).
2.6.2 NTBC Stock solution preparation; (makes 250 mL sterile 2 mg/mL NTBC stock)
1) Dissolve 3g NaHCOs in 30 mL H2O and place at 5°C for ~2 hours, vortex until dissolved.
2) Add 500mg NTBC to NaHCOs solution and dissolve at 10°C for ~3 hrs whilst stirring.
3) As NTBC dissolves the solution will turn yellow.
4) When fully dissolved, add remaining 220 mL H20 to reach final volume.
5) Sterile filter in a laminar flow hood.
6) Wrap in foil and store in refrigerator.
2.6.3 NTBC working solution preparation
1) Autoclave 1 L H2O and refrigerate overnight.
2) Place autoclaved H2O and NTBC stock solution into a sterile laminar flow hood.
3) Add 8 mL of 2 mg/mL NTBC stock to 1L H20 and cap tightly before removing from
hood.
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2.6.4 Mouse care
C57/B16 FAH HGD +/-, mice were housed in the Grompe laboratory at Oregon Health & 
Science University (in accordance with the Institutional Animal Care & Use Committee) and 
maintained on NTBC (Nitisinone™) for periods of time up to two months following birth, 
NTBC was then withdrawn.
The time periods of withdrawal were as follows:-
- 11 months off NTBC
- 2 weeks off NTBC
- 2 days off NTBC
- 1 day off NTBC
Mice were sacrificed by exposure to CO2. Sacrificed animals were dissected as described 
below to ensure standard harvest procedures
2.6.5 C57/BI6 FAH HGD +/- dissection 
2.6.5.1, Skin
1) Remove ears by snipping skin starting at the top of the head in between each ear, and 
tracing around each ear and fix.
2) Cut the skin around the neck and peel off over the eyes and nose, cutting at nose if 
necessary.
3) Cut the skin down the back of the mouse to the base of the tail.
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4) Stretch the skin out to the sides of the mouse, and peel off the skin over each limb.
5) Detach skin entirely and fix.
2.6.5.2. Abdomen
1) Lift belly skin and cut up to sternum and down each side following the ribcage.
2) Remove the viscera (guts), cutting just above stomach to leave oesophagus intact, and fix.
2.6.5.3. Thorax
1) Cut ribs on each side up to forelimb armpits (clamshell) and across neck above sternum 
and fix.
2) Remove/tease apart white tissue on top of heart. Lift up heart and tease free from 
surrounding tissue by cutting from below. Cut heart completely free above aortic arch 
(leaving arch intact) and wash in PBS to remove excess blood before fixing.
2.6.5.4. Limbs
1) Pinch top of lower limb close to spine and cut leg free by cutting into pelvic bone, to 
protect the head of the femur. Fix leaving muscle attached.
2) Repeat with 2 lower limb, but remove muscle from detached leg. Sever bones above and 
below knee joint to allow fixative penetration and formalise.
2.6.5.5. Head and Trachea
1) Open jaw with scissors and cut through cheek muscle and bone to free lower jaw and 
tongue. Cut toward abdomen, pulling lower jaw down till tracheal passage visible. Cut upper
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head away and fix. Carefully lift and cut away neck muscle till trachea exposed for fixative 
penetration,
2) Sever spine just below remaining ribcage and fix thorax including attached upper limbs, 
trachea and lower jawbone/tongue.
3) Cut away muscle close to spine on lower body including attached tail, and fix.
Each body part was formalin fixed for 1 day before removing from solution and wrapping in 
formalin soaked gauze, and placing in ziplock bag. Each bag should contain all the body parts 
from one mouse and labelled with treatment, date of dissection and initialled. Samples were 
then shipped to Liverpool for anaylsis.
2,1 ssNMR
2.7,1 Reagents
4mm zirconia rotors and Bruka AVANCE-400 9.4 Tesla wide bore spectrometer were purchased from 
(Bruker, Karlsruhe, Germany).
2.7.2 Method
Ochronotic and nonochronotic cartilage samples were prepared for NMR by grinding under liquid 
nitrogen in a pestle and mortar to a consistency resembling that of a fine powder. The highly 
pigmented ochronotic cartilage was noticeably harder to grind. After brief drying under vacuum to 
remove surface moisture, samples were packed into 4 mm outer diameter zirconia rotors (Bruker, 
Karlsruhe, Germany) and 13C NMR spectra obtained using a Bruker AVANCE-400 9.4 Tesla wide 
bore spectrometer equipped with a standard dual channel broad band probe, at a magic angle spinning
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rate of 12.5 kHz and radio frequencies of 400.1 MHz (‘H) and 100.5 MHz (l3C), 13C signal intensity 
was enhanced using standard cross polarization (CP) MAS techniques ('H tt/2 pulse length 2.5 ps, ’H 
cross polarization field 70 kHz, cross-polarization contact time 2.5 ms, broadband TPPM15
decoupling during signal acquisition at a 'H field strength of 100 kHz, recycle time 2 s, typical 
number of scans accumulated per spectrum ca. 20,000). Chemical shifts were referenced to the 
methylene signal from solid glycine at 43.1 p.p.m. relative to tetramethylsilane at 0 p.p.m.
2.8 MECHANICAL TESTING
2.8.1 Mechanical testing protocol
Unfixed tissues were washed in sterile PBS immediately following surgery. Cubes of articular 
cartilage were dissected from the articular surface. Cartilage cubes were removed from the sample as 
close to the subchondral bone as possible and were then measured. Samples were stored overnight at 
4oC in pH 7.4 PBS. Wet samples were placed on a 9cm petri dish. Excess saline was removed from 
the surface and around the periphery of the tissue. Samples were mechanically tested by compression 
on a Nene M5 tensile tester using Nene software with a SOON load cell. Samples were loaded at a rate 
of 0.5mm/minute. Data was recorded as load-displacement. The stress strain curves were plotted for 
each sample and Young’s modulus calculated.
2.8.2 Statistical analysis
Statistical differences were determined by applying Kruskal Wallis with Dunn’s Multiple 
Comparison test using Graphpad Prism 5 software.
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2.9 PATIENT DEMOGRAPHICS AND SYMPTOMS
Sample Age Sex Joint Symptoms prior to removal Samole characteristics
AKU1 59 M Hip Chronic kidney disease, previous 
Achilles rupture and muscle rupture. 
Previous joints replaced, 1st age 55.
Full depth blanket pigmentation 
of articular cartilage.
AKU2 53 M Knee Previous surgeries, Diagnosed aged 16. Patchy surface pigmentation 
and extensive in deep zone.
AKU3* 59 M Hip Both knees previously replaced. Eye 
pigmentation. Prostate stones.
Patchy absence of cartilage 
from the articular surface and 
extensive full depth
pigmentation of remaining 
articular cartilage.
AKU4 46 M Knee Previous hamstring tear. No previous 
joint replacements. Ear pigmentation.
Faint pigmentation close to the 
subchondral junction, absence 
of pigmentation from the 
middle, superficial and articular 
layers.
AKU5 58 F Knee Previous spinal surgery related to AKU. 
Diagnosed age 54
Extensive pigmentation of 
femoral condyles, particularly 
in the central regions of both 
condyles, with full depth 
pigmentation in these areas. 
Peripheral to these regions; 
pigmentation at subchondral 
boundary and into middle zone, 
but absent from superficial and 
articular surface.
AKU6 69 F Knee 3 previous joint replacements, L Knee, 
L shoulder & L hip.
Dense pigmentation of
condyles, particularly medial 
condyle, which had dark 
fissures in the surface. Cartilage 
had full depth pigmentation. 
Lateral condyle showed patchy 
pigmentation, located at the 
subchondral boundary and into 
middle zone.
AKU7 60 F Hip Previous fracture, 2 arthroscopies, 
previous hamstring and tendon tears. 
Cervical, lumbar & sacroiliac joint 
disease. Joint pain in both knees, 
shoulders, hands and feet, L hip & R 
ankle. Eye & ear pigmentation. No 
previous joints replaced.
Loss of articular cartilage with 
a thin rim remaining around the 
equator, this showed full depth 
ochronotic pigmentation.
AKU8 53 M Knee Previous arthroscopy, renal stones,
previous fracture, pain in both knees. 
Lumbar and sacroiliac joint disease. Ear 
pigmentation. No previous joints 
replaced.
Dense central pigmentation of 
condyles, which was less at the 
peripheral surfaces. Pigment 
was present in full cartilage 
depth at contact surfaces. At the 
peripheral surfaces pigment 
was seen at the subchondral 
boundary and deep zone.
AKU9* 61 M Hip Both knees and hip previously replaced. 
Eye pigmentation. Prostate stones.
Extensive loss of articular 
cartilage, a small thin amount 
was left on the periphery of the 
head, all that remained was 
heavily pigmented. [
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0A1 51 F Knee Previous partial medial menisectomy. 
X-Ray showed mild osteoarthrosis in 
the medial tibio-femoral compartment 
and in the superior aspect of the patello- 
femoral compartment. Joint effusion 
noted. No intra-articular bodies. Normal 
patello-femoral alignment. MRI
demonstrated degenerate meniscal 
remnant. Subchondral oedema and 
marginal osteophyte formation.
OA2 74 M Knee End stage medial tibio femoral arthrosis 
noted on the left with varus deformity 
and severe lateral PTFJ OA with lateral 
patella migration noted. Old healed 
proximal fibular diaphyseal fracture 
noted on this side.
OA3 62 M Knee Bilateral end stage medial tibiofemoral 
OA was noted with severe lateral 
tibiofemoral and patellofemoral
arthrosis. There was a large amount of 
marginal eccentric bone formation on 
the trochlear and patellae bilaterally 
with a 28mm calcified chondral body 
noted within a right popliteal cyst. 
Bilateral genu varus was present.
Table 2.1: ^4 table demonstrating the demographics and symptoms of patients involved in this study. 
^Denotes same patient
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3. Macroscopic presentation of AKU joint samples.
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3,1 INTRODUCTION
The first objective of this Thesis is to document the presentation of ochronosis in joint 
replacement samples from AKU patients. Joint replacement for ochronotic osteoarthropathy 
in alkaptonuria is common and is the most effective treatment at alleviating joint pain in 
patients with this condition. There are numerous case reports detailing the end stages of the 
disease, all with varying severity and presentation. The clinical presentations are often similar' 
across patients; with darkening of the urine easily identifiable if AKU has already been made. 
The presentation of joint pain in many cases is generally earlier than would be expected of 
someone who had joint degeneration associated with osteoarthritis, although the radiographic 
and clinical symptoms are similar' (Balint 2000 & Lagier 2006). The presentation of 
individual cases is often accompanied by a review of literature on the disorder. Most reports 
are generally descriptive of the patients’ presentation and condition of the surgical specimen 
and any interesting abnormalities that arise that may in part be attributed to the underlying 
ochronosis, hi surgical specimens it is common for large areas of cartilage to be pigmented, 
and in places missing from the surface of the bone. There is usually little description of 
involvement of bone pigmentation, although pigmentation of cells has been seen. Even in 
cases where multiple joints have been replaced, there is little comparison between these joints 
to distinguish common regions of pigmentation in these patients. (Demir 2003 & Carrier 
1990). Determining regions of pigmentation that are common across surgical samples may be 
indicative of regions predisposed to early onset, or the most rapidly progressive pigmentation.
This study was aimed at detailing and describing the macroscopic presentation of ochronosis 
in specimens obtained from patients with AKU undergoing joint replacement surgery due to 
ochronotic osteoarthropathy. Where feasible, samples, were photographed during surgery, 
then on return to the laboratory environment in order to obtain an overview of distribution of
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pigmentation, across a sample, across the AKU population in this study and from within the 
same patient where possible.
3.2 RESULTS
Sample Age Sex Tissue
AKU3 59 M Hip
AKU5 57 F Spine
AKU6 59 M Hip
AKU8 42 M Arthroscopy
AKU9 46 M Knee
AKU 10 58 F Knee
AKU11 69 F Arthroscopy
AKU 12 69 F Knee
AKU 13 59 F Hip
AKU 14 65 M Hip revision
AKU 15 53 M Knee
AKU 16 61 M Hip
AKU 18 70 F Knee
AKU 19 59 F Knee
AKU21 51 F Knee
Table 3.1:- Demographics of patient with AKU from whom samples collected as part of this
project
Average, age of hip replacement (yrs) 
Average, age of knee replacement (yrs) 
Average, age of male hip replacement (yrs)
57
61.6
56 
59.6
Average, age of female hip replacement (yrs) 64.5
Average, age of male knee replacement (yrs) 49.5
Average, age of female knee replacement (yrs) 59.25
Table 3.2:- Average age of patient joint replacements from the patient samples obtained in 
this project.
3.2.1 Ochronosis in hips
In order to understand the presentation of ochronosis in the hip joint, 5 surgically resected 
femoral heads and their accompanying tissues were examined. Samples were photographed 
and documented from a pathological point of view.
AKU3
A 59 year old male with known alkaptonuria attended surgery for a left THR. The femoral 
head displayed normal spherical shape over the majority of the head, but displayed abnormal 
thickening and shape at the neck of femur, where this region was as wide as the equatorial 
regions of the head of femur. The whole articular cartilage surface was ochronotic. There was 
a large osteophyte located on the neck of the femur and this in parts displayed ochronotic 
darkening consistent with that seen in the articular cartilage. Areas overlying the greater 
trochanter and parts of the joint capsule displayed dense ochronosis (Fig.3.1).
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Figure 3.1:- Photograph showing the macroscopic appearance of AKU3 femoral head at the 
time of surgery. The black colouration is ochronotic pigment which is located uniformly 
across the cartilage on the femoral head and sporadically on the soft tissues (*).
Following surgical removal the femoral head was sawn into an anterior and posterior half 
though the fovea. Consistent with the macroscopic observation of the whole hip, the cut 
surface showed full depth pigmentation of the articular cartilage, from the subchondral bone 
through to the articular surface. There was thinning of the cartilage superior and inferior to 
the fovea and also on the lateral aspect of the femoral head towards the neck of the femur. 
The neck of the femur showed a diameter similar to that of the widest point of the head of the 
femur. This was particularly easily identified on the lateral aspect. The cut surface also 
showed that there was no comparable ochronotic pigmentation in the bone matrix as to that 
seen in the cartilage matrix. However there were darker aspects of the bone matrix compared 
to other regions. These darker regions appeared in the areas that would be consistent with 
transmitting the highest loading from the pelvis down into the neck of the femur and onto the 
diaphysis.
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Figure 3.2:- Photograph showing the macroscopic appearance of the internal cut surface of 
AKU3 femoral head at time of surgery.
AKU6
A 59 yr old male with known AKU presented for a right hip replacement due to ochronotic 
arthropathy.
AKU 13
A 59 yr old female attended hospital for a left total hip replacement. The femoral head 
showed a large area of denuded bone around the superior surface. There were numerous 
osteophytes seen in this region which displayed no evidence of ochronosis. The equator of 
the femoral head showed dense ochronosis of the articular cartilage, although it was clearly 
evident that the cartilage layer in this region was extremely thin. The descent from the 
equator of the femoral head down to the neck of the femur showed a gradual loss of 
ochronosis in the cartilage resulting in regions which then demonstrated no macroscopic 
pigmentation. There was little pigmentation of the surrounding capsular tissues. Observations 
of the acetabulum demonstrate that the acetabular labrum was densely pigmented. There were 
peripheral regions, away from the socket that showed less pigmentation, but were still
60
noticeably darker in colour. Macroscopic observations of the neck of femur demonstrated the 
presence of pigment beneath the periosteal surface. The internal cut surface of the femoral 
head showed darkening of the bone matrix, suggestive of ochronotic pigment located in the 
bone domain. This darkened matrix ran from the fovea obliquely across to the neck of the 
femur.
Figure 3.3:- Photographs showing the superior view (left), lateral view (middle) of AKU13 
femoral head at time of surgery. Photograph showing the macroscopic appearance of the 
acetabulum at time of surgery (right). All tissues demonstrate ochronosis in some region.
AKU 16
A 61 year old male with known AKU attended surgery for a left THR. The presentation of 
the patient was due to a rapid onset of progression, from normal to pain, discomfort and 
limited range of motion in the hip in the period of 18 months since attending hospital 
previously for his right THR. Once removed the femoral head was sawn into two halves. 
Articular cartilage was present in places (predominantly below the equator) and was 
completely full of ochronotic pigment. There was no unpigmented articular cartilage. The 
cartilage, although pigmented demonstrated a smooth articular surface and was only thinned 
towards the periphery. The halves both displayed numerous pathological features. The most 
striking of which were the deformed shape of the femoral head, the posterior aspect of which
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appeared to have collapsed and flattened as part of the arthropathic remodelling process. On 
the superior and posterior aspect of the head the articular was large regions of denuded bone. 
On parts of this region were numerous osteophytes, some of which had grown over the 
ochronotic articular cartilage although the osteophytes showed no sign of ochronotic pigment 
(Figure 3.5). In amongst the osteophytes and on the denuded area were numerous minute 
pieces of ochronotic cartilage, these appears to be impacted into the bone surface. The 
femoral neck appeared normal, with no suggestion of widening. The synovial and capsular 
tissues were densely ochronotic and fibrosed. In places these tissues had spread over the 
surface of the ochronotic articular cartilage, progressing up from the region of the neck of 
femur. The acetabulum displayed dense ochronosis. The cut surface of the femoral head 
demonstrated a lack of pigmentation comparable to that seen in the articular cartilage. There 
were however darker regions of bone matrix and periosteum.
Ochronotic cartilage
Bone
Osteophytes
Figure 3.4:- Photograph showing the macroscopic appearance of the superior aspect of half 
of the AKU16 femoral head following surgical excision.
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Figure 3.5:- Photograph showing the macroscopic appearance of superior aspect of the 
AKU16 femoral head following surgical excision. Note numerous small osteophytes located 
on the bone on the superior aspect.
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Ochronotic cartilage
Figure 3.6:- Photograph showing the macroscopic appearance of internal cut siuface of the 
midline of the AKU16 femoral head. Pigmented articular cartilage can clearly he seen 
located on parts of the femoral head and pigmentation can be seen located in the hone 
domain in parts. Note the abnormal shape of the cross section as a result of aggressive 
remodelling. Pigmentation also appears to he in the periosteum in the surface towards the 
top of the image.
AKU18
A 70 year old female with known AKU attended surgery for a right THR. The femoral head 
demonstrated a normal spherical shape. There was cartilage present around the equator and 
down to the neck of the femur. All cartilage was ochronotic, with regions appearing 
extremely thin. Superior to the equator there were large regions of denuded bone, on this 
region were numerous small osteophytes and numerous minute pieces of ochronotic cartilage 
that appeared to have been impacted into the exposed bone surface. In the fovea of the hip the 
insertion of the ligamentum teres showed dense ochronotic colouration. The neck of femur 
showed no change in shape. It was also covered in capsule, some of which was heavily 
ochronotic, some areas darker in appearance and some showing normal colouration. The
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periosteum of the neck of femur showed colouration, appearing more ochronotic than the 
trabecular matrix underlying it.
Ligamentum Teres
Figure 3.7:- A photograph showing the macroscopic appearance of superior view of AKU18 
femoral head following surgical excision. Note the pigmentation of the ligamentum teres in 
the fovea.
Figure 3.8:- A photograph showing the macroscopic appearance of the superior articular 
surface of AKU18 femoral head.
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3.2,2 Ochronosis in knees
AKU9
A 46 yr old male with known AKU attended hospital for a left TKR. Observations of the 
tibial plateau demonstrated darkened appearance of central regions of the medial plateau; 
similar presentation was seen on the lateral plateau. Away from the central load bearing areas 
pigmentation was difficult to identify with the articular cartilage looking normal. On the 
medial plateau there were small abrasions on the articular cartilage surface around the contact 
points, correlating with the densest ochronotic pigmentation. There were no similar abrasions 
seen on the lateral plateau. There was distinct pigmentation present within both the lateral 
and medial menisci. The pigmentation in the menisci appeared beneath the surface with the 
articular edges appearing free from pigment. A cross sectional observation of the menisci 
revealed that the pigmentation in the meniscus was in the centre with the periphery of the 
cross section appearing free from pigment. The densest pigmentation was seen in the medial 
meniscus on the anterior surface. Macroscopic observations of the cut underside surface of 
the tibial plateau showed a slight darkened appearance in the medial side within the bone 
matrix. There was no pigmentation consistent with that seen in the cartilages.
The cruciate ligaments demonstrated ochronosis, appearing slightly darker in colouration, 
suggesting deep pigmentation with absence of pigment at the external surfaces. There was 
also a large ochronotic body present in the soft tissues of the infrapatella bursa. This was 
solid in consistency with fibres of ochronotic tissues interspersed with non-ochronotic 
regions. The femoral condyles displayed a spectacular distribution of pigment, with regions 
free from ochronosis, to areas which were dense with pigmentation. The ochronotic regions 
correlated with the main articular contact points of both the medial and lateral condyles. 
Towards the periphery of these regions the pigmentation was not as evident and disappeared
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into areas which showed no pigmentation at all. The surfaces of the condyles, even in regions 
which were showing underlying pigmentation showed no notable degenerative changes. The 
only exception to this was the posterior surface of the patella. This displayed a band of 
ochronotic pigmentation running horizontally in the articular cartilage. In the middle of the 
patella there was a large lesion, which showed dark ochronotic pigmentation and a large 
unpigmented osteophyte. The cut surface of the underside of the patella demonstrated dark 
ochronosis, suggesting the presence of pigmentation in the bone matrix.
Figure 3.9:- A photograph showing the macroscopic appearance of the articular surface of 
the AKU9 tihial plateau. Pigmentation is dark in appearance and not present in all cartilage.
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Figure 3.10:- A photograph showing the macroscopic appearance of the posterior articular 
surface of AKU9 patella. A large lesion is seen with dense ochronosis around its periphery.
Figure 3.11:- A photograph showing the macroscopic appearance of ochronotic loose body 
removed from AKU9. This body shows large regions of dense ochronotic fibres within it.
AKU10
A 58 year old female with known AKU attended hospital for a right TKR. Examination of the 
distal lemur demonstrated dusky articular cartilage across all regions of the articular surface. 
Periphery of the distal femur showed numerous periarticular osteophytes which did not 
demonstrate any noticeable ochronotic pigmentation. On the medial femoral condyle was a 
large lesion which measured 4cm in length and 1.5cm in width. In comparison the lateral 
femoral condyle demonstrated less pigmentation with only focal regions of dense 
pigmentation. The posterior surface of the patella showed large regions of denuded bone, 
with only a small rim ot pigmented articular cartilage present around the periphery.
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Numerous osteophytes were seen on the posterior surface. Beyond this rim of cartilage 
numerous periarticular osteophytes were present, these displayed no ochronotic pigmentation. 
Examination of the menisci demonstrated a dusky ochronotic appearance to these structures. 
The anterior surface displayed dense pigmentation whilst there was no pigmentation at the 
surface of the other sides. However, the rest of the menisci had a dusky colouration to it, 
appearing to be manifest from deposition deeper in the tissues.
Distal femur
Patella
Figure 3.12:- A photograph showing the macroscopic appearance of right distal femur of 
AKUIO during TKR surgery. Note the large lesion in the medial femoral condyle. The 
posterior surface of the patella shows a rim of normal and then ochronotic cartilages 
surrounding an area of denuded hone.
AKU12
A 69 yr old female attended hospital for a right total knee replacement. The cartilage 
covering the medial aspect of the tibial plateau showed a dusky appearance across the 
majority of the surface. The medial weight bearing aspect showed the darkest pigmentation 
with lighter pigmentation towards the periphery. This presentation was also evident on the 
lateral plateau. The meniscus of the medial side was snapped off during surgery, but
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displayed dense ochronotic pigmentation within the whole structure. There were only the 
peripheral surfaces that failed to display pigmentation. The lateral meniscus displayed dense 
pigmentation throughout with only the external edges failing to show pigmentation. The 
lateral meniscus was also damaged during the surgery, with it fracturing in half, dividing it 
into an anterior and posterior half. The soft and connective tissues, including the cruciate 
ligaments also displayed ochronotic pigmentation in a patchy presentation.
Dissection of the tibial plateau into an anterior and posterior half revealed the macroscopic 
distribution of pigment through the articular cartilages. There were large differences between 
the presence and distribution between the lateral and medial sides. The medial side 
demonstrated pigmentation of the articular cartilage from the subchondral bone almost to the 
full depth of the articular' cartilage. The pigmentation was absent from the most medial 
aspect. There was dense pigmentation in the cartilage overlying the intercondylar eminence. 
On the lateral aspect there was almost full depth ochronosis of the cartilage, except in the 
most lateral aspect. There was also some apparent damage to the cartilage in the medial 
aspect of the tibial plateau, this appeared lesion-like in presentation, similar’ to the lesions that 
are observed in osteoarthritis, although it did not extend through to the subchondral bone, 
with the damage appearing in the superficial and medial zone.
The posterior aspect of the patella showed dense ochronotic pigmentation in places. These 
were intermittently dispersed between areas of exposed bone. The pigmented cartilage 
remained predominantly on the superficial and medial surfaces. There was numerous 
osteophytes present, the largest of which was on the inferior medial aspect and was 
unpigmented. In the centre of the lateral half of the patella there was also a smaller 
unpigmented osteophyte. On the underside of the patella there appeared to be dense 
ochronosis within the bone matrix on the lateral aspect.
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The femoral condyles also displayed a large variation in the presence of ochronotic pigment, 
some regions were completely pigmented and others appeared macroscopically unaffected by 
pigment. In particular the medial condyle showed dense black pigmentation on the medial 
aspect with regions where articular cartilage was missing from the surface. The pieces of 
synovium which were obtained showed variation in pigmentation, with some areas showing 
dense ochronosis and other regions appearing macroscopically unaffected.
Figure 3.13:- A photograph showing the macroscopic appearance of the tihial plateau of 
AKU12 following its surgical excision and removal of a 5mm slices through the midline. Note 
the dense ochronosis of the meniscus that is still attached.
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Figure 3.14:- A photograph showing the macroscopic appearance of internal cut surface at 
the midline of AKU12 showing distribution of pigment through the cartilage. Pigmentation 
appears to be more prevalent in the deep cartilages.
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Ochronotic cartilage
Osteophyte
Figure 3.15:- A photograph showing the macroscopic appearance of the posterior articular 
surface of the patella from AKU12 sample. Note the ochronotic, non-ochronotic and absent 
cartilage.
AKU15
A 53 year old male with known AKU attended surgery for a left total knee replacement. The 
tibial plateau demonstrated dense regions of ochronosis on both the medial and lateral sides. 
The heaviest ochronosis was seen in the centre of the medial tibial plateau and on the lateral 
plateau, which showed a densely uniform dark colouration. Pieces of capsular and soft tissue 
that were still attached to the plateau displayed little evidence of ochronosis when compared 
to the articular cartilage. The posterior femoral condyles both showed a degree of 
pigmentation. The lateral condyle was much more severely pigmented, with a dark uniform
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pigmentation across the whole of the surface; the peripheral regions appeared normal and 
white. The articular surface of this region appeared topographically normal, with no evidence 
of damage to the surface. The medial condyle was less pigmented, with approximately half 
the surface showing ochronotic pigment. The peripheral surfaces showed large osteophytes, 
which were not pigmented. The remaining chamfers from the lateral and medial sides 
displayed a similar distribution of pigment seen on the tibial plateau and the posterior 
condyles, with the lateral side being more widely affected and demonstrating the most 
ochronosis. Both lateral and medial sides displayed little in the way of damage to the articular 
surfaces, other than the presence of the ochronotic pigment in the tissue. The macroscopic 
distribution of pigment in the articular cartilage was seen as full depth in the lateral side. 
Medially the regions where macroscopic pigmentation was seen showed almost full depth 
pigmentation. As progression to non-pigmented regions was made the distribution of pigment 
was associated with the deeper cartilages. There was no evidence of pigmentation at the 
articular surfaces without it also being present in the deeper zones. The menisci showed 
regions of dense ochronotic pigmentation. The lateral meniscus showed a more uniform 
ochre colouration than that of the medial. The medial meniscus was also much smaller than 
the lateral, both in size and diameter. The pigmentation in the menisci was present through 
the middle of the structure, with little in the way of pigmentation present towards the 
insertions, these appeared macroscopically normal. The ACL showed no macroscopic 
ochronosis. There was a loose body removed from the joint which showed dense regions of 
ochronosis within the tissue. The mass was extremely hard, both in regions with and without 
ochronotic material present.
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Figure 3.16:- A photograph showing the macroscopic appearance and anatomical 
distribution of the pieces ofAKU15 surgically resected specimen
AKU19
A 59 year old female with known AKU attended surgery for a left TKR. The tibial plateau 
showed regions of dense ochronosis. The medial plateau was dark in colouration with only 
the very periphery showing any obvious white cartilage colouration to it. The lateral plateau 
was more severely affected by ochronosis than the medial aspect. The central part of the 
lateral side showed denuded bone, surrounded by a dark rim of ochronotic cartilage. 
Radiating out from this rim was less pigmented cartilage, but this was not possible to identify 
any unpigmented cartilage on the lateral articular surface. Both menisci showed dense 
ochronosis with only the outer most regions showing the absence of pigmentation. The 
insertions of the menisci also showed very little in the way of pigmentation. The femoral 
condyles display regions of dense pigmentation, particularly the lateral condyles. There was a 
large lesion on the lateral condyle where denuded bone and a large non-pigmented osteophyte
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could be seen growing over the pigmented articular cartilage. There was only non pigmented 
cartilage present on the most lateral aspect of the lateral condyle. On the lateral aspect, the 
lateral epicondyle displayed dense ochronosis of the overlying fascia. The patellar surface of 
the distal femur showed large regions of denuded bone, particularly on the lateral side. The 
medial condyle was pigmented across all pigmented surfaces, the only region that showed no 
pigmentation was the most medial aspect of the cartilage. On the medial condyle there was a 
large fissure, approximately 2cm in length, running through the midline. The synovial and 
capsular tissues displayed patchy ochronosis. There was no obvious ochronosis of the adipose 
tissues surrounding the joint. The posterior surface of the patella showed large areas of 
denuded bone in the centre, with a rim of dark ochronotic cartilage surrounding the denuded 
area. There were large osteophytes at the periarticular regions of the patella. The denuded 
bone also showed numerous osteophytes overlying parts of the rim of ochronotic cartilage.
Distal femur
Tibial plateau 
Patella
Figure 3.17:- A photograph at time of surgery showing the anatomical distribution of pigment 
across the knee joint of the AKU19 specimen. Note the pigmentation of the fascia overlying 
the periosteal surface on the lateral aspect.
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AKU21
A 51 year old female with known AKU attended surgery for a right TKR. The tibial plateau 
displayed regions of dense ochronosis. The medial plateau had large regions of denuded bone 
demonstrating no signs of ochronosis. There was a densely ochronotic region at the anterior 
medial aspect of the intercondylar eminence. On the lateral aspect there was a dusky 
appearance across the entire articular surface, with densely ochronotic regions at the anterior 
region. The femoral condyles showed regions of dense ochronosis at the midline and the 
peripheral regions demonstrated less pigmentation. The posterior surface of the patella 
showed dense degeneration. The periarticular surface showed large osteophytes; internal to 
this was a dense rim of ochronotic cartilage. The central part of the patella consisted of 
denuded bone with numerous osteophytes, which in parts were overlying ochronotic 
cartilage.
Figure 3.18:- A photograph showing the macroscopic distribution of ochronotic pigment 
across the tibial plateau and femoral condyles.
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Figure 3.19:- A photograph showing the macroscopic appearance of posterior articular 
surface of the patella from AKU21. Note the osteophytes growing within the rim of 
ochronotic cartilage.
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3.2.3. Arthroscopies
AKU8
A 42 yr old male with known AKU attended hospital for bilateral arthroscopy due to bilateral 
knee pain. He attended clinic previously in 2006 to assess ochronosis of both knees following 
complaints of pain. On attending clinic the anaesthetic strategy was aimed to be a spinal 
block, however due to the patients highly calcified and degenerated discs it was not possible 
to administer this so a general anaesthetic was administered. This visit to clinic was to 
observe the left and right knees. The patient complained of right knee pain and no pain was 
associated with his left knee. Arthroscopic observations revealed no pigmentation in the right 
knee. Observations in the left knee revealed ochronosis of the menisci and darkened 
appearance of the articular cartilage. There were also large pieces of ochronotic cartilage 
loose in the synovial fluid, although it was not possible to observe exactly where these had
become detached from.
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Figure 3.20:- Images taken at the time of bilateral arthroscopy showing the appearances of 
the articular cartilages. Note the top image shows no sign of ochronosis of the cartilages 
whereas the bottom images shows ochronosis of the tibial cartilage and the meniscus as 
indicated by the location of the probe. (Images kindly provided by Mr Clarke, Rugby St Cross 
Hospital)
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AKU11
A 69 year old female with known AKU attended hospital for a right knee arthroscopy. 
Samples removed demonstrated a mix of ochronotic and non-ochronotic matrix.
Figure 3.21:- A photograph showing the appearance of cartilage samples taken from 
arthroscopy which demonstrate areas of ochronotic and non-ochronotic cartilage. These 
samples came from the knee that would later be replaced (sample AKU 12).
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3.2.4 Spine and revision surgeries
AKU5
A 57 yr old female with known AKU, presented for elective surgery due to chronic pain and 
stiffening of the lower thoracic and proximal lumbar spine. The T12 and LI vertebrae were 
fused in order to alleviate pain related to calcification of the intervertebral disc between these 
two vertebrae. Tissues obtained were articular facet LI, vertebral body of T12, fat, muscle 
and over lying skin. The skin showed no obvious skins of ochronosis. The facet showed a 
dark colouration, typical of ochronosis, but not to the extent of articular cartilage. Both the 
joint facet and lamina showed ochronotic pigmentation. The ligament overlying these tissues 
was the most ochronotic piece of this sample.
AKU 14
A 65 yr old male with known AKU attended hospital for a left revision total hip replacement. 
Due to the complexity of the operation, numerous pieces of bone were removed from around 
the existing prosthesis to enable its removal and prepare the bone surface for insertion of the 
new prosthesis. Macroscopic examination of the removed tissues revealed no presence of 
ochronotic pigment of the tissues. Interestingly no pigmentation or discolouration was seen 
on the surfaces of the removed prosthesis.
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3.2.5. Discussion
These observations demonstrate the largest single study of alkaptonuric joint specimens 
undertaken. The combined specimens of 6 knees, 5 hips, 2 biopsies from arthroscopies and a 
spinal surgical specimen provide a unique gross anatomical insight into the distribution of 
pigment across joint tissues, both within a patient and across a small percentage of the AKU 
sufferers in the UK (believed to be in the region of 300, although to date 78 have been 
identified) (Ranganath, 2010). The most striking feature was the non-uniform distribution of 
ochronotic pigment across the joint tissues. Within the hips and knees there was no uniform 
observation of the deposition of pigment in a specific area compared to another. Samples 
from within a patient (AKU 10 & AKU 19; Figs. 3.12 & 3.17 respectively) show no 
similarities in the distribution of pigment at the macroscopic level. The lateral aspect of 
AKU 19 showed a much more degenerative change than the lateral aspect of AKU 10; which 
had a far more medial degeneration. Similarly the right sided samples from with a patient 
AKU 12 (knee - Fig. 3.13) & AKU 18 (hip - Fig. 3.8) show differential distribution of 
pigmentation, although the time between the degeneration of the knee and hip (approx 5 
months) is of interest the significance cannot be determined.
Examination of the hip specimens reveals interesting pathology; only one specimen 
demonstrated the presence of macroscopic ally observable non-ochronotic cartilage. The 
femoral head (Fig. 3.3) from this sample showed non-ochronotic cartilage near the neck of 
femur. All other femoral heads demonstrated the presence of ochronosis in the regions of 
cartilage still present. There was a common absence of cartilage from the superior aspect of 3 
of the femoral heads, suggesting that the wear and tear of routine use results in loss of
83
cartilage. This may in part be attributed to the hard ochronotic cartilage of the femoral head 
being articulated against the hard pigmented articular cartilage of the acetabulum, consistent 
with those seen in Fig. 3.3. The presentation of these regions is interesting, as this would 
usually be seen in osteoarthritic samples, where focal lesions had initiated the breakdown of 
cartilage, causing the underlying bone to become exposed. The large areas of exposed and 
denuded bone on the hips demonstrate presence of ochronotic cartilage, present in the joint 
space for a period of time, before becoming embedded in the denuded bone surface. This is in 
part similar- to the process of osteoarthritic degeneration, which sees cartilage fragments 
released into the joint space as fibrillation occurs, degeneration of the menisci which become 
prone to tearing and proliferation of synovium can all increase the presence of detritus in the 
usually fluid filled joint space (Felson, 2010).
The knee samples show non-uniform distribution of pigment. There was no medial or lateral 
trend, which is not surprising given the differences in gait throughout the human population. 
Across the knee samples the most consistently degenerated area was the posterior surface of 
the patella. This region consistently showed large denudation of bone, with an ochronotic rim 
of cartilage and osteophytes. Amongst the knees there were also large loose bodies removed. 
These were hard in composition with a mixture of ochronotic and non-ochronotic regions.
All osteophytes seen on both hip and knee samples demonstrated an interesting lack of 
ochronotic pigment, the absence of pigmentation of these structures raises an interesting 
question about the timing of pigmentation, with the chondrocytes in these structures 
displaying all major components and the distribution of articular cartilage when fully formed 
(Gelse, 2010). This would suggest that the cartilage structures in the body do not pigment 
during or immediately following formation.
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Whilst the pigmentation of cartilage was widespread in the tissues of the patient samples, 
there were few other signs of degeneration of the cartilage, the articular surface was 
predominantly normal in most regions of all samples. There were a few lesions present across 
the patient samples; however there is little evidence to suggest that these are due to matrix 
degradation associated with arthritis, particularly given the presence of large pieces of 
pigmented cartilage throughout the joint synovium, embedded in the denuded bone surface 
and free in the joint spaces.
The description of ochronotic osteoarthropathy being of early and rapid onset (Maxwell, 
2005) is supported by the mean age of primary surgery of our patient cohort compared with a 
sample representing national mean ages of hip and knee replacements (hips; M =67.5, 
F=70.4, knees; M=69.4, F=70.9) (Culliford, 2010). The AKU patients in this study 
demonstrated a younger mean age (hips; M = 59.6, F = 64.5, knees; M = 49.5, F= 59.25) for 
their primary surgery.
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4. Ultrastructural analysis of ochronotic tissues
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4.1 INTRODUCTION
This chapter describes the ultrastructural presentation of ochronosis throughout bone 
cartilage and joint tissues. The literature describes in depth the ultrastructural presentation 
of ochronotic synovium and the cartilage that is embedded within it. Chapter 3 of this 
Thesis describes the macroscopic presentation of ochronosis as seen in tissues from 
patients with alkaptonuria. As seen with the macroscopic presentation there are large 
differences in the presence of pigment across tissues, both across bone, cartilage and soft 
tissues. This chapter provides a comprehensive analysis of alkaptonuric joint tissues at 
the ultrastructural level, providing an in depth look at the most affected component of 
alkaptonuric tissues, the collagen fibres. This chapter also describes for the first time a 
distinct pattern of binding and the earliest noted sign of pigment nucleation.
4.2 RESULTS
4.2.1 TEM of AKU Cartilage
At low magnification collagen fibres were difficult to distinguish in the matrix and were 
surrounded by numerous dark deposits when observed in longitudinal section. Amongst 
the collagen fibres, the extracellular spaces were filled with dark globular and granular 
deposits that appeared extremely electron dense. Inside of some these deposits there was 
crystalline material (Fig. 4.1).
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Figure 4.1:- Low power photomicrograph showing numerous ochronotic granules and 
globules present in the cartilage matrix (+). A few short collagen fibres (*) can be seen 
in the field of view. (x9,900).
With increasing magnification collagen fibres became more clearly identifiable in the 
matrix, particularly in longitudinal section. The 67nm banding pattern typically 
associated with the fibrillar collagens could clearly be seen. An observation of collagen 
fibres in transverse section was more difficult, except in regions where the fibres had 
been completely encrusted by ochronotic pigment, this gave a negative outline of the 
body of the collagen fibre in the matrix.
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Figure 4.2:- An electron photomicrograph showing numerous collagen fibres (*) in 
longitudinal section with sporadic ochronotic deposits located along their length 
(arrows). It is more difficult to distinguish collagen fibres in transverse section but some 
can be seen amongst ochronotic deposits. (x20,500).
Across the matrix collagen fibres demonstrated large variations in their diameter along 
short distances of the fibre, although these did not always appear to be in relationship to 
the presence of detectable ochronotic pigment on their external surfaces. There were also 
small granules of ochronotic pigment present on the surface of some fibres, much small 
than along the fibres.
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Figure 4.3:- A high power electron micrograph showing numerous collagen fibres (*) 
with large electron dense ochronotic granules located along their length (arrows).
(x43,000).
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Figure 4.4:- A high power photomicrograph showing the close relationship between 
ochronotic pigment (arrow) and collagen fibres (*) in the matrix. (x87,000).
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Figure 4.5:- A high power photomicrograph showing the presence of ochronotic pigment 
(arrows) on the superior and inferior surfaces of a collagen fibre (*). Lines of 
measurement have been placed onto the image to attempt to demonstrate the periodicity 
of the collagen fibres. Yellow = 69.58nm, Red = 62.68nm, Green = 65.56nm. (xl60,000).
Throughout the examination of the cartilage sections it was difficult observe any 
chondrocytes within the tissue sections examined.
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4.2.2. TEM of OA cartilage
Examination of OA cartilage demonstrated numerous collagen fibres present in the 
matrix. It was clear that there was no ochronotic pigment present in the spaces of the 
extracellular matrix.
Figure 4.6:- A low power electron photomicrograph showing numerous collagen fibres 
(*) in both transverse and longitudinal section. There is no evidence of any ochronotic 
pigment associated with the fibres and spaces can clearly be observed between matrix 
components. (x8,200)
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Figure 4.7:- An electron micrograph of osteoarthritic cartilage matrix showing numerous 
randomly oriented collagen fibres (*).67nm banding can clearly be seen on the fibres. 
(x43,000).
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Figure 4.8:- A high power electron micrograph of an individual collagen fibre (*) 
demonstrating no electron dense ochronotic deposits along the fibre body from OA 
cartilage. 67nm banding is clearly seen, (xl60,000).
Fibres were clearly seen both longitudinally and transversely. Those fibres seen in 
transverse section demonstrated normal cross sectional appearances and had no evidence 
of dark ochronotic deposits passing through their fibre body, or around their peripheries.
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4.2.3 TEM of AKU bone
Examination of mineralised bone from the vertebrae of an individual with alkaptonuria 
ochronosis revealed no pigmentation in the bone matrix. Collagen fibres could clearly be 
observed in the matrix. Mineralised collagen could be seen at the edge, along which an 
osteoclast appeared to be located.
Figure 4.9:- Low power electron micrograph showing the presence of mineralised 
collagen matrix (top right) and a large region of cellular organelles (bottom/middle left).
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Figure 4.10:- A low power electron photomicrograph shows mineralised collagen can he 
seen with the typical 67nm handing. No electron dense deposits can he identified. 
(x26,500).
High power examination of the bone matrix did not reveal any obvious sign of large 
ochronotic deposits or early signs of ochronosis like those seen associated with the 
collagen fibres in the cartilage and capsule matrices.
97
4,2.4 TEM of AKU Capsule
At low magnification collagen fibres are easily identifiable in transverse and longitudinal 
section. Present amongst the fibres were numerous electron dense granules of ochronotic 
pigment. These granules varied in position amongst the fibres. Some fibres had single 
granules of pigment located within the visible cross section of the fibre, or sometimes 
connected to the periphery of the fibre. Other fibres possessed more than one pigment 
granule inside the fibre body. In some instances multiple pigment granules had no 
identifiable connection with the perimeter of the fibre. In proximity to these granulated 
fibers there were also fibres which appeared to have been completely replaced or 
encrusted in pigment (Fig. 4.11).
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Figure 4.11A high power TEM photomicrograph showing collagen fibres in transverse 
section. Numerous fibres appear with small electron dense granules located within the 
fibre body. Other fibres appear to have been completely replaced by pigment (arrows). 
Some fibres show no obvious association with pigment. (x87,000).
Analysis of other regions showed a more severe or possibly advanced form of pigment 
associated with the fibres when viewed in transverse section. This pigmentation appeared 
again as electron dense shards but much more crystalline in structure and often protruded 
from the body of the fibre. The shards also appeared to bridge between fibres often 
connecting one fibre to another neighbouring fibre, or in some instances more than one 
neighbouring fibre. These large shards were sometimes seen attached to a large granules
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located in the centre of an individual fibre. There were often fibres in the region of 
interest that had no notable shards associated with them. Fibres with pigment sticking out 
from them often appeared swollen when compared to their non pigmented neighbours. 
Pigment protruding from fibres was in some instances observed binding to “extra- 
fibrillar” pigment (Fig. 4.12). Fibres which appeared free from pigmentation appeared 
structurally abnormal. They did not show the circular cross section associated with 
collagen fibres but presented as more of a pentagonal or hexagonal cross section 
(Fig.4.12).
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Figure 4.12:- TEM photograph showing large electron dense ochronotic shards located 
within the fibre body and often protruding out into the inteifibrillar space and connecting 
to other fibres (top right).(CircIes represent overlay of fibre perimeter to show protrusion 
of shard from fibre). Shards can also be seen originating from large granules located 
within fibre bodies.(arrow). Numerous fibres show no notable dense pigmentation but 
appear structurally abnormal displaying many variations on shape and diameter, 
(x160,000).
Numerous novel observations were noted when viewing the collagen fibres in 
longitudinal section. It was easy to identify the typical 67nm cross banding that is
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normally associated with the fibrillar collagens. The most distinct feature is the presence 
of many electron dense ochronotic shards on the surface of the collagen fibres giving a 
speckled appearance. It is also of interest that there is often more than one pigment 
granule/shard associated with a single collagen fibre. The pigment is present on fibres of 
all diameters, in all different shapes and sizes across the tissue. It is clear that there are 
also regions of fibres and whole fibres that are free from any form of pigmentation. It was 
seen in some regions that there was a gradient of pigmentation running from collagen 
fibres that were totally free from pigment across to regions of heavy pigmentation. It was 
also observed that there were regions of pigmentation there were so heavy and dense that 
the collagen fibre had been completely replaced, or encrusted into pigment. This 
phenomenon was observed across a distance of less than a few hundred nanometres (Fig. 
4.13). Most noticeable is the presence of a periodic banding pattern of ochronotic shards 
on an individual collagen fibre. The pigmentation overlaps with the periodic banding 
associated with the fibrillar collagens. (Fig. 4.13 inset).
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Figure 4.13:- Ultrastructural appearance of ochronotic ligamentous capsule. Collagen 
fibres viewed in longitudinal section show a distinct electron dense pigment on their 
smface. Not all fibres present with pigment deposition. Numerous pigment shards can be 
seen on a single fibre. Gradient of pigmentation can be seen running right (no pigment 
on fibres) to left (large electron dense shards replacing fibres) (x20,500). Inset shows a 
distinct periodic binding pattern associated with pigment granules on a single fibre.
This regular periodicity of ochronotic pigment binding was seen on more than one fibre 
within the tissue (Fig. 4.14). Alongside the regular pattern observed on some fibres we 
were able to note very early signs of pigment deposition. These small granules were seen 
to appear in a regular pattern on the longitudinal surface of the collagen fibres. These
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deposits appear to be the earliest noted and detectable signs of pigment deposition (Fig. 
4.14). High power magnification of larger pigment shards on the longitudinal surface of 
the fibres shows shards to be bridging some of the cross bands on the fibrillar surfaces 
(Fig. 4.14).
Figure 4.14:- Ultrastructural appearance of collagen fibres from ochronotic ligamentous 
capsule. (Left) Individual collagen fibre showing a regular binding pattern along the 
surface (thin arrows) (left x20,500). (Right) Collagen fibre showing nucleation of 
ochronotic pigment in a distinct pattern (thin arrows). Pigment can also be seen bridging 
across the cross ban e collagen fibres (thick arrows) (right x87,000).
TEM examination of the cells within the ligamentous capsule displayed numerous 
features of interest. Many cells displayed small dark shards of ochronotic pigment (Fig
VV
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4.15). These were comparable in shape and size to those observed on the collagen fibres 
within the matrix. Some of the fibroblasts observed showed comparable small electron 
dense granules located within the cell nucleus (Fig.4.16). In some areas fibroblasts 
displaying cytoplasmic pigmentation showed no sign of necrosis. Cells displaying larger 
amounts of pigmentation and they also displayed more signs of necrosis, such as 
organelle disruption and discontinuities in the plasma membrane (Fig. 4.16 bottom inset).
Figure 4.15:- A low power electron photomicrograph showing a fibroblast amongst the 
collagen matrix with numerous electron dense deposits located within its cytoplasm. 
(x6,000).
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Cells were also seen with numerous small fibrillar structures located within their 
cytoplasm. On and around these fibrillar structures were numerous small electron dense 
granules suggesting association between the two (Fig. 4.16 top inset). Fibroblasts were 
also seen in some regions without notable electron dense granules within their cytoplasm.
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Figure 4.16:- TEM photograph of a fibroblast on the periphery of collagen fibres in the 
ligamentous capsule. Numerous small electron dense granules can be seen in the 
cytoplasm (large arrows). There are also electron dense granules located within the 
nucleus of the cell (small horizontal arrow). (x26,500). Insert (bottom) TEM 
photograph showing fibroblast with numerous electron dense ochronotic granules within 
the cell. Cell organelles are difficult to distinguish due to the cell being in necrosis 
(x20,000). (top) TEM photograph showing abundant electron dense granules in the cell 
cytoplasm associated with fibrillar structures (x60,000).
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4.2.5 TEM of spinal ligament
Regions of spinal ligament examined by TEM revealed large regions of collagen fibres 
interspersed with large elastic fibres and large electron dense ochronotic deposits. 
Fibroblastic cells were seen frequently throughout the matrix. Elastic fibres were easily 
identifiable due to the vastly increased size compared to individual collagen fibres, these 
were normally at least 3 times larger in diameter, but occasionally seen in excess of 10 
times the diameter. (Fig. 4.17)
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Figure 4.17:- A low power electron micrograph showing the location of numerous 
bundles of collagen fibres (c) interspersed by elastic (e) fibres and large ochronotic 
deposits. The green line shows the cross-sectional diameter of an ochronotic deposit 
which is 137/.18nm. The red line demonstrates the thickness of a bundle of elastic fibres 
passing through the field of view, this bundle is 715.66nm in diameter. The yellow line 
demonstrates a large ochronotic deposit present amongst the collagen fibres and in close 
proximity to an elastic fibre. Three other ochronotic deposits can be seen in this column 
of collagen fibres, there is another ochronotic deposit amongst the collagen fibres in the 
bottom left of the image. A fibroblast (f) can be seen amongst the collagen fibres on the 
right hand of the image. (x9,900).
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The fibroblasts within the matrix showed no sign of necrosis, they were seen both in 
regions of ochronotic and non-ochronotic matrix. Fibroblasts were observed in non 
ochronotic matrix with ochronotic deposits located intracellularly (Fig. 4.18 & Fig. 4.19).
Figure 4.18:- A low power electron micrograph showing a fibroblast (f) in the 
ligamentous matrix with ochronotic pigment in a cytoplasmic vaculoe. Collagen and 
elastic fibre bundles can be clearly seen. (x20,500).
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Figure 4.19:- A high power electron micrograph showing a fibroblast located amongst 
the collagen fibres with ochronotic like deposits located in vacuoles within its cytoplasm.
(x43,000).
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Figure 4.20:- A low power electron micrograph showing the appearance of ochronotic 
like deposits associated with the collagen fibres in the matrix (arrows). (x26,500).
When the matrix was examined at high power there were large regions of collagen fibres 
in proximity to large ochronotic deposits. When observed in transverse section the 
collagen fibres displayed highly irregular shapes. Although it was often difficult to 
distinguish detectable ochronotic pigment associated with these fibres.
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Figure 4.21:- A high power electron photomicrograph demonstrating the presence of 
abnormally shaped collagen fibres in the matrix. No dense ochronotic deposits are seen 
associated with the fibres in the field of view. There is a large ochronotic deposit (o) 
present in the bottom of the image, which appears in part to be associated with a large 
elastic fibre. (x60,000).
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4.2.6 TEM of in vitro cultures
As described in literature; deposition of ochronotic pigment occurs in cultures of 
osteosarcoma cells (SaOS-2 and MG63) with HGA added to their culture medium (Tinti, 
2010). As part of this chapter and the paper described in the previous reference, an 
electron microscopic study of these cultures along with my own novel cultures of C20 
human chondrocytes was undertaken. Alongside this a study of the formation of HGA 
polymerised product from pure HGA crystals in water was also performed. This chapter 
and part of the referenced paper represents the first time anyone has studied in vitro 
models of ochronosis and pure polymerised HGA using ultrastructural techniques.
Examination of all cultures revealed numerous cells and sporadic regions of cell matrix 
(Fig. 4.22 & 4.23). Regions of matrix looked extremely primitive compared to the highly 
ordered matrix seen in human joint tissues such as cartilage and fibrous capsule. The 
matrix was most evident in regions immediately surrounding cells and within fibro- 
positor like structures of the cells themselves (Fig. 4.22 & 4.23). The fibres that were 
observed looked pro-collagen like in structure with thin wispy fibres that displayed no 
evidence of the 67nm periodic banding pattern synonymous with fibrillar collagens. 
Similar fibres were observed in both the osteosarcoma and chondrosarcoma cultures. 
When these fibres were viewed in longitudinal section there were numerous dark electron 
dense deposits observed in association with the fibres. These were also seen 
intracellularly.
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Figure 4.22:- A low power electron photomicrograph showing the relationship between 
cellular and extracellular culture components in MG63cells cultured in 3.3x10 4M HGA. 
Electron dense ochronotic deposits can be seen associated with structures in the bottom 
right hand corner of the image. (x6,000).
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Figure 4.23:- A low power photomicrograph of MG63 cells cultured in 3.3x1 O'4M HGA. 
Numerous thin fibres (F) can be seen in the middle of the image amongst cellular 
structures. Small dark granules can be seen associated with these fibres. (x9,900).
As seen in Figure 4.22 & 4.23 there are clear fibres located between regions of individual 
cells, possibly fibropositor structures. These were also seen in SaOS-2 cultures (Fig. 
4.24) and chondrosarcoma cultures (Fig. 4.25).
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Figure 4.24:- A low power electron micrograph showing the presence of fibres and 
cellular components in SaOS-2 cells cultured in 3.3x10 4M HGA. (xl6,500)
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Figure 4.25:- A low power electron micrograph showing the relationship between 
cellular and extracellular components in C20 human chondrosarcoma cells cultured in 
3.3x1 O'4M HGA. (x8,200).
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Figure 4.26:- A high power electron photomicrograph of C20 human chondrocytes 
cultured in 3.3x10 4M showing the presence of numerous extracellular fibrils with dark 
ochronotic granules present amongst them. (x43,000).
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Figure 4.27:- A high power electron photomicrograph showing the presence of 
ochronotic granules with extracellular matrix fibres in cultures of MG63 cells cultured in 
3.3x104M HGA (identical to those seen in figure 4.26, chondrocyte cultures). (x60,000).
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Figure 4.28:- A high power electron photomicrograph showing the presence of electron 
dense ochronotic deposits associated with the extracellular fibres of MG63 cells cultured 
in 33x10 4MHGA. (x105,000).
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Figure 4.29:- A high power electron photomicrograph showing the close association of 
ochronotic pigment with extracellular fibres in the matrix ofC20 cells cultures in 3.3x10' 
4M HGA. (xl35,000).
Examination of regions of matrix reveals transversely sectioned fibres that demonstrated 
a variety of cross sectional shapes including oval, hexagonal and pentagonal. Fibres 
showed varying sizes of electron dense ochronotic deposits. These deposits were seen 
around the periphery of some fibres and in the internal part of other fibre bodies. These 
fibres and the associated deposits were observed in both the osteo and chondro cell
cultures in HGA.
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Figure 4.30:- A high power electron photomicrograph demonstrating fibres in transverse 
section in cultures of C20 chondrocytes cultured in 3.3x10 4M HGA. Fibres demonstrate 
notable ochronotic deposits associated with there periphery and within their bodv.
(x160,000).
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Figure 4.31:- A high power electron photomicrograph showing fibres in cross section in 
cultures of SaOS-2 osteosarcoma cells cultured without HGA. (xI05,000).
One of the most striking features of these cultures under the TEM was the necrotic 
appearance of many cells in both the osteosarcoma (SaOS-2 and MG63) (fig. 4.32) and 
chondro (C20) (Fig. 4.33) cultures. These were characterised by disruption of the plasma 
membrane and rearrangement of the cellular organelles. These characteristics were 
evident of cells in all cultures regardless of the presence of ochronotic pigment within the 
cytoplasm or in the immediate extracellular domain.
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Figure 4.32:- A low power electron photomicrograph showing the rearrangement of 
cellular organelles and disruption of the plasma membrane representing cell necrosis in 
an MG63 cells cultured in 3.3xlO'4M HGA. (x8,200).
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Figure 4.33:- A low power electron photomicrograph showing necrosis of a C20 cell 
cultured in 3.3x10 4M HGA, with organelle rearrangement and disruption of the plasma
membrane. (x6,000).
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4.2.7. TEM analysis of pure HGA polymer
Pure HGA polymer, which appeared as a dark black tar like material that was insoluble in 
water, 70-100% ETOH and acetone was observed under the TEM. Large dark crystal like 
granules were observed at low magnification (Fig. 4.34). Within these deposits large even 
more electron dense shards were observed.
Figure 4.34:- A low power electron micrograph showing the presence of a pure HGA 
polymeric derivative located on the TEM grid. The large granule shows a darkened 
appearance with numerous large electron dense ochronotic granules located within its
structure. (x],250).
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Examination of these granules at a high power revealed that dense ochronotic shards 
were over 10pm in diameter. Numerous granules were located within the large less dense 
deposit (Fig. 4.35)
/
Figure 4.35:- A low power electron photomicrograph of pigment granules measuring the 
diameters of the more dense ochronotic deposits. Green = 10.75pm, Red = 7.82pm, 
Purple = 6.14pm, Yellow = 1.08pm & Blue = 0.66pm. (x2,550).
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4.2.8 ssNMR of ochronotic cartilage
C solid state NMR spectra of ochronotic cartilage and non-ochronotic cartilage from an 
alkaptonuric patient (AKU12), are shown in Figure 4.36. Both datasets were acquired 
using the solid state NMR technique known as cross polarization, involving transfer of 
NMR intensity from highly sensitive and abundant *H atoms to inherently less sensitive, 
low abundance (ca. 1.1% of all carbon) 13C atoms. The method greatly enhances the 
intrinsically weak signal from I3C in the sample, and in fact in many cases, such as the 
present one, is essential for achieving adequate signal in reasonable time. The method 
however is selective for molecules which are fairly rigid and therefore does not permit 
observation of, for instance, the abundant highly mobile glycosaminoglycan (GAG) 
species which are major constituents of cartilage. Indeed the spectrum of the control 
material is dominated by signals from rigid collagen molecules, although some GAG 
signals, presumably from immobilized GAG chains, are also visible. A few assignments 
of signals to GAG, and to specific protein functionalities (methyl groups, aromatics, 
amides, carboxylates) or amino acid carbons (glycine, proline, hydroxyproline) are 
indicated.
The most striking difference between the spectra of the control and the ochronotic 
cartilage is a marked broadening of most, if not all, signals in the ochronotic material. 
This is emphasized by the inset in Figure 4.36 which shows the signal from the y-carbon 
atoms of hydroxyprolines (a convenient well resolved spectroscopic marker of this amino 
acid and therefore of collagen itself) in the control cartilage overlaid with that from the 
ochronotic cartilage. The most likely explanation of this generalized signal broadening is
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a decrease in collagen molecular order. The precise atomic level nature of this 
disordering cannot yet be defined; it could be attributable to disruption of the regular 
tropocollagen triple helical structure by the presence of HGA and its polymeric derivative
Amide
Methyls
Carboxylate
Aromatic
20 ppm
in the matrix.
Figure 4.36: Solid state / ?C NMR spectra acquired under cross polarization conditions 
from heavily pigmented ochronotic articular cartilage from an alkaptonuric patient (a), 
and "control " non-pigmented articular cartilage from the same patient (h). A selection of 
signal assignments, to collagen functional groups, amino acids and GAGs, are shown. 
The inset is an overlay of the hydroxyproline y-carbon signal from control (black) and 
ochronotic (red) material; it demonstrates the increased signal linewidth in the spectrum 
of the ochronotic cartilage relative to control.
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4.3 DISCUSSION
Macroscopic examinations of the tissues from patients revealed widespread variations in 
the pigmentation observed in all regions. Areas show dense ochronosis whereas 
millimeters away demonstrate regions of no macroscopic ochronosis. This is further 
confirmed by the histological examination of tissues.
Ultrastructural examination of cartilage reveals that there is widespread pigmentation in 
the matrix, associated with collagen fibres and possibly other matrix components such as 
proteoglycans, which has been described previously (Mohr, 1980). However it appears 
that not all the matrix components when examined ultrastructurally show the features of 
ochronosis in tissues that appear macroscopically completely pigmented. It also appears 
that there are large deposits present in the matrix that do not have any distinguishable 
matrix components associated with them, although it may be that any nearby components 
have in fact been completely engulfed by polymerised pigment and thus are not 
distinguishable. Interestingly in the large ochronotic deposits observed in the cartilage 
matrix there appeared to be other crystalline material that may be other material(s) or 
proteins that have been incorporated into the polymerisation process and are not HGA or 
any of its intermediary or end stage derivatives. The process of polymerisation is clearly 
related to the presence of HGA, as similar electron dense deposits were not observed in 
the OA cartilage that was analysed as control tissue, but it is unclear in vivo whether 
other circulating or location specific molecules or proteins are incorporated into the 
pigment as part of the polymerisation process.
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There is an interesting association between deposition of HGA pigment and calcium as 
observed in calculi of certain tissues and organs; such as that described in the 
submandibular calculi of a patient with AKU in chapter 8. More in depth analysis of 
kidney and prostate stones from patients with AKU has revealed that there is the usual 
calcium compounds present in these calculi along side an amorphous material (probably 
ochronotic pigment). Although it is difficult to deduce whether calculi induce 
pigmentation or if the alkaline conditions that the stones are constantly subjected to due 
to their anatomical location results in a separate polymerisation that results in deposition 
in these stones (Sutor, 1970). Whilst the presence of ochronotic pigment in the matrix of 
cartilage at the ultrastructural level is not blanket, its overall presence in the tissues is 
sufficient to bring about numerous pathologies; alteration of local biochemical, 
biomechanical factors and cellular homeostasis that result in the end stage arthropathy 
observed.
The association with calcium is an interesting point given that the time taken for bone to 
mineralise to 2/3ld,s its final mineral content is only 3 weeks (Fuchs, 2008), which in 
vitro is sufficient time for osteoblast like cells to synthesise matrix which undergoes 
microscopical and ulirastructurally detectable deposition of pigment, although the final 
mineral content in vivo takes approximately a year to achieve. This would suggest that 
there maybe other protective mechanisms involved in bone, such as that the nucleation 
site required for initiation of deposition of ochronotic pigment is one of the first occupied 
by the apatite in the mineralisation of bone collagen. The examination of ligamentous 
capsule was consistent with previous examinations of soft joint tissues, that pigmentation
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was patchy with both pigmented and non-pigmented regions (Helliwell, 2008 & Lagier, 
1980). Whilst macro and microscopic observations of collagen in capsule reveal distinct 
differences in the presence of ochronotic pigment across the tissue, ultrastructural 
examination shows that there are often unaffected fibres within the heavily pigmented 
regions, similar to my observations in densely ochronotic cartilage. Analysis shows a 
previously unobserved ultrastructural feature in the capsular tissue, a gradient of 
pigmentation across numerous collagen fibres where pigmentation is absent on a number 
of fibres and across a short distance of only a few hundred nanometres pigmentation 
appears to initiate and then become blanket on the collagen fibers. The identification of a 
pattern on the fibres may suggest that there is a promoter or favourable point of 
nucleation which once commenced may recruit other matrix proteins into the polymeric 
pigment. The initiation or nucleation may occur in a manner analogous to the 
mineralisation which occurs on the collagen fibres of calcifying bone. The small 
nucleating pigment appears as a regular pattern and as such may provide clues to the 
exact point to which the HGA is attracted in these tissues and could be used in the future 
to elucidate the binding mechanism as a therapeutic target. The identification of this 
earliest point of binding is an important discovery as this confirms that collagen is indeed 
the preferential binding site, but as yet the exact site on the fibre is unknown. What is 
positive about this discovery is that the large amount of HGA that is present in these 
tissues doesn’t appeal- to be the limiting factor in what is driving or initiating pigment 
binding or deposition. If this were not the case pigmentation would be much more severe 
and widespread over every fibre. We know that HGA is a very small and highly water 
soluble molecule due to its excretion in massive quantities in urine of affected individuals
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(Suwannarat, 2005) as well as its presence in joint fluids, prostatic secretions (Krizek, 
1971), and possibly in the cerebrospinal fluid (Liu, 2001).
Examination of spinal ligament by TEM revealed ochronosis associated with some 
matrix collagen fibres and intracellularly. There were appearances of elastic fibres that 
had electron dense deposits on parts of their periphery. This observation is in 
contradiction to another case where examination of arterial tissue showed no pigment 
associated with the elastic fibres (Gaines, 1989); although the comparison between the 
two tissues is not exactly the same, the elastic fibres are unlikely to be different in 
structure, even given that they are from different sites.
It looks as though there maybe a further process by which pigmentation and 
polymerisation may occur intracellularly, whether this is related to deposition on collagen 
fibres is difficult to determine due to the observations that are seen in surgical samples 
often represent the end stage of a deposition process that is not well understood. I can 
confirm in my observation that there are numerous deposits present within the cells that 
are consistent with the extracellular deposits seen on the collagen fibres.
It is clear that there are still many questions over the pigmentation that occurs in 
alkaptonuria. Pigmentation may occur during collagen synthesis; this would be likely to 
affect the final triple helix of the collagen causing changes in functionality, of both the 
cartilaginous and capsular tissues. This maybe supported in part by the detection of 
numerous pigment shards running through the body of the collagen fibres examined. It 
appears most likely that the collagen in tissues acts a nucleation site for pigment
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deposition and polymerisation occurring on a currently unknown site or part of the fibre, 
consistent with my observations. This nucleation may occur at neighbouring sites and 
then join together to form larger deposits as seen by the bridging of shards across 
numerous collagen fibre cross bands.
Intracellular deposition may occur due to the presence of HGA within the cytoplasm. The 
prolonged presence of HGA may result in a concentration threshold being achieved 
within the cell causing the auto oxidation and polymerisation of HGA to its pigmented 
polymer. This would be consistent with the auto oxidation of other dihydroxy aromatic 
compounds such as tyrosine and L-DOPA (Foster, 1950). Questions must be asked as to 
why not all collagen fibres in cartilage and capsule are affected. The presence of HGA 
cannot be the limiting factor, there must be other local factors which are limiting to the 
deposition of pigment. One such limit may be the availability of nucleation sites. It is 
clear from my evidence that there is more than one site of initiation and deposition per 
collagen fibre in tissues as demonstrated by the numerous deposits on a single fibre. This 
would suggest that there are preferential sites of nucleation and possibly local factors 
within tissues such as pH, or presence of other currently unidentified factors that may 
play a role in promoting deposition. Numerous decades of exposure of collagen fibres 
should present sufficient time for deposition to occur on all fibres to some extent. This 
may not be the case if pigment is broken down within the tissues by a currently 
unidentified mechanism, or there are local protective mechanisms. Similar to those which 
protect mineralised collagen fibres as a whole. However other evidence in this thesis
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suggests that the breakdown of pigment, particularly when in its bound form to matrix 
proteins is not possible.
Pigmentation in cells of different tissues, not just those of joint tissues, for example the 
urinary system supports the suggestion that pigmentation may occur when local 
concentrations of HGA pass a specific threshold. Alternatively the local factors such as 
the pH in some tissues, such as the urinary system, or prostate may be alkaline enough to 
promote pigmentation in a manner parallel to the oxidation that occurs in urine (Krizek, 
1971).
Examination of the ultrastructural appearance of in vitro cultures reveals widespread 
pigmentation of matrix fibres in both osteosarcoma and chondrosarcoma cultures, 
although my previous data shows that in in vitro cultures the chondrosarcoma cells show 
more rapid and severe deposition, this cannot be distinguished in TEM examination. It is 
suggested that pigmentation in tissues takes many years and that there may be protective 
mechanisms, which with the ageing process become less efficient or cease to function. In 
the osteosarcoma cultures the pigmentation of the synthesised collagen fibres, presumed 
to be type I, but may also be type V or XI (Fernandes, 2007), shows that the protective 
mechanisms in vivo are not present in these cultures - one of which may be 
mineralisation - as the matrix of these cells does not mineralise in our routine culture 
media, but may also be other currently unidentified factors. The confirmation of 
pigmentation of the collagen fibres in these cells is a promising tool for further 
investigations into the pathogenesis of ochronosis, as the earliest points of detectable
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ochronosis are the time when treatment would need to be administered to prevent further 
pigmentation. Consistent with the observations in vivo the specific nucleation sites for the 
pigment appear to occur multiple times along individual fibres in vitro.
This chapter describes for the first time the earliest signs of pigment deposition in tissues 
from patients with AKU, as seen in the cartilage and ligamentous capsule. This is also the 
first description and analysis of ultrastructural deposition in an in vitro model of 
ochronosis. Here I demonstrate a clear pattern of binding of ochronotic pigment to 
collagen fibres. Furthermore we show the earliest nucleation point of pigment deposition 
on these fibres. I also confirm the presence of pigment in fibroblasts at the electron 
microscopic level. It is clear that whilst there is a vast knowledge of the end point of the 
disorder there is little to suggest a clearer understanding of the early stages and 
mechanisms of the disorder. These results represent a vast advancement in this area. 
Further investigations using this model may provide some information about whether 
collagen is pigmented pre or post assembly and whether fibres are pigmented prior to 
their excretion from the cell. There is evidence in both these cultures that the fibres are 
pigmented in fibro-positor like structures in these cultures which would indicate that 
pigmentation may occur as cells are excreting fibres from their cell. Whilst pigment is 
seen in the cells in both cultures it is difficult to ascertain whether these intracellular 
deposits are associated with fibres.
It should be noted that the ability to obtain high quality sections for TEM imaging of 
bone (undecalcified) and ochronotic cartilage are extremely difficult due to the brittleness
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of bone tissues due to the presence of mineralised matrix in bone and the ochronotic 
pigment in cartilage which causes fracturing and shattering of sections, even when cut on 
a diamond knife. Furthermore, the ochronotic cartilage appeal's highly hydrophobic when 
floated out on to water making it difficult to float onto copper grids for imaging, should 
sectioning be successful. OA cartilage sections did not exhibit similar hydrophobia when 
being floated out for sectioning.
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5. The role of calcified cartilage and subchondral bone in the initiation and progression of 
ochronotic arthropathy in alkaptonuria
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5.1 INTRODUCTION
As described in chapters 3 & 4 of this thesis the striking results of numerous years of exposure to 
HGA in the joint tissues can be seen. Over many years, HGA polymerises and becomes 
deposited by a currently unknown mechanism in these collagenous tissues, a process termed 
ochronosis (O’Brien, 1963, Helliwell, 2008, Zannoni, 1969). Recent work has shown, as 
described in chapter 4, that there is pigmentation associated with the periodicity of fibrillar 
collagen, possibly suggesting that there is a preferential binding site for the ochronotic pigment 
on the collagen fibres (Taylor, 2010). Although cartilage is a preferential site for ochronosis, 
pigmentation is observed in other tissues, such as the submandibular gland, even in the absence 
of cartilaginous matrices (Helliwell, 2008, Taylor, 2010, Krizek, 1971). With increased exposure 
to HGA and continued polymerisation in joint tissues, the end stage of the disorder is a severe 
osteoarthropathy. Although there is no proven link between the presence of HGA and shortened 
lifespan, the quality of life is severely affected and the only current treatments to have any 
proven clinical benefit are either liver or renal transplantation or more commonly joint 
replacement surgery (Introne, 2002, Kobak, 2005, Araki, 2009, Spencer 2004, Phornphutkul, 
2002). This chapter, describe the progression of articular cartilage degeneration in ochronotic 
arthropathy from initiation of pigmentation to complete joint failure. It has been previously 
suggested that the presence of HGA alone is not the determining factor in pigment deposition; 
Chapter 8 of this Thesis (Taylor, 2010). Although AKU is rare there are numerous publications 
detailing the end stage of the disease resultant from pigment deposition and recently the earliest 
observed signs of ochronosis associated with collagen fibres have been seen (Taylor, 2010). 
However little is known about the mechanism(s) involved in progression from this initiation to 
the clinical end point. This Chapter provides evidence that intact tissues are initially resistant to
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pigmentation and that focal cellular and extracellular matrix abnormalities cause joint tissues to 
be susceptible to pigmentation. Pigmentation initially manifests at the boundary of the 
subchondral bone and calcified cartilage before proceeding towards the articular surface.
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5.2 RESULTS
5.2.1. Macroscopic
Examination of samples revealed a spectrum of pigmentation from focal ochronosis to complete 
pigmentation across all zones of cartilage (Table. 1). In the samples that were not completely 
pigmented, the focal deposits were in regions known to be subjected to the greatest load bearing 
during locomotion, e.g. knee medial tibial plateau compared to lateral. (Andriacchi, 2009) It was 
also observed that pigmentation of the articular surface was central rather than peripheral in 
advanced ochronosis (Chapter 3, Fig 3.12 inparticular). These are the region(s) associated with 
initiation and severe pathology in primary knee osteoarthritis (Pelletier, 2007). The medial tibial 
plateau of heavily pigmented samples showed high mottling and fissuring of the articular surface 
(Fig. 3.12 in chapter 3).
5.2.2. Material Properties of cartilage samples
Surgical dissection of cartilage from the joint specimens revealed an interesting phenomenon. 
Dissection revealed that the pigmented cartilage was difficult to remove from the bone and was 
much stiffer than non-pigmented cartilage (findings that were subsequently confirmed by 
mechanical testing - Fig. 5.2). This was even evident when compared to aged osteoarthritic 
cartilage as well as healthy cartilage. Alongside this numerous orthopaedic surgeons commented 
on the “brittle and stubborn” properties of the ochronotic cartilage. In some instances it was 
noted that the ochronotic cartilage presented more resistance than the bone which it was 
overlying (n=5).
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5.2.3. Mechanical loading of cartilage
Routine processing of samples for SEM revealed that the enzymatic action of Tergazyme 
(alkaline bacterial pronase), which effectively digests non-calcified ECM} was unable to break 
down the pigmented hyaline articular cartilage (Fig. 5.5).
5.2.3.1. Mechanical loading
Loading of articular cartilage cubes from freshly surgically resected medial femoral condyles 
revealed large differences in Young’s modulus of heavily pigmented vs nonpigmented and 
osteoarthritic cartilage (Fig. 5.2). The mean Young’s modulus of pigmented cartilage showed a 
more than 5x greater modulus than cartilage which was non-pigmented (136MPa vs 22MPa). 
Similar differences in the Young’s modulus between the ochronotic and osteoarthritic cartilage 
were also observed. This demonstrates the vast increase in stiffness attributed to the presence of 
ochronotic pigment in the cartilage of patients with ochronotic osteoarthropathy. The difference 
in stiffness of these tissues was significant, p<0.01 (Fig.5.2). Interestingly there was no 
significant difference between the non-pigmented alkaptonuric cartilage and the osteoarthritic 
cartilage.
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Figure 5.1:- Macroscopic images and raw values demonstrating the location from which the 
cartilage samples were removed from a medial femoral condyle and mechanically tested in order 
to determine Young’s modulus. NV = no value. Left: cut surface of medial aspect of medial 
femoral condyle demonstrating the distribution of pigment within the cartilage matrix. Right: 
view of articular surface of medial femoral condyle demonstrating the distribution of ochronotic 
pigment.
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* *
Figure. 5.2: Graph showing Young's modulus of pigmented, non-pigmented and osteoarthritic 
cartilage. Graph demonstrating the differences in Young's modulus of pigmented, non-pigmented 
cartilage and osteoarthritic cartilage. Differences between the pigmented vs. non-pigmented, 
and pigmented vs. osteoarthritic were highly significant. p<0.01.
5.2.4. Enzymatic digestion of cartilage
Attempts were made to culture chondrocytes from samples obtained at surgery. These were 
digested out from the matrix as described in Chapter 2. Samples were treated with hyaluronidase, 
trypsin and collagenase. AKU cartilage was predominantly ochronotic, with a few regions that 
were relatively normal in colour. The OA cartilage showed no ochronosis (Fig.5.3). Following
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incubation in the enzyme solutions the ochronotic cartilage showed no change in its appearance 
or presence on the culture dishes. Whereas the OA cartilage matrix had been completely digested 
and chondrocytes liberated from their matrix (Fig. 5.4).
Figure 5.3:- Photograph showing the appearance of cartilage shards prior to addition of 
proteolytic enzy’tnes required to release cells from the cartilage matrix in order to culture in 
monolayer. Samples are as follows (top left to bottom right): OA1, AKU6, AKU9, AKU12,
AKU13, AKU15.
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Figure 5.4:- Photograph showing the appearance of cartilage shards following the addition of 
proteolytic enzymes required to release cells from the cartilage matrix in order to culture in 
monolayer. Samples are as follows (top left to bottom right): OA1, AKU6, AKU9, AKU12, 
AKU13, AKU15. Note the absence of cartilage shards from the OA1 dish, demonstrating the 
function of enzymes on non-ochronotic cartilage.
As part of routine preparation for SEM analysis (see chapter 2) samples were treated with 
Tergazyme. an alkaline bacterial pronase which routinely removes all non-mineralised matrices 
and cells from tissues. It was surprising to observe that the ochronotic cartilage was impervious 
to the action of this solution, whereas non-ochronotic alkaptonuric cartilage and that from OA 
samples is routinely digested away (Boyde, 2003).
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Figure 5.5:- An SEMphotomicrograph (Wx) showing the sliver of ochronotic hyaline articular 
cartilage that was removed from an ochronotic femoral head (AKU1). This strip was impervious
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to Tergazyme action. The smooth surface seen is that of the articular surface. The rough side is 
the subchondral side.
Figure 5.6 : A high magnification (2Ox) SEMphotomicrograph showing the subchondral side of 
the strip of ochronotic hyaline articular cartilage which fractured off from the underlying 
calcified matrix of an ochronotic femoral head (AKU1). Note that the chondrocyte morphology? 
can clearly be seen (within square). This would not normally be evident in non-ochronotic
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cartilage because the pigment would not be there to give an outline of the lacunae, but also the 
matrix would have been digested away.
Figure 5.7:- A higher power (lOOx) SEMphotomicrograph showing the location and morphology' 
of chondrocytes located in the ochronotic cartilage matrix.
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5.2.5 Histological observations
Histological analysis of H&E stained sections confirmed macroscopic observations regarding the 
presentation of pigmentation. There was a large variation in pigmentation across samples and 
within samples. Mildly pigmented samples showed that pigmentation was associated with 
individual chondrocytes in the calcified cartilage and included both intracellular and pericellular 
pigmentation of the chondrocyte lacunae and territorial matrix (Fig. 5,8a & c). At this stage, 
there was no pigmentation in other (more superficial) cartilage zones and little evidence of 
advanced arthritic changes at the articular surface (Fig. 5.8a & b).
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Figure 5.8:- Photomicrographs of articular cartilage in AKU sample showing the earliest 
detectable pigmentation in the calcified cartilage, (a) A merged stack of 4 photomicrographs 
showing the full thickness of articular cartilage. Note the pair of chondrocytes and their 
territorial matrix on the bone/calcified cartilage boundary’ with ochronotic pigmentation of the 
matrix. The rest of the articular cartilage shows no ochronotic pigmentation and no 
microscopical evidence of degeneration. H&E. Bar = 50pm. (b) Higher power view of articular 
surface of cartilage demonstrating healthy chondrocytes. Bar = 20pm. (c) Higher power view of 
pigmented chondrocytes in calcified cartilage showing the initiation of ochronosis in their 
territorial matrix. Bar = 20pm.
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Samples with more widespread ochronosis had a greater frequency of chondrocyte intracellular 
pigmentation in the calcified cartilage and territorial matrix. With the widespread ochronosis, 
pigment was absent from the interterritorial matrix. As pigmentation of chondrocytes and 
territorial matrix became more widespread, there was still no evidence of pigmentation in the 
hyaline cartilage and at the articular surface. When, the pigmentation front extended into the 
non-calcified hyaline cartilage matrix, the deep and middle zones had blanket pigmentation and 
the territorial matrix in these zones was even more intensely pigmented. However, alongside this 
widespread pigmentation the interterritorial matrix of the calcified cartilage matrix was 
unpigmented. Pigmentation was also absent from the superficial zone and articular surface. 
Hyaline cartilage began to show Assuring at the deep surfaces close to the subchondral interface. 
Pigmentation of the interterritorial matrix and the articular cartilage was only observed in 
samples with the most advanced and widespread pigmentation. In addition, the most pigmented 
samples had dense pigmentation of the extracellular matrix in all deep and middle zones of the 
hyaline cartilage. There was no calcified cartilage present and the subchondral bone was absent 
in almost all of the section in these most pigmented samples. In regions where there was 
subchondral bone still present, osteoclasts could clearly be seen resorbing the thin bone matrix to 
the point of contact with the pigmented hyaline articular cartilage (Fig. 5.9). Pigmented cartilage 
was adjacent to, and impacted onto, the trabecular structures which were thin and showed 
evidence of osteoclastic resorption. The pigmentation in the calcified cartilage was consistently 
associated with the territorial matrix and at no stage showed the pattern of blanket pigment 
deposition observed in the non-calcified hyaline cartilage matrix.
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Figure 5.9:- Pigmentation in the full depth of the articular cartilage, (left) Calcified cartilage 
and subchondral bone plates have been almost completely resorbed. Osteoclasts can be seen 
resorbing the last remnants of the subchondral bone plate, (right) Higher power view of 
osteoclastic resorption of subchondral bone and calcified cartilage up to the pigmented hyaline 
cartilage. Bar = 50pm.
There was a general lack of pigment in bone matrix in all samples but intracellular ochre- 
coloured deposits were observed in osteocytes and their lacunae (Fig. 5.10 & 5.11). Pigmentation 
observed in osteocytes was present in two types; granular and blanket pigmentation. 
Pigmentation could also be seen in the canalicular network. In some sections, osteoclasts were 
seen engulfing pigmented osteocytes as they were released from the surrounding matrix, (Fig. 
5.11). Pigmentation was seen in the osteocytes from all samples showing cartilage matrix 
pigmentation.
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Figure 5.10:- Osteocyte liberated from the mineralised matrix follow ing osteoclastic action on 
the surrounding matrix (arrow’). Bar = 20ym (AKUl).
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Figure 5.11:- Photomicrograph showing the overview of hone matrix with numerous dead and 
necrotic osteocytes in the hone matrix, demonstrating granular intracellular pigmentation. In the 
marrow space numerous multinuclear cells, presumed to he osteoclasts can he seen, some of 
which display large intracellular ochronotic deposits. Numerous liberated pigmented osteocytes 
can he seen in the marrow space.
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Figure 5.12:- Photomicrograph showing numerous multinuclear cells in the marrow space. One 
of which shows multiple ochronotic deposits within its cytoplasm, some of these appear to be 
pigmented osteocytes.
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Figure 5.13:- Multinuclear cells engulfing pigmented osteocytes following liberation from the 
resorbed matrix (arrows). Bar = 20pm.
In samples with advanced ochronosis, shards of pigmented cartilage were embedded in the 
marrow space cavity between trabeculae. The ochronotic fragments were surrounded by fibrous 
tissue, mononuclear and multinuclear cells all showing intracellular ochronotic pigmentation. 
Shards of pigmented cartilage, lost from the articular surface, could be observed embedded in 
synovium; this was present in 8 out of the 8 samples. (Fig. 5.14 & 5.15).
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Figure 5.14:- A large piece of ochronotic carlilage is seen embedded in inflamed synovial tissue. 
Note the chondrocyte lacunae present in the ochronotic matrix.
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Figure 5.15:- A high power photomicrograph showing the presence of another ochronotic shard 
of cartilage located in the synovial tissue. Pigmented chondrocytes can be seen located within 
their lacunae in the ochronotic matrix.
Examination of the most severely pigmented samples revealed that there were two types of 
pigmentation in the matrix (Fig. 5.16). There was blanket pigmentation in the deep zone, which 
was more intense around the territorial matrix (Fig. 5.16d). In some samples in the superficial 
and middle zones, there was a granular rather than blanket pigmentation with a ground pepper­
like appearance (Fig. 5.16c). This was also observed in the chondrocyte lacunae and the 
chondrocyte cytoplasm (Fig. 5.16).
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Figure 5.16:- (a) Overview of full thickness depth of AKU femoral condyle showing ochronotic 
pigmentation at the deep and middle cartilage layers. Bar = 50pm (b) High power 
photomicrograph of the articular surface showing the absence of pigmentation from the matrix. 
Chondrocytes show dense intracellular ochronotic granules. Bar = 20pm. (c) High poM'er 
photomicrograph of the middle zone showing dense ochronotic granular pigment in the 
extracellular matrix. Chondrocytes show intracellular deposits. Bar = 20pm. (d) Blanket 
deposition in the extracellular matrix of the deep zone, chondrocytes show intracellular 
pigmentation, some are also necrotic. Bar = 20pm. H&E. Necrotic cells were identified by their 
shriveled and homogeneous glassy appearance. Their nuclear and cytoplasmic components are 
difficult to distinguish.
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Pigmentation of the chondrocytes, osteocytes and osteoclasts was widespread in heavily 
pigmented samples. Interestingly there was also pigmentation observed in mononuclear cells 
within the marrow space and in the synovial tissues (Fig. 5.17). These pigmented mononuclear 
cells were seen alongside pigmented fibroblastic cells in the fibrous tissues. Also within the 
marrow space ochronotic deposits were observed associated with the adipocytes and their 
collagenous matrices (Fig. 5.17 & 5.18).
Figure 5.17: High power photomicrograph of the marrow space ami hone domain showing 
numerous pigmented mononuclear cells located within the fibrous tissue of the marrow space. 
Superior to this multinuclear cells can be seen engulfing pigmented ochronotic cartilage, some 
of which show pigmented osteocytes and other ochronotic deposits in their marrow space.
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Figure 5.18: Photomicrograph showing numerous pigmented and partially pigmented 
mononuclear cells in the symovial tissue. The cells appear pigmented in the absence of detectable 
pigment associated with the surrounding collagenous matrix.
Figure 5.19:- Photomicrograph showing the adipocytes and their collagenous matrices in the 
marrow space. Numerous ochronotic deposits can he seen amongst the collagen network.
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This variation ot pigmentation allows observations of macroscopic pigmentation to be correlated 
with microscopic presentation, as seen in table 5.1.
Severitv of
Pigmentation
Cartilage Bone
Calcified Deep Middle Superficial Articular O/cvte O/clast Lacunar
/Canalicular
Initiation/Mild F,P.TM No No No No • IC No No
Moderate Y.P.TM F.IC No No No IC No No
Advanced Y.P,TM Y.IC.BM Y,IC No No IC,P Y Y
Severe Y.P.TM Y.IC.BM Y.IC.BM Y.IC.BM, Y.IC.BM IC.P Y Y
End Stage No y.icbm Y.IC.BM Y.IC.BM Y.IC.BM IC,P Y Y
Table 5.1:- A table showing the microscopic features of cellular and matrix presentations of 
ochronosis when correlated with the severity of pigmentation. Key: BM=Both Matrices, i.e. 
territorial and interterritorial F=Few, IC=Intracellular, P=Pericellular, TM= Territorial 
matrix, Y=Yes. At end stage hyaline cartilage is often missing from the joint surface, so has been 
scored from cases where it was present, calcified cartilage is no longer present and thus shows 
no pigmentation at this stage.
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5.2.6. Fluorescence microscopy
Consistent with histological examination, fluorescent microscopy confirmed the presence of 
ochronotic pigment in the articular cartilage, commencing in the calcified zone and being absent 
at the articular surface with no notable arthritic changes. There was also confirmation of the lack 
of calcified cartilage and loss of subchondral bone in the most pigmented sample(s).
Figure 5.20: A fluorescent photomicrograph of the deep articular cartilage and subchondral 
region. Ochronosis can be seen in the deep cartilages which show little fluorescence. In the more 
superficial regions there is more fluorescence from the matrix consistent with less pigmentation 
of the matrix.
In some regions pigmented ochronotic cartilage projected deep into the bone domain. The 
cartilage at the articular surface exhibited high fluorescence as pigmentation progressed, whilst
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the deeper zones, where pigment had been deposited, hardly fluoresced and appeared dull ochre 
in colour (Fig. 5.20 & 5.21).
Figure 5.21:- A fluorescent photomicrograph showing the fluorescence of the articular surface 
and the pigmentation front beneath it, which shows no fluorescence due to the presence of 
ochronotic pigment. No arthritic changes are seen at the articular surface.
Bone exhibited a high autofluorescence, except in the osteocytes which exhibited the same 
colouration as the pigmented chondrocytes and their pericellular matrix (Fig. 5.22). Other 
osteocytes exhibited no fluorescence.
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Figure 5.22: A fluorescent photomicrograph showing the ochre appearance of regions of hone 
matrix in ochronotic samples. These regions appear non-ochronotic under transmitted light 
microscopy.
Interestingly, in the transmitted light examination of the unstained histological sections, there 
appeared to be no pigment associated with the bone matrix, but regions of the bone matrix 
exhibited colouration similar to the ochre coloured matrix under fluorescence light, indicating 
the presence of pigment. These areas of pigmentation appeared to be located in between the 
lamellae (Figure 5.23a&b).
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Figure 5.23a&b:- a) Top - An unstained section from an ochronotic femoral head showing the 
ochre appearance of unstained cartilage. There are ochronotic chondrocytes located in regions, 
with pigmentation surrounding their pericellular matrix, h) Bottom - Fluorescent image of the 
same unstained section. Ochronotic cells and their matrix appear dull in colour, consistent with 
the appearance of the densely pigmented hyaline articular cartilage. Regions of the hone matrix 
exhibit dull colouration similar to the appearance of ochronotic cartilage, suggestive of pigment 
present in the hone matrix, appearing to he between the lamellae.
Fluorescence microscopy also confirmed the presence of ochronotic shards of cartilage in the
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marrow cavity, surrounded by fibrous tissue which appeared to engulf the fragmented shards 
(Fig. 5.24). The fragments of cartilage were often seen enclosed within thick fibrous bands of 
tissues bridging from one trabecular structure across to another (Fig. 5.25).
Figure 5.24:- A fluorescent photomicrograph showing the presence of large ochronotic shards of 
cartilage present in the marrow space and surrounded by mononuclear cells and collagen fibres.
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Figure 5.25:- A photomicrograph showing the presence of pieces of ochronotic cartilage located 
in the marrow space and engulfed in fibrous tissue which is seen bridging between existing 
trabeculae. Regions of the fibrous tissue exhibit brighter fluorescence than the pre-existing
matrix to which it is attached.
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5.2.7. SEM
3D BSE SEM analysis in the most pigmented, macerated sample showed the complete absence 
of the subchondral bone plate. There was no calcified cartilage present in the sample (as seen in 
Fig. 5.9). Pigmented hyaline articular cartilage appeared as the dark (because it is not 
mineralised) substance attached to the trabecular bone structure that had survived intact through 
the routine processing of the sample (Fig. 5.5).
2D compositional qBSE SEM imaging of the most pigmented sample revealed mineralised 
matrix with numerous dead osteocytes, identified due to their dense lacunar mineralisation. The 
bone outline could clearly be observed, but there was no mineralised cartilage or subchondral 
bone plate present. Overlaying topographical and compositional images showed the presence of 
non-mineralised bone where the subchondral junction should be (Fig.5.27). The bone cartilage 
interface appeared as non-calcified cartilage in contact with unmineralised bone.
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Figure 5.26:- 3D BSE SEM image showing the hone architecture from a Tergazyme macerated 
ochronotic femoral head (as seen in Fig. 3.1 & 3.2, chapter 3). Note that there is no subchondral 
plate. Remnants of pigmented hyaline articular cartilage are visible as dark stained material on 
the proximal surfaces of the trabeculae.
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Figure 5.27: Topographical BSE SEM image with grayscale compositional BSE image of 
mineral density’ overlaid. Pigmented hyaline articular cartilage (PHAC) is present in the upper 
right hand. Some of the hone matrix is not mineralised (N). Normal mineralised trabecular bone 
can be seen (B) located within the marrow space (MS).
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Figure 5.28:- Colour coded qBSE-SEM of same region in Figure 5.27 with halogenated 
standards applied showing the mineral density of the matrix. Regions of normal mineral can be 
seen, alongside regions of lower mineralisation towards the articular surface and around 
resorption lacunae. The key demonstrates mineral density with red being normal mineral 
density, pink and grey are hypermineralised regions and blue, yellow and green hypomineralised
regions.
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qBSE-SEM analysis revealed a range within normal limits of mineralisation densities in regions 
of trabecular bone (red colouration in Fig. 5,28), whilst additionally showing completely 
unmineralised bone matrix patches. In the most severely pigmented sample, there was no mineral 
content in any region of the cartilage, confirming absence of cartilage mineralisation and loss of 
any pre-existing calcified cartilage. The mineralised bone trabeculae showed regions of lower or 
zero mineralisation density that were in contact with the non mineralised tissues (blue, green and 
yellow colouration in Fig. 5.28) and showed evidence of osteoclastic action in the form of 
resorption lacunae (Fig. 5.28), This demonstrates that pigmented, unmineralised hyaline articular 
cartilage was confluent with non-mineralised bone. 3D BSE SEM of femoral condyles from 
AKU and OA patients revealed an interesting comparison. OA femoral condyle showed little 
evidence of damage to the articular cartilage with no sign of fissures or abrasions on the surface 
(Figure 5.29).
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Figure 5.29: Macroscopic image of surgical samples from a 51 yr old female who underwent 
surgery’ for pre diagnosed unicompartmental OA. Samples show little in the way of surface 
damage indicative of moderate or late stage OA.
The subchondral architecture of the OA samples revealed widespread sclerosis with subchondral 
trabeculae showing distinctive thickening, particularly in the midline. There was no evidence of 
bone marrow lesions in this sample (Fig. 5.30).
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Figure 5.30:- 3D SEM image of OA femoral condyle demonstrating subchondral sclerosis. A 
small osteophyte can be seen. The subchondral plate can clearly be seen.
The AKU femoral condyle showed incomplete cartilage pigmentation, with the pigment present 
extensively in the cartilage matrix but not completely up to the articular surface (Fig. 3.16, 
chapter 3). The subchondral architecture showed evidence of thinning with presence of a bone 
marrow lesion located in the periphery of the condyle. The trabeculae showed no sign of 
sclerosis comparable to that seen in the OA sample (Fig. 5.30).
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Figure 5.31:- 3D SEM image showing AKU femoral condyle with focal subchondral thinning, 
early stage and BML presence.
The most severely pigmented AKU sample was a femoral head that showed a focal bone marrow 
lesion towards the periphery of the sample. There was sporadic evidence of sclerosis. However 
most interesting was the complete absence of the subchondral plate (Fig. 5.32).
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Figure 5.32:- 3D SEM image showing end stage arthropathy following subchondral remodelling 
of A KU femoral head showing complete loss of the subchondral plate across the sample, with 
impacted pigmented hyaline articular cartilage on bone trabeculae. Evidence of focal sclerosis 
and regions of porosis were clearly seen.
Another 3D SEM imaged femoral head showed similar regions of focal sclerosis and porosis. 
This femoral head is seen macroscopically with cartilage missing from the articular surface (Fig. 
5.33).
Figure 5.33:- 3D SEM showing end stage arthropathy following subchondral remodelling of 
AKU femoral head. Note subchondral plate absence, sclerosis (s) and porosis (p).
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5.3. Discussion
This chapter describes the deposition of ochronotic pigment in articular cartilage from the initial 
focal deposition associated with individual chondrocytes in calcified cartilage, through 
proliferation of pigment throughout the hyaline cartilage and associated resorption of the 
subchondral plate ending in complete joint destruction. These findings add weight to the theory 
that extracellular matrix is normally resistant to ochronosis, but becomes susceptible to 
pigmentation in response to tissue injury. The injury to tissues to induce pigmentation may begin 
with microtrauma (Meyer, 2008). Once pigmentation is initiated, it appears to spread, preventing 
matrix degradation by proteolytic enzymes and cells, having a protective effect on the collagen 
fibres. However with the increase in stiffness due to the presence of the pigment, it appears 
whilst pigmentation is protective against degradation it may induce mechanical damage through 
normal loading of ochronotic cartilage, causing shards to become broken off and embedded in 
the synovium (Figs. 5.24 & 5.25). Although it has previously been suggested that the calcified 
matrices do not undergo ochronosis (Di Franco, 2000), our results suggest that the initial 
pigmentation starts deep in the cartilage, at or close to the mineralising front, associated with 
individual chondrocytes and their territorial matrices. The conditions that allow pigmentation 
have not been identified but could be related to mechanical or oxidative damage, or alteration in 
chondrocyte gene expression. Given the observed in vitro toxicity of HGA (Tinti,2011), this 
may be considered an etiological factor of the disease. There is a wide range of concentrations 
used in vitro; 0.1 pM to 1 mM which covers the physiological range of HGA in vivo (Taylor, 
2007 & Tinti, 2011). The relationship between intracellular and extracellular pigmentation is not 
understood. Focal pigmentation is always associated with pigmented cells, indicating that the 
cellular action is required for the initiation of pigmentation. However, even though pigmentation
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might commence intracellularly there is no doubt that it can proceed extracellularly and the vast 
majority of ochronosis arises from the spread of pigmentation to established matrix - not by 
secretion of newly pigmented matrix. Once pigmented, ochronotic matrix appears to be resistant 
to turnover by matrix-degrading enzymes as demonstrated by its resistance to Tergazyme and the 
presence of ochronotic cartilage shards embedded in the synovial tissues, with presence of 
multinuciear cells in the vicinity, but no evidence to suggest they are degrading the ochronotic 
tissue.
The route whereby HGA reaches the site of initial pigmentation is not clear. It could diffuse from 
the synovial fluid, where the concentration is thought to be similar to plasma, through the hyaline 
cartilage, or it could permeate through the calcified cartilage from the underlying subchondral 
bone consistent with the transit of other low molecular weight compounds (Arkill, 2008).
Observations of samples with more advanced ochronosis indicate that once the initial pigment 
has been deposited, there is proliferation to other chondrocytes and then to inter-territorial 
matrix. This proliferation of pigmentation suggests that focal ochronosis alters the biomechanical 
and/or structural properties of adjacent tissue making it susceptible to pigmentation. This 
additional pigmentation leads to further damage and a downward spiral of tissue destruction. 
Dissection revealed that pigmentation alters the mechanical properties of cartilage, making it 
brittle and hard to cut indicating an increase in the Young’s modulus which has been confirmed 
by mechanical testing (Figs. 5.1 &5.2). Focal changes in mechanical properties lead to stress 
concentrations or risers, which could consequently induce, further mechanical damage in 
adjacent tissue (Hoch, 1983 & Alexopoulos, 2005). Mechanical damage and or inflammation are
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known to up regulate stress genes in early OA (Goldring, 2008). Pigmentation is shown to begin 
in the pericellular and territorial matrices of individual chondrocytes, and thus matrix turnover 
events in these regions could be an important factor for initiation of pigmentation (Catterall,
2009) , and may provide evidence for why pigmentation commences around the cells prior to 
moving into the inter-territorial matrices. This is one possible mechanism for the proliferation of 
pigmentation, but other mechanism(s) cannot be ruled out including chemical damage to the 
matrix by, for example, oxidative stress resulting from the initial deposition of pigment (Braconi,
2010) .
In association with extensive hyaline cartilage pigmentation, there is remodelling of the calcified 
cartilage and underlying bone leading to a presentation reminiscent of bone marrow lesions. 
Eventually the aggressive resorption leads to complete loss of the subchondral plate. This 
extraordinary phenotype has not previously been reported in pathological conditions. It is likely 
to be a consequence of stress shielding of the underlying calcified cartilage beneath the stiff shell 
of pigmented cartilage, with enhanced osteoclastic activity resorbing the shielded subchondral 
bone and calcified cartilage. There is thinning and hypomineralisation of some underlying 
trabeculae and sclerotic changes in others similar to that previously reported in bone marrow 
lesions in OA (Hunter, 2009, Interna, 2010 & Interna, 2010). Although the aggressive resorption 
appears to be focal, it is noteworthy that enhanced urinary excretion of crosslinked N- 
telopeptides of type I collagen has been reported in alkaptonuric patients (Aliberti, 2003). 
Although remodelling of subchondral bone and articular cartilage has been reported in 
rheumatoid arthritis (Goldring, 2003), the complete loss of the subchondral bone seen in AKU is 
exceptional. Although a previous report concluded that bisphosphonates were not beneficial in
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patients with advanced ochronosis (Aliberti, 2007), our findings suggest that bisphosphonate 
therapy maybe worthy of reconsideration with administration, either before significant 
subchondral bone and calcified cartilage loss (i.e. primary prevention) or during early phase of 
subchondral bone and calcified cartilage loss (secondary prevention/treatment).
As a consequence of the subchondral bone loss, the brittle pigmented cartilage becomes 
impacted onto the poorly mineralised trabecular bone. Fracturing of the cartilage causes 
fragments to be displaced into the marrow space and engulfed by the marrow cells and become 
embedded in the synovium and capsular tissues (Araki, 2009 & Gaines, 1987). The end stage of 
the disorder shows complete loss of pigmented cartilage from the articular surface (Fig. 3.3).
Pigmentation was not detected in mineralised bone matrix, but osteocytes, osteoclasts and 
osteoblasts all displayed intracellular pigmentation, as well as the canalicular network and 
osteocyte lacunae. Osteoclasts were also seen phagocytosing pigmented osteocytes. Although 
generalised rates of bone formation have been observed to be almost normal in ochronotic 
individuals (Aliberti, 2003), these observations demonstrate focal hypomineralisation. There was 
no evidence of generalised osteomalacia and previous studies show no evidence of vitamin D 
deficiency in AKU patients (Fisher, 2004).
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Figure 5.34:- Schematic diagram showing the progression of joint destruction in ochronotic 
osteoarthropathy from initial pigmentation to eventual loss of cartilage based on the findings in 
this chapter, (a) Normal articular cartilage and subchondral bone plate, (b) Initiation of 
pigmentation around a single chondrocyte, (c) Pigmentation spreads to neighbouring 
chondrocytes, (d) Pigmentation progresses into the matrix of the non calcified hyaline cartilage, 
(e) Extensive hyaline cartilage pigmentation and complete loss of calcified cartilage and 
subchondral plate. Pigmented articular hyaline cartilage now sits directly on bone trabeculae. 
Trabecular structures are thinned by osteoclastic resorption, (f) Pigmented hyaline cartilage is 
brittle and prone to fracture (s). Shards of pigmented cartilage from the articular surface become 
embedded in synovium, whereas on the subchondral aspect, fragments become embedded into 
the marrow spaces.
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This research clearly highlights the central role that the bone cartilage interface plays in the 
initiation of ochronosis in AKU, and the importance of the calcified cartilage and subchondral 
bone in the subsequent arthropathy. The absence of the calcified cartilage itself is of major 
pathological significance. Calcified cartilage has often been neglected in the study of joint 
degeneration in OA, but it is clearly the tissue through which loads are distributed from the 
hyaline articular cartilage to the underlying subchondral bone (Ferguson, 2003). There are, 
however, many reports highlighting a role for subchondral bone in the pathogenesis of OA 
(Karsdal, 2008). It has been suggested that the structural integrity of articular cartilage is reliant 
on normal subchondral bone turnover, intact chondrocyte function and normal biomechanical 
stresses (Karsdal, 2008, Felson, 2004 & Flayami 2004).
AKU has already been documented as mimicking or causing premature OA (Balint, 2000 Sc 
Lagier, 2006). The examination of our results show there may be a large overlap of OA with the 
pathogenesis of AKU, and there is also growing evidence that in OA, alterations in the 
composition and biomechanical properties of cartilage are facilitated by increased bone turnover 
(Karsdal, 2008, Hayami, 2004 & Hayami, 2006).
It is tempting to speculate that the initial pigmentation is associated with pre-existing, possibly 
OA-related changes which make the cartilage matrix susceptible to pigmentation and that HGA 
is acting as an endogenous marker of degenerative changes. Joint arthropathy in AKU has some 
parallels with other joint diseases including OA but also has some unique characteristics. Further 
study of this rare disorder may contribute to the understanding and treatment of joint
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degeneration in AKU but also of OA.
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6. Ochronosis in a murine model of alkaptonuria
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6.1. INTRODUCTION
Other studies in this Thesis have demonstrated that ochronosis of cartilage is initiated in 
individual chondrocytes and their territorial matrix, before progressing to a more widespread 
pigmentation of the cartilage matrix (Taylor, 2011). Elucidation of the mechanism of 
initiation and progression of ochronosis will indicate new opportunities for intervention. 
Whilst therapies for AKU have been suggested and in some instances trialed, there is still not 
a clear direction about treatment(s) for AKU.
It has been suggested that NTBC, the therapeutic agent used in treating tyrosinaemia type I, 
may prove beneficial in treating AKU by blocking the production of HGA in the breakdown 
of tyrosine (Suwannarat, 2005). The efficacy and safety associated with the use of this drug 
for treating AKU has not yet been determined. Recent research has shown that there is an 
increase in oxidative stress to cells associated with high HGA (Braconi, 2010). Furthermore, 
preliminary in vitro work has demonstrated that anti-oxidants may prove useful in treating the 
disorder (Braconi, 2010 & Tinti, 2010). These results support numerous published reports 
suggesting that ascorbic acid may be of benefit in treating AKU (Morava, 2003, Wolff, 1989 
& Forslind, 1988). Mixed results have been observed when using ascorbic acid in vivo, 
however, ascorbic acid itself is a co-factor of p-hydroxyphenyl pyruvate dioxygenase, the 
enzyme immediately upstream of HGD, in the breakdown of tyrosine to HGA and thus 
pigment formation (Lorenzini, 2003). The benefit of low protein diets to slow ochronosis in 
AKU is questionable given that people who have observed the low protein diet still go on to 
develop ochronosis in their tissues (de Haas, 1998). This is probably due to the fact that HGA 
production arises from tissue turnover in the body as well as from the breakdown of ingested 
protein. The understanding of the progression of ochronosis in AKU has not advanced 
significantly towards defining a therapeutic strategy since Garrod described the disorder as
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“an inborn error of metabolism” over 100 years ago (Garrod, 1902 & Garrod 1908). Even 
with the groundbreaking identification of the enzyme responsible (HGD) and the cloning of 
the HGD gene (Fernandez-Canon 1996 & Granadino, 1997), sufferers of the disorder are still 
subject to the debilitating effects of the polymeric derivative of HGA in their tissues.
There is a clear need for a mouse model for this disorder to provide longitudinal data into the 
disease progression, because of the nature of the human specimens being a single time point 
in the progression of an individual sufferer's disease, these time points are usually late or end 
stage, which is beyond when any possible therapy may have beneficial action. Humans are 
also subject to intrinsic and extrinsic factors which are person specific, it is difficult to 
understand the complete time course, and an understanding of when pigmentation 
commences, and what lifestyle factors may influence this at a given point. Whilst the 
discovery of the mechanism has demonstrated the possibility of novel therapeutic 
interventions, a novel model is needed for studying the points and efficacy of each 
intervention. A mouse model would also provide valuable data on any new therapy, but more 
importantly may also have given valuable data on the effects of existing therapies. Whilst 
AKU mice do exist, even with elevated plasma HGA and urinary excretion of HGA, they do 
not appear to exhibit the human arthropathic features. The murine model of AKU was 
produced in 1993 by mutagenesis. These mice arose by intraperitoneal injection of 
ehthlynitrosourea (250mg/kg) of eight week old mice from an inbred stock carrying seven 
recessive mutations. Following recovery, these animals were then mated to 129/Sv-T/+ mice. 
Independent micro-pedigrees were achieved by systematic sibling mating for more than 10 
generations. The AKU mutation was then backcrossed onto both the BALB/cByJ (albino) 
and the C57/BL/6J (pigmented) backgrounds. These animals were previously thought not to 
exhibit ochronosis, despite excreting sufficient HGA to cause darkening of urine
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(Montagutelli, 1994). The mice have a truncated protein form of the HGD enzyme resulting 
from a splice mutation (Manning, 1999).
FAH (fumarylacetoacetate hydrolase) -/- HGD+/- animals were originally produced by 
crossing AKU mice (obtained from Montagutelli at the Pasteur Institute in Paris) with 
FAHAexon5. These mice were then crossed to obtain the desired phenotype (without 
controlling for strain background) (Manning, 1999). A proportion of these animals appeared 
to show a reversion to the less severe AKU phenotype following withdrawal of NTBC. The 
FAH/HTT1 strain would normally succumb to the tyrosinaemia type 1 that follows 
withdrawal of NTBC. The reversion of nodules within the liver to the homozygous negative 
form for HGD is thought to arise from the production of mutagenic compounds in the liver 
due to the FAH deficiency, namely the presence of fumarylacetoacetic acid (FAA) and 
maleyl acetoacetic acid, (MAA) and subsequent spontaneously formed derivatives. These 
mutagenic compounds appear to cause a deletion or conversion from the wild type HGD 
allele, resulting in double mutant HGD and FAH hepatocytes, and these have a selective 
advantage within the population of liver cells because they do not produce the toxic FAA and 
MAA derivatives (Manning, 1999). Other experimental models have been reported, but are 
generally not useful or viable for experimental studies (Keeling, 1973 & Bonduranat, 1965). 
Following anecdotal descriptions of ochronosis in these mice, this chapter describes a 
recently undertaken a macro and microscopic study of the tissues of FAH-/-,HGD +/- mice 
which have been withdrawn from NTBC. This chapter details the detection of ochronosis in a 
murine model of AKU for the first time and similarities between the initial stages of the 
pigmentation in the murine model and those of the human condition. This murine model may 
also prove beneficial for screening therapeutic agents for treating the condition.
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6.2. RESULTS
Mouse ID Sex Time off NTBC
271 M 11 Months
272 M 11 Months
280 F 11 Months
282 M 11 Months
283 M 11 Months
285 F 11 Months
2089 F 2 Weeks
2091 F 2 Weeks
240 F 2 Days
241 F 2 Days
236 M 1 Day
237 M 1 Day
Table 6.1:- details ofFAH-/-, HGD +/- mice analysed as part of this chapter and amount of 
time ojfNTBC prior to analysis
Mice were dissected as described in Chapter 2.
6.2.1 Macroscopic observations of murine tissues
The skin and ears, abdominal viscera, femoral heads or knee joints displayed no similar 
pigmentation to that seen in aged human organs and structures in mice of any age. The livers 
of mice that had been withdrawn from NTBC for 11 months showed pale discolouration in 
regions. This was only seen in the mice which had been removed from NTBC for 11 months, 
all other livers appeared normal. The kidneys of some the mice which had been removed 
from NTBC for 11 months displayed regions of ochronosis; these were interspersed across
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the kidneys, with non-ochronotic regions showing pale discolouration. These regions of 
ochronosis appeared as large dark nodules, bulging from the external surface of the kidneys. 
These were only seen in 4 of the 6' mice which had been off NTBC for this amount of time; 
these three mice were all male. The female kidneys, showed similar regions of pale 
discolouration but lacked the ochronosis seen in their male counterparts. The ochronotic 
nodules were located beneath the fibrous capsule; they protruded deep down into the cortex. 
It was difficult to ascertain whether they were located in the renal columns or the medulla.
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Figure 6.1:- Macroscopic image showing kidneys of mouse M283 (male) in situ; which had 
been off NTBC for 11 months. Large dark ochronotic nodules are seen in the kidney tissues.
Figure 6.2:- Macroscopic image of kidneys from mouse M271 {male) sectioned through the 
midline to show the internal surface and large ochronotic deposits can be seen with the 
medulla. Mouse had been off NTBC for 11 months.
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Figure 6.3:- Macroscopic images of kidneys from mouse M272 (male) sectioned though the 
midline to show the internal surface with ochronotic deposits. Mouse had been off NTBC for 
11 months.
Figure 6.4:- Macroscopic images of kidneys from mouse M282 (male) sectioned through the 
midline to show the internal surface with ochronotic deposits. Mouse had been off NTBC for 
11 months.
Figure 6.5:- Macroscopic images of kidneys from mouse M283 (male), as seen in situ in 
figure 6.1, sectioned through the midline showing ochronotic deposits. Mouse had been off 
NTBC for 11 months.
The kidneys from mice which had been off NTBC for 2 weeks displayed a speckled 
appearance but showed no external or internal signs of ochronosis. The kidneys from the
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mice which were off NTBC for 1 and 2 days respectively displayed a light colouration but no 
sign of ochronosis.
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6.2.2. Histology
Mouse M283 off NTBC for 11 months 
6.2.2.1. Heart
Figure 6.6:- Low power photo micrograph showing the aortic valves and heart musculature 
from the heart of M283. No obvious ochronosis can be seen.
Microscopic observations of the heart tissues revealed absence of ochronotic pigmentation 
from all tissues. High magnification observation of the heart valve revealed that no 
ochronosis associated with extracellular matrix or intracellularly, either chondrocytes or 
fibroblasts. There was also no pigment present in the muscular tissues. The cells all appeared 
healthy.
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Figure 6.7:- A high power photomicrograph showing fibroblast-like cells and their matrix of 
the aortic valve. No extra or intracellular ochronosis is seen.
6.2.2.2. Tracheal cartilages
Observation of the tracheal cartilages showed no evidence of ochronosis. The extracellular 
cartilage matrix and the surrounding fibrous tissue matrix appeared normal. The cartilage 
matrix stained heavily for proteoglycans. The chondrocyte lacunae were empty, with no 
evidence of the presence of chondrocytes in the majority of the lacunae; those that were 
present showed signs of necrosis. It is possible that within this tissue, absence of 
chondrocytes could be the earliest detectable pathological change. The epithelial lining cells 
of the trachea showed no sign of intracellular ochronosis.
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Figure 6.8:- A high power photomicrograph showing the cartilaginous rings of the trachea 
with no evidence of ochronosis intra or extracellularly. Numerous lacunae are empty and 
those chondrocytes that are present appear necrotic.
The thyroid cartilage displayed no evidence of ochronosis. There was dense matrix 
proteoglycan staining. Examination of the chondrocytes displayed some necrotic looking 
chondrocytes located in their lacunae.
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Figure 6.9:- A lower power photomicrograph showing an over view of the thyroid cartilage 
from M283. No obvious sign of ochronosis is seen in the cartilage matrix or with the enthesis 
of the thyro-arytenoid muscles.
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Figure 6.10:- A high power photomicrograph showing the chondrocytes in their matrix within 
the thyroid cartilage. Many chondrocytes look necrotic and some display an ochre colour 
suggestive of intracellular ochronosis.
High magnification examination of the chondrocytes showed that some displayed ochre 
colouration of the cytoplasm. The enthesis of the thyro-arytenoid muscles displayed no 
pigmentation.
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6.2.2.3. Kidneys
Microscopic examination of the kidneys revealed widespread pigmented nodules throughout. 
H&E staining demonstrated the pigment was present in numerous large cast-like structures. 
The peripheral fibrous capsule around these casts showed granules of ochronotic pigment 
associated with the fibrous matrix components, these granular deposits were also seen in the 
cytoplasm of fibroblasts in these regions. Within these pigmented casts were numerous 
mononuclear cells. These cells showed numerous dense granular deposits of ochronotic 
pigment within their cytoplasm. There were often numerous mononuclear cells at the 
periphery of these cast-like structures and they displayed large cytoplasmic deposits of 
ochronotic pigment.
In the tubules of the kidney numerous ochronotic deposits were seen, presumed to be urine 
which had undergone polymerisation. Surrounding some of these tubular deposits were had 
columnar cells in the vicinity that had numerous granules of pigment located in their 
cytoplasm and also associated with the nearby matrix.
There were numerous tubules in the kidneys of these animals which demonstrated sloughing 
of cells, indicative of acute tubular necrosis. The inflammation and deposition of pigment in 
these kidneys made determination of some regions of microscopical anatomy difficult to 
interpret. It was difficult to distinguish proximal from distal tubules and both of these from 
collecting ducts. Kidneys from younger mice which had been off NTBC for a shorter period 
of time displayed no similar pigmentation (Figs. 6.17-6.19).
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Figure 6.11:- A low power photomicrograph showing a large cyst-like structure from the 
kidney of M283 (as seen in Figure 6.1) Ochronotic pigment is dear around the periphery of 
the structure and large amounts of intra and extracellular pigment are seen in the centre of 
the structure. The intracellular pigmentation is clearly located within mononuclear cells.
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Figure 6.12:- A high power photomicrograph showing the presence of intracellular granular 
deposits in mononuclear cells within the cyst. There is also extracellular pigment seen 
amongst these cells.
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Figure 6.13:- High power photomicrograph of the periphery of the cyst like structure. This 
demonstrates intracellular pigmentation in fibroblast like cells and extracellular 
pigmentation associated with the fibrous tissues.
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Figure 6.14:- A high power photomicrograph showing the ochronotic appearance of urine in 
the tubules of the kidney from M272. Granular pigment is also seen within fibroblasts in the 
collagenous matrix.
6.2.2.4. Schmorls staining of kidneys
Staining of near serial sections of kidneys from mice off NTBC for 11 months confirmed the 
observations seen in the H&E sections. It also highlighted pigmentation around the casts that 
were undetected by H&E staining.
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Figure 6.15:- High power photomicrograph showing the presence of intracellular ochronotic 
deposits within the mononuclear and fibroblast like cells.
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Figure 6.16:- A high power photomicrograph showing the ochronotic urine in the tubules of 
the kidney from M283. This staining also detects ochronosis associated with the lining cells 
of the tubules, fibroblastic cells and their associated matrices.
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Figure 6.17:- A low power photomicrograph from the kidney of mouse off NTBC for 2 weeks 
(M2091). No detectable Ultra or extracellular ochronosis.
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Figure 6.18:- A low power photomicrograph showing the kidney of mouse off NTBC for 2 
days (M240). There is no detectable sign of ochronosis either intra or extracellularly.
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Figure 6.19:- A low power photomicrograph showing the kidney of mouse off NTBC for 1 day 
(M236). There is no detectable intra or extracellular ochronosis.
6.2.2.5 Knee Joints
Overview of the knee joints revealed normal cartilage matrix located on the underlying bone 
architecture. There was no ochronosis of the cartilage matrix on the distal femur or proximal 
tibia; as seen widespread in the human joint articular cartilage matrix. The surface of the 
articular cartilage appeared normal with no pigmentation or degeneration.
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Figure 6.20:- A high power photomicrograph showing the overview of the knee joint from 
M283. all major anatomical features of the knee joint are seen: distal femur, tibia, fibula, 
patella and meniscus.
High power observations of the distal femur revealed numerous chondrocytes deep in the 
cartilage matrix, in close proximity to the subchondral bone, with a dusky appearance to their 
pericellular matrix. The chondrocytes were a mixture of isolated cells and pairs of 
chondrocytes. These chondrocytes and their lacunae showed a spherical shape. There were 
regions on the distal femur that displayed an absence of subchondral plate beneath the 
articular cartilage.
The proximal tibia showed numerous hypertrophic chondrocytes, some of which showed 
intracellular pigmentation. In other regions of the proximal tibia the articular surface showed 
discontinuity at the surface and underlying chondrocytes showed dense pigmentation. The
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head of the fibula also showed chondrocytes in singular and groups that had dense 
pigmentation of their territorial and pericellular matrix. These again were closest to the 
subchondral bone, no similar' pigmentation was seen in the chondrocytes close to or at the 
articular' surface. The meniscus displayed a small number of chondrocytes on the superior- 
surface which had a dusky appearance around their periphery. There were no chondrocytes in 
the centre of the structure which displayed this pigmentation.
There was also pigmentation in the enthesis of the muscle inserting into the fibula showed 
pigmentation in the fibrocartilagenous insertion. The chondrocytes showed intra and 
pericellular' pigmentation.
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Figure 6.21:- A high power photomicrograph showing the distal femur (top), meniscus 
(central) and proximal tibia (bottom). Deep chondrocytes of the distal femur show
ochronosis in their pericellular matrix.
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Figure 6.22:- A high power photomicrograph of the proximal fibula show clear intracellular
ochronosis of the deep chondrocytes along with their pericellular and territorial matrices, 
some cells appear dead or necrotic. No comparable ochronosis is seen at the articular 
surface of in the osteocytes.
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Figure 6.23:- A high power photomicrograph showing the distal femur. Numerous 
chondrocytes and their periceeluar and territorial matrices show ochronosis. There is no 
comparable pigmentation in the interterritorial matrices and at the articular surface.
6.3 DISCUSSION
This Chapter presents the first data showing ochronosis of tissues in a murine model of 
alkaptonuria. It has previously been published that mice with the AKU genotype do exist 
(Montagutelli, 1994). However, these animals do not go on to display the usual phenotypic 
ochronosis seen in the adult human, even though they have elevated levels of urinary HGA 
(Montagutelli, 1994, Suzuki, 1999). It has been suggested that the endogenous production of 
ascorbic acid is a protective mechanism against the gradual ochronosis of tissues in these 
animals (Kamoun, 1992), or that they do not live long enough to allow deposition to occur in 
their tissues, or that urinary excretion is so complete that tissues do not experience high
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concentrations of HGA. Here we show that tissues, including those of the joints, show 
ochronosis in mice carrying the mutation for the disease and displaying the high urinary 
excretion of HGA, when combined with the effects of a second mutation in the FAH gene.
It has been proposed that ascorbic acid, which is produced endogenously in these animals 
may act as a protective factor. These results suggest that the presence of ascorbic acid is not 
sufficient to completely prevent pigmentation in all mice. While mice that have been AKU 
from birth have not yet been shown to display any pigmentation, longitudinal studies of their 
lifespan do not exist, so it is difficult to completely rule out pigmentation in aged specimens. 
It has previously been suggested that HGA is not the sole determining factor in pigmentation 
(Taylor, 2010). The sporadic distribution of pigmentation in the HGD/HTT1 animals would 
lend further weight to that theory that not all animals or regions of these animals show 
pigmentation following the initial conversion to the AKU phenotype many months before 
sampling. 10 months off NTBC with buildup HGA should be sufficient for pigmentation to 
occur across numerous cartilaginous structures.
Detection of pigmentation within the kidneys in these animals is not surprising from a 
functional point of view given this is the site of filtration of the blood and the high metabolic 
activity that occurs here. It is well documented that the darkening of urine is a sign of 
ochronosis and kidney manifestations in humans are not uncommon: for example, the passing 
of pigmented kidney stones. There are also descriptions of pigmentation within the kidneys in 
humans and histologically associated manifestations of the deposition in these tissues 
(Helliwell, 2008 & Gaines, 1989).
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The kidneys in these animals are of interest as it maybe that the effects of the withdrawal of 
NTBC on these animals and the effects of FAA on the non AKU regions of the kidneys, 
causing damage, would seriously affect the ability of the kidneys to perform their function, 
the loss of normal functionality may also be similar to the renal slow down experienced by 
human AKU sufferers with ageing, limiting the ability of the kidneys to excrete EGA 
(Lindeman, 1985). However, there is currently no longitudinal data detailing the urinary (and 
plasma) levels of EGA in AKU patients prior to known ochronosis, or the change over time. 
Such data would indeed be useful, perhaps observations at a young adolescent age and then 
compared following a removal of a known ochronotic joint or detection of ochronosis in the 
sclera or pinna.
It has been shown and widely accepted that there is EGA present in the urine of the HGD-/- 
and FAH-/-HGD+/- knockouts. There is currently no evidence describing the concentration 
of the EGA in the urine, or more importantly the plasma of these animals. However, we show 
that regardless of the concentration, it is sufficient to undergo polymerisation and deposit as 
ochronotic pigment in multiple tissues. Absence of deposition in the cardiac connective 
tissues are not of major note, given that not all AKU patients present with cardiac 
involvement, this suggests that lifestyle factors may play a role in the deposition process. 
Whatever these factors may be, they are yet to be elucidated.
Deposition in the cartilage of these mice shows that there is sufficient EGA present to allow 
for polymerisation and deposition. It has been shown in chapter 5 that deposition in the 
human condition starts focally, associated with single chondrocytes in the calcified cartilage,
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progressing towards the articular surface with intracellular deposition appearing to precede 
the extracellular deposition (Taylor, 2011). It appeal's that the initiation in these animals is the 
same, demonstrating that these animals may be valuable for screening therapeutic strategies 
for inhibiting or reversing pigment deposition in AKU. Whilst bone changes are seen in the 
human disorder (Taylor, 2011), they were not observed in these mice, bone matrix was 
devoid of pigmentation, and also bone cells. This also adds weight to the hypothesis that 
mineralisation is protective in the disorder. It must be appreciated that bone changes appear 
secondary to the cartilage changes in the progression of AKU, so while bone changes were 
not observed in these animals, they may occur at a later stage, once the cartilaginous changes 
become more widespread.
The observations within the murine chondrocytes of two distinctly different types of 
pigmentation (granular and blanket) is interesting, as this suggests that similar to the human 
condition, pigmentation may actually arise under two different mechanisms within these 
tissues (Taylor, 2010). This adds further weight to our claim of synonymy with the human 
condition. Murine models have proved useful for investigation into disorders on the tyrosine 
metabolic pathway, particularly with the AKU mouse model which was influential in 
decoding the location of the then unknown human mutation (Montagutelli, 1994, Poliak, 
1993 Sc Janocha, 1994). The proposed treatment of alkaptonuria using NTBC came about 
from investigations into mice deficient in the FAH gene. These animals are exposed to the 
buildup of toxic tyrosine metabolites neonatally, once FAH production begins around day 16. 
The homozygous animals do not survive beyond 24 hours of birth; however administration of 
NTBC to mothers whilst pregnant, on day 15 of gestation results in the neonatal effect of 
FAH deficiency being abolished (Grompe, 1995). The use of NTBC for treatment of HTT1 is 
now a widely used treatment, although it is not without risks - patients are vulnerable to
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hepatocarcinomas (from the underlying hereditary tyrosineamia) and there are further 
complications associated with the elevated tyrosine plasma levels (Manning, 1999).
The animals which were FAH knockout or FAH knockout and HGD heterozygote showed 
deterioration with their health following withdrawal from NTBC. In contrast to this the 
animals which were double knockouts at the FAH and HGD gene were healthy at 4, 7, 9 & 
11 weeks off NTBC (Manning, 1999). A similar phenotype and spontaneous mutation has 
also been described in Aspergillus (Fernandez-Canon, 1995). The reversion to the AKU 
phenotype of both these systems showed the distinct darkening of urine and media (Manning, 
1999 & Fernandez-Canon, 1995). Furthermore it has been shown that kidneys from FAH-/- 
animals are pale and increased in size, confirming that they are abnormal (Grompe, 1995). 
This in itself may result in an increase in the stresses in the kidneys which in turn promotes 
ochronosis in the surrounding AKU genotype/phenotype regions of these kidneys.
It is encouraging that the earliest signs of pigmentation in these animals have been observed 
and are synonymous with that of the human condition. It is this critical time point that the 
ochronosis would need to be treated in human AKU, to prevent full ochronotic 
osteoarthropathy developing. From our published evidence and that described in the literature 
it is unlikely that once the pigment is deposited it can be turned over, as seen by the inability 
of Tergazyme to degrade ochronotic cartilage in Chapter 5 (Taylor, 2011). This time point in 
the murine model will provide a useful tool for screening potential therapeutic agents. 
Detection of ochronosis in murine tissues represents a distinct advance in the knowledge and 
understanding of alkaptonuric osteoarthropathy and will allow us to gain a better 
understanding into the molecular pathogenesis of the disorder.
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7. Identification of trabecular excrescences, novel microanatomical structures, 
present in bone in osteoarthropathies
221
7.1 INTRODUCTION
Turnover of skeletal tissues occurs as part of development and continues throughout life, 
in both health and disease. It is usually held and widely stated that skeletal architecture is 
finely regulated in accordance with homeostatic requirements by bone modelling (net 
deposition or resorption) and remodelling (resorption and subsequent deposition) and that 
one of the major influences on remodelling is mechanical loading. The tissue level 
responses at the micro and ultrastructural levels are complex chains of events involving a 
number of specialised layers within the joint, namely; hyaline articular cartilage (HAC), 
articular calcified cartilage (ACC), subchondral bone (SCB), trabecular and cortical bone. 
The relationships between bone and cartilage are highly dependent on reciprocal normal 
functions of the tissues. Under normal loading, HAC transmits forces down through the 
ACC to SCB, resulting in high shear stresses at the osteochondral junction region brought 
about by differences in the material properties of the calcified and non-calcified tissues. 
Remodelling of bone is usually highly regulated with a balance of bone removal and 
formation (Frost, 1964) in what is generally considered to be a coupled mechanism 
(Parfitt, 1982). However, alterations in trabecular architecture with the normal ageing 
process suggest that the coupling mechanism is not as tightly regulated as it appears to be 
in earlier life (Jayasinghe, 1993 & Jayasinghe, 1994).
Remodelling is regulated by a complex interaction of systemic and local factors including 
paracrine and autocrine signals. The topography of the surface that is produced by the 
osteoclasts is also important in regulating new bone formation (Gray, 1996). While 
coupling and (re)modelling is focal at multiple locations at any given time (Frost, 1991), 
the systemic hormones and the cells exhibit a multitude of wider reaching effects which
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result in the replication of undifferentiated cells, recruitment of cells and the 
differentiated function of cells (Hill, 1998).
Deviation from the finely balanced and highly regulated (re)modelling process results in 
numerous recognised pathological conditions in the mineralised tissues. These include 
osteoporosis, in which resorption exceeds formation (Russell, 2003). Aberrant 
remodelling of bone underlying cartilage is frequently observed in arthropathies, the most 
common of which is osteoarthritis (OA). There is still much debate about what instigates 
pathological change(s) in tissues in OA and whether the defect occurs in the HAC or the 
SCB first, or whether they occur simultaneously. However, the changes in both tissues 
bring about altered loading across the joint tissues.
The recognition of AKU as a rare form of OA is also supported by common end point 
treatment of both disorders - joint replacement (Kraus, 2011). In AKU, it is commonly 
held that cartilage is the predominantly affected tissue, although it has been shown that 
capsular tissues are also involved. Ochronotic pigment derived from polymerisation of 
homogentisic acid (HGA) is initially associated at the ultrastructural level with the 
periodicity of the collagen fibrils, as seen in chapter 4 (Taylor, 2010). The evidence for 
the association of HGA pigment with collagen is clear, but until recently it was accepted 
that bone is relatively unaffected, particularly compared to cartilage (Di Franco, 2000). It 
has been shown that part of the progression of the destructive mechanism in AKU 
involves an up-regulation of the osteoclastic activity in the mineralised joint tissues of 
these patients resulting in the unprecedented complete resorption of the SCB plate and 
ACC, as seen in chapter 5 (Taylor, 2011). This resorption may be induced by altered 
loading, possibly as a result of stress shielding due to the altered mechanical properties of
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the overlying HAC. Ochronotic pigment deposition increases the stiffness of the HAC 
matrix, resulting in abnormal distribution of load through the tissues and Chapter 5 of this 
Thesis (Taylor, 2011). Alternatively, HGA polymer deposition may inhibit the 
mineralisation of HAC to become ACC and the reserve of ACC may eventually be used 
up.
In this chapter, analyses of samples from AKU arthropathies were undertaken following 
our previous discovery of the extraordinary SCB and ACC phenotype and compared them 
with more common OA arthropathy samples (Taylor, 2011). In performing this study we 
were able to identify novel microanatomical structures in bone of patients with 
ochronotic arthropathy which may be the result of the abnormal loading in the tissues 
following changes in the load distribution across the joint because of aggressive 
remodelling of the SCB & ACC plate. These microanatomical structures were discovered 
using 3D SEM. This high depth of field technique, even when used at low magnification, 
allowed the identification and observation of numerous excrescences on free bone 
surfaces. Subsequently, conventional light microscopic histology and quantitative 
backscattered electron mode scanning electron microscopy (qBSE-SEM) both confirmed 
their presence in the calcified matrix. The number and type of excrescence were more 
difficult to distinguish by these latter imaging methods as they are limited either by the 
thickness of the specimens - ~5pm for light microscopy - or by the information depth of 
the method - - 0.5pm for 20kV qBSE-SEM.
Unexpectedly these structures were subsequently observed in 'ordinary' osteoarthritic 
samples that were being used as control, reference specimens for the investigation, and,
224
retrospectively, other archival OA samples used for BSE SEM studies. These structures 
add evidence to the literature that already describes the abnormal structure and function 
of tissues in joint arthropathy
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7.2 RESULTS
7.2.1. 3D topographical SEM imaging of AKU Bone
3D topographical SEM imaging of the most severe ochronotic arthropathy sample 
revealed localised porotic bone within the femoral head. The more porotic regions were 
peripheral. In the centre of the sample, there was a greater amount of bone with fewer 
distinguishable trabeculae. The majority of mineralised matrix was present as large bone 
plates joined together by short trabeculae. Close examination of the trabecular plates and 
rods in the regions of high bone volume revealed the presence of numerous excrescences 
on the surface and frequently some distinct discontinuity with the established bone 
surface (Fig. 7.1-7.4).
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Figure 7.1: 20kV BSE 3D SEM images of carbon coated, macerated slice of femoral head 
from a 59 year old male who underwent a left total hip replacement for ochronotic 
osteoarthropathy. Numerous excrescences project from the otherwise smooth contour of 
the internal bone surfaces. Top centre shows an excrescence on pre-existing resting 
surface. Its surface is partly scalloped, suggesting osteoclastic resorption. Surface- 
osteocyte lacunae can also be seen in other parts of the excrescence. Image field is 2700
microns wide and high.
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Figure 7.2: 20kV BSE 3D SEM images of carbon coated, macerated slice of femoral head 
from a 59 year old male who underwent a left total hip replacement for ochronotic 
osteoarthropathy. Numerous, many thin, free-ended (unloaded), resorbed trabeculae. 
Some have been partially resorbed, before new bone deposition over their surfaces 
(bottom right). Image field is 2700 microns wide and high.
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Figure 7.3: 20kV BSE 3D SEM images of carbon coated, macerated slice of femoral head 
from a 59 year old male who underwent a left total hip replacement for ochronotic 
osteoarthropathy. Another field of mostly plate-like trabeculae with numerous stucco 
projections from otherwise smooth surfaces. Image field is 2700 microns wide and high.
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Figure 7.4: 20kV BSE 3D SEM images of carbon coated, macerated slice of femoral head 
from a 59 year old male who underwent a left total hip replacement for ochronotic 
osteoarthropathy. Large microcallus patches (arrows) formed from woven bone can be 
seen in the left hand side of the image. Several areas show incomplete integration of old 
and new bone packets. Also note incomplete, resorbed trabecular ends. Image field is 
2700 microns wide and high.
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There appeared to be various morphologies of excrescence. One very common type 
appears to have arisen from the incomplete resorption of something projecting above the 
general plane of the local bone surface, perhaps arising from partial removal of secondary 
or extra trabeculae, not part of the original stock of normally distributed trabeculae and 
which must have formed in prior marrow space. Extra trabeculae made of immature 
(woven) bone are a common accompaniment of osteoarthritis. These are characterised by 
deeply scalloped surfaces and rugged edges (Fig. 7.1 & 7.5). The resorption involved 
here is deeper and shows larger pits or scoops than those of normal resorption fields, an 
example of which is shown in Fig. 7.6.
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Figure 7.5: 20kV BSE 3D SEM images of carbon coated, macerated slice of femoral head 
from a 59 year old male who underwent a left total hip replacement for ochronotic 
osteoarthropathy. A normal resorbed area is seen at left with shallow, skimming 
osteoclastic resorption: this packet' has been partly infilled with nearly completely 
mineralised bone; the scene is thus typical of normal resorption-formation coupling. This 
contrasts strongly with the rugged scalloped edges of the obvious 'stucco' excrescences. 
Image field is 900 microns wide and high.
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Figure 7.6: 20kV BSE 3D SEM images of carbon coated, macerated slice of femoral head 
from a 59 year old male who underwent a left total hip replacement for ochronotic 
osteoarthropathy. An area of normal, but unrepaired resorption on the side of a massive 
trabecula is seen at centre. Image field is 900 microns wide and high.
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Figure 7.7: 20kV BSE 3D SEM images of carbon coated, macerated slice of femoral head 
from a 59 year old male who underwent a left total hip replacement for ochronotic 
osteoarthropathy. Excrescence just below centre resulted from incomplete resorption oj 
prior trabeculae and is covered with nearly completely mineralised new bone matrix with
continuous collagen fibre bundle profiles in this superficially anorganic, peroxide treated 
sample (Boyde, 1972). Image field is 900 microns wide and high.
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Figure 7.8: 20kV BSE 3D SEM images of carbon coated, macerated slice of femoral head 
from a 59 year old male (AKU3) who underwent a left total hip replacement for 
ochronotic osteoarthropathy. Higher magnification detail of an immature bone patch seen 
in Fig 7.4. This microcallus patch is typical of those found in other ageing human bone 
samples, including in osteoporosis. Image field is 900 microns wide and high.
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The second appearance of excrescence is similar to the first but they have been smoothed 
over by new bone deposition (Fig. 7.7). Neither of these types resemble the common type 
of microcallus patch (another form of excrescence but which is not consider novel) found 
in older human trabecular bone, and which was also found in this study, an example of 
which is shown in Fig. 7.8, which is a higher magnification of part of the field of view 
shown in Fig. 7.4.
A third appearance merges with the others, but more resembles coarse stucco and seems 
to have arisen where resting surfaces have been focally reactivated. These appear as 
random patches on the bone surface (Fig. 7.1 & 7.3). These deposits are frequently poorly 
attached to the prior trabecular wall in our macerated SEM samples, as demonstrated by 
clearly observable discontinuities between the excrescences and the otherwise continuous 
trabecular surfaces.
Analyses other pathological and normal bone have not yielded similar structures to date. 
(Li, 1999, Boyde 2003 & Boyde,2003).
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7.2.2 Histology of AKU bone
Histological observations of the bone in ochronotic samples revealed multiple 
excrescences throughout the tissue, although the low section thickness makes it difficult 
to distinguish between types (Fig. 7.9 & 7.12). Examination of AKU histological sections 
using autofluorescence revealed differences in the fluorescence of the established bone 
matrix and excrescences which were attached to their surface (Fig. 7.13).
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Figure 7.9: Light microscopy of decalcified paraffin-embedded sections demonstrating 
excrescences on bone surface from a 59yr old male patient (AKU3) who underwent hip 
replacement surgery for ochronotic osteoarthropathy. H&E stained, in transmitted light, 
showing excrescences on both surfaces of a trabecula.
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Figure 7.10: Light microscopy of decalcified paraffin-embedded sections demonstrating 
excrescences on bone sufface from the femoral condyle of a 46yr of male (AKU9) who 
underwent knee replacement surgery for ochronotic osteoarthropathy. H&E stained, in 
transmitted light, showing excrescence on the marrow suiface of a thin subchondral 
plate, beneath the articular cartilage.
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Figure 7.11: Higher power light microscopy of decalcified paraffin-embedded sections 
demonstrating excrescences on bone surface from the femoral condyle of a 46yr old male 
(AKU9) who underwent knee replacement surgery’ for ochronotic osteoarthropathy. H&E 
stained, in transmitted light, showing excrescence on the marrow surface of a thin 
subchondral plate, beneath the articular cartilage. Note the incomplete incorporation 
into the thin subchondral bone plate.
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excrescences on bone surface from the femoral condyle of a 58yr old female (AKU10)
who underwent knee replacement surgery for ochronotic osteoarthropathy. H&E stained,
in transmitted light, showing an excrescence on the trabecular suiface.
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Figure 7.13: Epifluorescence of an unstained section under blue excitation, showing the 
difference in fluorescence of the established matrix and the excrescence from a 59yr old 
male (AKU3) patient who underwent hip replacement surgery’ for ochronotic 
osteoa rth ropa thy.
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7.2.3 qBSE - SEM imaging of AKU bone
qBSE - SEM imaging of AKU bone was performed to examine the bone quality of the 
AKU samples. Overall, mineralisation densities in trabeculae were within the normal 
range. Some of the trabecular surfaces showed surface abnormalities consistent with the 
3D topographical images. Obvious excrescences showed increased mineralisation density 
(higher qBSE grey levels) than the underlying normal mineralised bone architecture (Fig 
7.14 & 7.15). A few excrescences display preparative cracks at their attachment surfaces 
with the trabeculae, i.e., they were less well integrated with the existing bone. Other 
regions where normal new bone packets which formed over non-resorbed surfaces may 
also show artefactual detachment during sample preparation for SEM, as shown in Fig. 
7.15. In Fig. 7.14 trabeculae show normal structure and range of mineral density. 
Excrescences (11 in the field of view) can be seen on the trabecular surfaces. The bulk of 
the trabeculae exhibit normal density range, but the excrescences show 
hypermineralisation when compared to the trabeculae.
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Figure 7.14: 20kV qBSE-SEM images of polished and carbon coated PMMA embedded 
slice of femoral head from same 59 year old ochronosis case: image fields are 2700 
microns high and wide. Mineralisation density1 was determined by reference to 
halogenated dimethacrylate standards. For explanation, see table in inset. Grey levels 
were adjusted such that the value from the monobrominated standard was adjusted to 
zero and that for the monoiodinated standard to 255 (as detailed in Boyde, 1999 and
Boyde, 2005).
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Figure 7.15: 20kV qBSE-SEM images of polished and carbon coated PMMA embedded 
slice of femoral head from same 59 year old ochronosis case: image fields are 2700 
microns high and wide. Mineralisation density was determined by reference to 
halogenated dimethacrylate standards. For explanation, see table in inset. Grey levels 
were adjusted such that the value from the monobrominated standard was adjusted to 
zero and that for the monoiodinated standard to 255 (as detailed in Boyde, 1999 & 
Boyde, 2005). Trabeculae show normal architecture, with plane of poor integration
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between pre-existing unresorbed bone and overlying newly formed bone at lower left. 
Excrescence on left of this latter trabecula is also not well integrated and also not 
deposited on a resorbed surface.l2A. 3D topographical SEM imaging of the 
osteoarthritic arthropathy samples
Examination of the osteoarthritic arthropathy samples used as reference material, with all 
the methods used - 3D- SEM (Fig. 7.16 & 7.17) light microscopy of sections (Fig. 7.18- 
7.20), and qBSE SEM (not figured) - showed similar excrescences (Figs. 7.16-7.20). 
These were present in the different forms observed in the ochronotic samples. 3D SEM 
also showed that there was some poor integration of the excrescences with the pre­
existing bone matrix surface.
In histology, the excrescences observed were numerous “peak like” structures projecting 
from the surface of the trabeculae and displaying a different colour to the mineralised 
bone matrix when stained with H&E (Fig. 7.18-7.20). At the contact surface between the 
existing trabeculae and the attached structure there was a distinct joint line, also the 
marrow space periphery of the structures displayed rough edges, both features suggesting 
that integration between the excrescences and trabeculae was either not complete or
occurred in an aberrant fashion.
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Figure 7.16: 20kV BSE 3D SEM images of carbon coated, macerated slice of medial 
femoral condyle from 51 year old female who underwent unicompartmental knee 
replacement for osteoarthritis. Numerous excrescences can be seen on the trabeculae, 
predominantly with rugged edges and scalloped surfaces. Some appear darker than the 
surrounding bone matrix, indicative of a lower degree of mineralisation because more 
recently formed. Field width and height is 4050 microns.
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Figure 7.17: 20kV BSE 3D SEM images of carbon coated, macerated slice of medial 
femoral condyle from 51 year old female who underwent unicompartmental knee 
replacement for osteoarthritis. Large excrescences on free bone surfaces with multiple 
deeply indented surfaces and intervening rugged edges can be seen. The peripheries of 
some of these conglomerates show a line of demarcation where they have not been well 
integrated with the pre-existing surfaces. Field width and height are 1780 microns.
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Figure 7.18: Low power photomicrograph of a H& E stained decalcified paraffin- 
embedded section from the medial femoral condyle of a 51 year old female knee OA case 
who underwent unicompartmental knee replacement for OA.
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Figure 7.19: Low power photomicrograph of an excrescence located on a trabeculae from 
medial femoral condyle from 74 year old male who underwent a total knee replacement 
for osteoarthritis.
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Figure 7.20: A high power photomicrograph of the excrescence from the previous figure 
showing its presence on the trabecular surface. At least two cells can be seen as part of 
the excrescence body. There also appears to be a relationship with the adipose matrix in
the marrow space.
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7.3 DISCUSSION
This chapter reports the discovery of novel microanatomical structures in bone from 
patients with AKU osteoarthropathy, which have been termed trabecular excrescences. It 
has recently demonstrated that the subchondral bone and calcified cartilage plates in 
AKU undergo extreme remodelling; giving them a unique phenotype (Taylor, 2011) and 
chapter 5 in this thesis. Investigation of the bone architecture revealed the presence of 
novel excrescences on the bone surface, originally detected by SEM analysis and 
subsequently confirmed using histological techniques.
Following on from this initial discovery, OA samples were examined as a control, these 
structures were discovered in some, but not all of the OA samples examined. To date, 
they have been observed in all the AKU material that have been studied (12/12), but only 
a proportion of OA (7/10). Their initial discovery in AKU, resulted in the theory that the 
presence of these structures may be in part related to the presence of the HGA or HGA 
pigment in the joint tissues of AKU patients, but the detection of these excrescences in 
the OA samples suggests that these structures arise due to aberrant osteoblast/osteoclast 
signalling, possibly brought on by abnormal loading on the joint tissues following 
alterations in the normal biomechanical interactions related to disease. It is important to 
consider that the highly abnormal phenotype in AKU joint tissues appears to be at least in 
part a result of aberrant loading due to the presence of ochronotic pigment altering the 
stiffness of cartilage (Taylor, 2011). The presence of these excrescences within some 
common OA samples provides further evidence for the role of abnormal loading across 
the joint in OA patients as significant in the onset and progression of OA (Griffin, 2005).
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The relationship between bone and cartilage in the progression of joint failure has been 
well investigated, and it is generally accepted that there are key roles for both in both the 
commencement and the progression of joint degeneration, particularly in OA (Burr, 
2004). It is clear that the basic description of changes involved in joint degeneration are 
not limited to bone and cartilage, but are more appropriately attributed to highly 
specialised sub-divisions of these tissues which are related to their homeostatic and 
biomechanical functions.
The detection of these 3 types of excrescence, which may or may not all be interrelated, 
may be indicative of altered phenotype of cells and the abnormal homeostasis and 
signalling in these tissues. One type of excrescence arises from incomplete resorption of 
branching trabeculae which do not appear to be part and parcel of the 'normal', pre­
existing trabecular architecture. It is common in OA for marrow spaces to be filled with 
immature 'woven' bone which some might describe as 'micro' callus, but the term callus 
should not be taken to imply that the tissue is formed in response to overt fracture. 
Similar obliteration of marrow space occurs in the densification of normal bone in 
response to heavy impact exercise with no evidence of any sign of trabecular 
microfracture (Boyde, 2005). Modelling of this excess bone tissue to restore the 
homeostatic mechanical loading balance might then result in this appearance.
However, these structures appeal' to be closely related to the another type of excrescence, 
in which short, branched trabeculae that had been subjected to partial osteoclastic action 
have been smoothed over by the deposition of new layers of bone by osteoblasts. The 
deposition of new matrix on these structures leads to smooth partial trabeculae projecting 
into the marrow space. The functional contribution of these partial trabeculae must be
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severely questioned given that without connections at both ends, they could not provide 
any form of structural support in biomechanical function.
The type of excrescence which appears as coarse stucco represents stuck on spots on 
resting surfaces that have been focally reactivated. In turn, their surface morphology 
appears very frequently also to be altered by subsequent resorption. The coupling 
between bone resorption and formation is supposedly tightly regulated in the normal 
mature young adult, such that bone is only removed if there is going to be new bone to 
replace it. Osteoblasts normally arrive at the sites of resorption recently vacated by 
osteoclasts (Parfitt, 2000). However, this coupling phenomenon does not exist in the 
growing and drifting skeleton, and is less tight in ageing when trabecular modelling 
occurs. It can also be severely unbalanced in pathological states to cause bone loss 
(osteoporosis) or deposition (sclerosis). The deposition of new bone on the surface of 
existing trabeculae without osteoclastic resorption suggests that such coupling does not 
exist in this case.
Whilst the tissues examined in this study are from two different diseases, they both 
display similar structures on the trabecular network. The advanced osteoarthropathy of 
AKU provides an unprecedented opportunity to investigate regional unloading and 
factors that might be involved in this process. The initial discovery working on AKU 
samples, where the novel microanatomical structures which were grouped as 
excrescences were identified easily on internal surfaces. The follow up observations of 
OA samples as controls for this study and the catalogue of OA samples that the authors 
have observed previously, demonstrated that these structures are present, but are not as
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obvious or widespread. This may suggest that whatever mechanisms are involved in their 
formation are more severe in the pathology of AKU.
In summary, through meticulous examination using a combination of light microscopy 
and SEM, identification of novel microanatomical structures in bone has been 
demonstrated. These were first identified in the osteoarthropathy of AKU, where they are 
abundant, and subsequently in OA where they proved more difficult to find. Their size 
and distribution would make these excrescences difficult to find using other imaging 
modalities, including microCT. Much further investigation is required to determine their 
development and functional significance and whether they are present in other 
pathological conditions. Interestingly the subsequent histological examination revealed that 
adipocytes exactly fitted the contours of the bone surfaces (Fig 7.18-7.20). A role for 
adipocytes as bone lining cells has been suggested previously (Boyde, 2006), but there is 
no literature proposing a role for adipocytes in templating or moulding the surface of 
bone. Immunohistochemistry shows that there is collagen VI in these excrescences 
(Unpublished observations, Taylor 2010). These results suggest that the deposition of the 
bone matrix within these mineralised excrescences is at least templated and modulated by 
adipocytes. However, the absence of osteoblasts from the forming surfaces raises the 
question of whether the matrix which is subsequently mineralised is partially synthesised 
by the adipocytes. Furthermore, it provides unequivocal evidence that adipocytes rather 
than inactive osteoblasts are the de facto lining cells on some bone surfaces. It is well 
recognised that adipocytes and osteoblasts can be derived from the same mesenchymal 
stem cells under the influence of different transcription factors. Furthermore there is
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evidence of transdifferentiation between the cell types. However, this is the first report of 
an intimate role for adipocytes in osteogenesis.
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8. Investigation into the deposition of ochronotic pigment in submandibular tissues
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8.1 INTRODUCTION
Whilst deposition of pigment in cartilage is well documented (O’Brien, 1963) deposition of 
pigment is also seen at non-cartilaginous sites (Helliwell, 2008). Although these presentations 
do not manifest uniformly in all patients, understanding the factois piomoting pigment 
deposition in these less common places may improve the understanding of the pigmentation 
process as a whole. There is a clear role for pH in the pigment formation process, 
demonstrated by Boedecker, and black colouration of alkaptonuiic uiine undei alkaline 
conditions in the presence of oxygen (cited by O’Brien). (O’Brien, 1963).
8.2. CASE HISTORY
A 47 year old male was diagnosed with AKU in 2007. Later, he presented with swelling of the 
submandibular salivary gland and an associated lymph node, which became worse after eating. 
Ultrasound examination of the gland revealed numerous stones. The right submandibular gland 
and associated lymph node were excised. Macroscopically, no obvious ochronotic 
pigmentation was noted. Numerous ochronotic “marble-like” stones were removed at the time 
of surgery. These were observed by the surgeon but not retained. This chapter describes for the 
first time the presence of ochronotic pigment in acinar cells of the submandibular gland of an 
alkaptonuric patient.
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8.3 RESULTS
8.3.1 Macroscopic examination of submandibular tissues
Macroscopic examination of the submandibular gland and lymph node blocks and slices did 
not show any unusual pigmentation, consistent with that usually observed in joint tissues; 
calculi were noted in the submandibular gland (arrows).(Figs. 8.1-8.4).
Figure 8.1:- Photograph showing AKU7AI block (lymph node) embedded in paraffin wax, 
with no obvious signs of ochronosis.
Figure 8.2:- photograph showing AKU7BI block (submandibular gland) embedded in paraffin 
wax, with no obvious signs of ochronosis. A calculus can be seen within the gland (arrow).
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Figure 8.3:- Photograph showing AKU7B2 block (submandibular gland) embedded in 
paraffin wax, with no obvious signs of ochronosis. Calculi can clearly be seen located within 
the gland (arrows).
Figure 8.4:- Photograph showing AKU7B3 block (submandibular gland) embedded in 
paraffin wax, with no obvious signs of ochronosis. A calculus can clearly be seen within the 
gland.
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8.3.2 Microscopic examination of submandibular tissue
Microscopic examination of the submandibular gland showed mild chronic sialadenitis, with 
no evidence of tissue destruction. Examination of extracellular connective tissue around the 
vessels and ducts in the gland did not display any ochronotic pigment. A calculus was present 
in the lumen of a lobar duct. H&E staining of the calculus revealed calcium (Fig. 8.5) and 
addition of 1 % HC1 resulted in its dissolution.
Examination of secretory acini displayed differences across the gland (Fig. 8.6). It was 
noticeable that the duct lumen of certain acini displayed dark granular pigmentation, which 
appeared to fill the lumen of some acini. Closer examination revealed the presence of pigment 
within the cytoplasm at the apical surface of the cells in the pigmented regions. Acinar cells 
displayed morphologically normal nuclei with no signs of apoptosis or necrosis despite 
pigment in the cytoplasm. The cells lining the salivary ducts showed no pigmentation. 
Microscopic examination of the lymph node showed no pigmentation in the connective tissues 
or macrophages.
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Figure 8.5:- Photomicrograph showing the remnants of a large calculus displaying calcium 
deposits along with other associated ochronotic deposits around the periphery. H&E
Figure 8.6:- Serous acini of the submandibular gland show variable amounts of dark 
pigmentation (arrows denote normal looking acini). Insert shows pigmentation in the apical 
parts of the serous cells at higher magnification. H&E
8.4 DISCUSSION
This is the first report of the presence of ochronotic pigment in the acinar cells and duct lumina 
of the submandibular gland in a patient with AKU. HGA is a small highly water-soluble 
molecule that does not accumulate in the body in health. In AKU the kidneys excrete large 
quantities of HGA into the urine, and, in alkaline conditions, the HGA undergoes oxidation to 
black pigment. HGA is present in tissues of the body because of its small molecular size and 
high solubility.
HGA is a small highly water soluble molecule (mw = 168) that does not accumulate in the 
body in health due to repaid metabolism in the liver and kidneys. The kidneys in AKU excrete
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large quantities of HGA into the urine and, in alkaline conditions; the HGA undergoes 
oxidation to a black pigment. HGA is present in tissues of the body due to its small molecular 
size and high solubility.
Saliva is a clear, slightly acidic mucoserous exocrine secretion that is composed of 99% water 
and has a normal pH of between 6-7; during low or peak flow this pH can range from 5.3-7.8 
(Humphrey, 2001). The saliva present in the oral cavity is the product of a process which sees 
the initial secretion in the serous acini modified along its path to the mouth. The secretion 
contains a mixture of ions including Ca2+, Na+, K+, HCO3" and Cl". Once in the striated ducts, 
saliva undergoes modifications altering its composition and pH. The ducts have low 
permeability to water causing the saliva to become more hypotonic (Bridges, 1981). The saliva 
produced by the acinar cells is more alkaline than the final product in the mouth and as such 
may be sufficiently alkaline to promote HGA polymerisation in a similar fashion to that seen 
in alkalinised urine.
Ochronotic pigment has been reported in calculi in other systems, most commonly in the 
kidney, prostate gland and glands in the prostatic urethra of male alkaptonuric individuals. 
Analysis of these calculi has shown calcium compounds including oxalate, phosphate and 
carbonate, along with a substituted calcium compound probably associated with the pigment 
(Krizek. 1971).
The presence of the pigment within the salivary acinar cells suggests that some cells or parts of 
cells may promote HGA polymerisation. The absence of pigment in cells and lumina of the
265
striated ducts suggests the saliva has been modified to an extent that it no longer promotes 
oxidation of HGA or that pigmented secretions are moved along fast enough not to accumulate 
or be obvious microscopically. Salivary gland calculi affect 1.2% of general adult population; 
80% occurring in the submandibular gland. Calculi are usually found in the excretory ducts. 
(Ledesma-Montes, 2007) The opportunity to study the calculi composition in this patient was 
not possible, but staining indicated presence of calcium as well as ochronotic-associated 
deposits.
Pigment accumulates in the cytoplasm of chondrocytes in alkaptonuric joints but the 
process(es) leading to pigmentation are uncertain (Helliwell, 2008). Pigmentation in 
chondrocytes could arise from within the cell, by pHdinked oxidation of HGA, as seen in the 
salivary acinar cells in our patient or by phagocytosis of pigment from the extracellular 
environment in a phagocytic manner. It is known that chondrocytes can phagocytose material 
in their extracellular environment (Castillo, 2004). Absence of extracellular pigmentation 
around the acinar cells in our case suggests the favoured method for pigmentation would be an 
intra-cellular mechanism linked to diffusion of HGA into cells, where changing pH in the 
cytoplasm or particular properties of secretory products of the cell promote polymerisation. 
There is currently no information on how much HGA is present in oral saliva, although it is 
assumed to be similar to that found in other body fluids. However, prostatic secretory products 
undergo darkening when left to stand, and secretions from sebaceous glands in the skin 
presumably contain HGA as they can stain clothing (Krizek, 1971, Turiansky, 2001).
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In this case it is unclear whether pigment deposition in acinar cells may have preceded, 
resulted from, or be unrelated to calculus formation. Given the incidence of calculus formation 
in submandibular tissues in the general population it is probable that calculus formation in this 
case was not caused by alkaptonuria and that acinar cell pigmentation may be unrelated to 
calcification in other parts of the gland. The effect of HGA on the submandibular acinar cells 
has not been documented; in our case the cells show no adverse signs due to the presence of 
HGA pigment.
Ochronotic pigmentation in less commonly examined areas of the body, such as 
submandibular tissues, may provide insights into the mechanisms of pigment formation and 
deposition. It is possible that intracellular HGA polymerisation occurs before secretion and 
binding to extracellular connective tissue fibres, although the process that could lead to this is 
unknown. Evidence supports association of HGA oxidised product with collagen in the 
absence of cells (Milch, 1961). There may be separate intracellular and extracellular 
mechanisms mediating ochronotic pigmentation that overlap in joint tissues. Here I present 
evidence to support the probable involvement of cells in the formation of HGA pigment, in the 
absence of collagen or other extracellular matrix components.
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9. Ochronosis in a mediastinal mass
268
9.X INTRODUCTION
As previously seen in Chapter 8, ochronosis in tissues without a collagenous scaffold has 
been described. Furthermore this case, in which deposition is observed in the 
submandibular gland, has shown association between the ochronotic pigment and 
calcium compounds. This chapter describes a further novel presentation of ochronotic 
pigmentation and the possible association between ochronotic pigment and calcium 
compounds.
9.2 CASE HISTORY
A 51 year old female with AKU attended the AKU clinical evaluation unit in Liverpool 
and assessed by whole body MR scanning. The MR scan of the thorax revealed a 9cm 
diameter, multicystic, partly calcified mass in the anterior mediastinum (Fig. 9.1). 
Surgical access to the anterior mediastinum was through a median sternotomy. 
Ochronotic pigmentation was not seen on any of the surfaces exposed during access to 
the mediastinum. The mass was located posterior to the manubrium and there were 
inflammatory adhesions between the mass and the posterior table of the sternum, the 
mediastinal pleura bilaterally (including the left phrenic nerve and the right lung), the 
pericardium and the innominate (left brachiocephalic) vein. The mass was resected en 
bloc with the pericardium, mediastinal pleura and part of the right upper lobe of lung. 
The patient made an uneventful recovery and was discharged home after 5 days. The 
specimens were photographed immediately following removal and then fixed in 10% 
phosphate buffered formol saline. Tissues were processed routinely for paraffin 
embedding and 5pm sections were cut and stained with haematoxylin and eosin.
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9.3 RESULTS
9.3.1 Macroscopic examination of Mediastinal tissues
A cystic mass measuring 9.5 x 7 x 2.5 cm was excised. Ochronosis was clearly seen 
macroscopically on the excised mass (Fig. 9.2). The external surface showed indurations 
and haemorrhage. Dissection showed a unilocular cyst with calcification in the walls. 
The cyst was full of yellow acellular material. The cut surfaces and internal lining 
showed ochronosis.
Figure 9.1:- MRI scans of the thorax. Sagittal and axial Tl weighted images demonstrate 
a large anterior mediastinal mass of cystic appearance in close relation to the great
vessels.
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Figure 9.2.:- Macroscopic appearance of excised mass with showing regions of dense 
ochronosis.
9.3.2 Microscopic examination of Mediastinal tissues
Examination of the tissues revealed that no cyst lining is seen. The cyst lining was 
replaced by histiocytes. Most of the histiocytes are mononuclear and multinucleate in 
nature, some of which contained ochronotic pigmentation. Also present in the wall is 
patchy inflammation and haemosiderin deposition. A foreign body giant cell reaction is 
also seen. In this specimen no benign immature or malignant epithelial tumour is seen. 
This is most likely a second pathology of an old benign cyst. Microscopic examination 
also revealed that the fibrous wall of the cyst showed patchy lymphocytic infiltration and 
variably dense ochronotic pigmentation in some areas. In these focal regions of 
pigmentation there were extracellular granules of ochronotic pigment associated with the 
collagen fibres. In some instances these fibres were completely encrusted by the granular 
pigment (Figs. 9.3 & 9.4). In the regions of pigmentation there were numerous fibroblasts
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which showed dense intracellular pigmentation. The cytoplasm was in some cells 
completely full of ochronotic pigment, with numerous distinct individual granules in a 
single cell (Fig. 9.5). There are regions of tissues and cells which display no ochronosis. 
This was being interpreted as ochronosis and in keeping with the history of alkaptonuria 
in this patient. In this specimen very focally in the background a rim of lymphoid tissue 
is seen.
Figure 9.3:- Photomicrograph of mediastinal tissues with ochronosis seen in the
extracellular matrix.
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Figure 9.4:- Photomicrograph of mediastinal tissues showing numerous pigment
granules amongst and encrusting the collagen fibres of the extracellular matrix.
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Figure 9.5:- Photomicrograph showing intracellular pigmentation of fibroblasts and 
granules of extracellular ochronotic pigment.
9.4 DISCUSSION
This is the first report of ochronosis associated with a mediastinal cyst, or any form of 
cyst, in a patient with alkaptonuria. It has been described previously that HGA, the small 
water soluble molecule which undergoes polymerisation to deposit as an ochre pigment, 
is assumed to be present in all tissues in the body, even with efficient renal excretion of 
the molecule (Taylor, 2010). Local tissue factors must promote the deposition of pigment 
in specific tissues. Mediastinal cysts are usually benign and are uncommon in the general 
population. Cysts arising in the anterior mediastinum are most commonly of thymic
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origin or mature cystic teratomas (Takeda, 2003). Although there are no particular 
features to indicate the nature of the cyst in this patient, the presence of ochronotic 
pigment in the cyst wall but not in other mediastinal tissues suggests that inflammation 
and fibrosis in the cyst wall have promoted pigment deposition.
The presentation of ‘non-uniform’ ochronosis in patients with AKU may illuminate 
pathological factors involved in mediating deposition of ochronotic pigment and provide 
clues to the pathogenesis of pigment deposition in the tissues that are more commonly 
affected by ochronosis, such as the articular cartilages of the weight bearing joints and 
the cardiac valves (Helliwell, 2008). The two distinctly different types of pigment were 
observed in the mediastinal mass from this patient are similar to those seen in 
collagenous ligamentous capsular tissue from the joint of a patient with AKU, as reported 
in Chapter 4 (Taylor, 2010). This suggests an overlap, whereby similar pathological 
changes are occurring, in the deposition process between the different sites and the 
potential for elucidating changes in the collagenous matrix that may influence pigment 
deposition. Mediastinal pigmentation has not been described in autopsy tissues of patients 
with AKU (Helliwell, 2008). It has been suggested that cyst formation in other tissues 
may be associated with an increase in oxidative stresses and reduced antioxidant enzyme 
protection (Maser, 2002). As cystic structures are induced by increased oxidative stresses 
in other species (Murgia, 2004), a local increase in oxidative stress in the cystic tissues of 
this patient may have provided suitable conditions to promote pigmentation. It has been 
shown recently that there is a significant effect on the protein synthesis, cell organisation, 
defence and stress responses when cells are subject to HGA (Braconi, 2010).
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Furthermore, chondrocytes cultured in HGA which are subject to antioxidants show 
decreased apoptosis, increased growth and partial restoration of proteoglycan release, all 
of which are caused by the presence of HGA (Tinti, 2010).
External scar tissues have not been shown to pigment, although scar tissue within 
cartilaginous structures displays ochronosis (Helliwell, 2008). The inflammatory 
response as part of scar tissue formation is interesting in AKU, as the presence of 
pigment itself does not seem to elicit a widespread inflammatory response in synovial 
tissue except as a foreign body type of reaction to cartilaginous debris (Mannoni, 2004). 
Several potential mechanisms may be involved. Inflammatory cells may secrete factors or 
alter the local physiological conditions and promote pigmentation. Secondly, the maturity 
and structure of the collagenous matrix may play a role in the preferential deposition of 
pigment around collagen bundles. Thirdly, the presence of proteoglycans and 
glycosaminoglycans in immature scar tissue may create conditions similar to those seen 
in articular cartilage in which pigment deposition is favoured (Clark, 1985). This would 
replicate the conditions in which pigmentation is seen in ageing joint tissues in AKU 
patients. The detection of calcified deposits within the mass and the presence of 
ochronotic pigmentation suggest that the polymeric HGA is not a homogenous mix of 
HGA polymer but can also recruit/encompass other molecules. It has been shown 
previously that HGA may associate with calcium compounds; Chapter 8 (Taylor, 2010). 
Calcification is often seen in mediastinal cysts and it may be that the calcification is in 
some way important for pigment deposition in these tissues. The interest of the 
pathological association of pigment with calcium is that it is assumed that collagen fibres
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in the normal bone matrix are protected from pigmentation in AKU because of the 
calcification process. This is the first report of ochronosis in a mediastinal cyst of a 
patient with alkaptonuria. The possible mechanisms that may contribute to the 
pigmentation in these tissues may inform the pathogenesis of ochronosis at other sites.
277
10. General Discussion
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It is over 100 years since Archibald Garrod used AKU to prove the ‘one gene, one 
enzyme’ theory, recognising that there was a recessive inheritance and coined the term 
‘inborn error of metabolism’ (Garrod, 1902 & Garrod, 1908). Whilst there have been 
significant advances in understanding the genetics of the disease such as the cloning and 
mapping of the HGD gene (Fernandez-Cahon, 1996 & Granadino, 1997), there has been 
limited progress in understanding the intermediary steps that see HGA converted to the 
pigmented polymer which causes ochronotic osteoarthropathy. This thesis represents a 
body of work which presents novel data into some of these intermediate steps and the 
opportunity for novel therapeutic interventions. Because of the rarity of AKU, it is 
unusual rare to be able to study many specimens in a single project/investigation. The 
unique opportunity for study of patient tissues and models allows for new observations to 
be made. In this work it has been able to compare and contrast the presentation in joints 
from within a patient and across the AKU population, from a macroscopic to the 
ultrastructural level.
The observations in Chapter 3 represent the largest description of a series of alkaptonuric 
joint specimens undertaken. The number of specimens studied represents over 15% of the 
identified AKU population within the UK; 78 patients (Ranganath, 2011), although there 
is no doubt that other ‘unidentified’ patients exist in the population. When compared with 
studies into more common diseases such as arthritis; the percentage of observed samples 
from the known population in this study far outnumbers that for the study of more 
common diseases. The striking observation of non-uniform deposition of ochronotic 
pigment across the cartilages demonstrates that the widespread presence of HGA within
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these tissues for many years appears not to be the limiting factor in pigment deposition, 
which has been suggested previously in Chapter 8 of this Thesis (Taylor, 2010). The 
observation of non-uniform and bi-lateral differences in presentation of pigmentation 
from knees within a patient suggests that the presence of HGA alone is not the seldom 
factor in dictating location of pigment (AKU10 & AKU19, Figs. 3.12 & 3,17 
respectively). Also, given that the knees are not presenting at the same time and with the 
same severity and progression of ochronosis is further confirmation that intrinsic and 
extrinsic factors in and on the joint are somehow involved in influencing regions of 
matrix to pigment over others. Observations of unilateral joints from within a patient 
show that pigmentation is not uniform and the time of degeneration of the joints is not 
identical presenting further evidence that HGA alone is not the sole cause. The short time 
(5 months) between the hip and knee degeneration is interesting and it would be valuable 
for overall disease progression to determine if the rapid degeneration of the later was in 
part related to the arthropathy and subsequent replacement of the former.
Observations of the hip samples demonstrate that the most superior regions on the 
femoral head appear to be most severely affected. The absence of cartilage from these 
regions suggests that pigmentation in these areas of cartilage results in the articulation 
between hip and acetabulum causes cartilage from these areas to become dislodged. 
Given that the with any movement of the hip the area around the fovea is the most 
frequently articulated area with any movement, compared with the inferior parts of the 
femoral head which would only articulate at certain ranges of motion, this would make 
sense that any pigmentation in this area would be more detrimental than to the areas
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which did not show as abundant pigmentation. Observations of the two pigmented 
surfaces; femoral and acetabular, can be seen in Fig. 3.13.
The observations of the knees show a high variability in the presence of pigment, with no 
uniform observations on the tibia! or femoral components. The high degree of variability 
may in part be related to the differences in gait across the human population, which raises 
the question of what repeated loading, or perhaps specifically; repeated traumatic loading 
may have in causing certain areas to pigment. Whilst it is exciting to speculate a role for 
loading on these abnormal tissues, it cannot be ignored that abnormal loading may induce 
pathological changes in these originally normal tissues? Further analysis using finite 
element anaylsis (FEA) modeling may be able to answer this question, but this analysis is 
outside the remit of this thesis. Observations of predominantly non-pigmented 
osteophytes on the cartilage of these tissues suggest that newly formed cartilage is 
usually resistant to ochronosis. It can be speculated that pigmentation in cartilage may 
occur over a number of years as either HGA needs to reach a local concentration 
threshold to pigment, as seen in pure HGA cultures, or there are protective mechanisms 
in vivo that may cease to function or become less effective with the ageing or 
introduction of other pathological processes in tissues. This is confirmed by the 
observations of histological and ultrastructural pigmentation of matrix fibres in 
osteosarcoma (Tinti, 2010) and chondrosarcoma cultures in HGA (Taylor, 2007) and as 
seen in chapter 4 of this thesis. It has been shown at lower concentrations of HGA that 
pigmentation still occurs in a number of days, rather than the years it appears to take in 
vivo (Taylor, 2007 & Tinti, 2010). The role of pathological processes in pigmentation is
281
also described in Chapters 8 & 9, particularly in relation to pigmentation in the 
mediastinal mass.
This cohort of patient samples and their ages at replacement confirm the widely held 
suggestion that ochronotic osteoarthropathy is of rapid and early onset (Maxwell, 2005). 
The total average age for replacement across our samples was >10 years younger than 
those which have been observed for the national mean for hip and knee replacements. 
The non-uniform presentation of ochronosis at the macroscopic level is mirrored at the 
histological and ultrastructural level. Examination of collagen fibres in both the cartilage 
and capsule of patient tissues shows association with the pigment. It is of note that even 
in the most pigmented ochronotic regions of tissue examined, when examined 
ultrastructurally not all fibres present with ochronosis on them (Fig. 4.13). A gradient of 
pigmentation was seen across a few hundred nanometres within capsular tissues. A 
similar phenomenon was not apparent in the cartilage. The presentation in cartilage on 
collagen fibres was much more severe, with larger deposits seen and appearing to 
incorporate other matrix components, such as proteoglycan, which has been described 
previously (Mohr, 1980). In the tightly packed collagen in the capsular tissues pigment 
was seen on the fibre surface in longitudinal section, numerous granule and shards of 
pigment could be seen on one fibre. The observation of small granules on a single fibre is 
a novel observation and represents the earliest observed deposition of ochronotic pigment 
seen in alkaptonuric tissues. These appear related to larger more shardlike deposits on 
neighbouring collagen fibres (Fig. 4.14). It has been proposed that the ochronotic 
pigment deposition on collagen fibres may occur in a manner analogous to the 
mineralisation of bone collagen (Taylor, 2011). The process of mineralisation in bone
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might actually prevent the deposition of pigment associated with collagen fibres in bone. 
This is in part supported by the observation of ochronotic pigment deposition in cultures 
of osteosarcoma cell lines that are cultured in 3.3x10"4M HGA. Even though the 
osteosarcoma cells used represent different maturities of osteoblasts; the cells and the 
matrix they synthesise are widely used in the study of bone. These cultures do undergo 
mineralisation with the addition of an exogenous phosphate donor in the form of beta- 
glycerophosphate (McQuillan, 1995). In future this may provide a useful tool to 
investigate the protective mechanism of mineralisation of collagen by adding beta- 
glycerophosphate to SaOS-2 cultures for 40 days, sufficient time to allow mineralisation 
and then add HGA to examine for association of pigment with in vitro cultures. Analysis 
of bone specimens reveals that there is no pigment associated with the collagen fibres in 
human AKU bone matrix. From the analysis of other non-mineralising type I collagen 
fibres, such as seen in the capsular ligament and spinal ligament, shows clear association 
of type I collagen with ochronotic pigment.
Consistent with histological examination, ultrastructural examination of cells revealed 
intracellular ochronotic deposits. These in some cases appeared similar to the earliest 
deposits associated with the collagen fibres in the ligamentous capsule. The deposits seen 
in cells ultrastructurally will have been undetectable using histological techniques, which 
suggest that those detectable by histology are advanced. The cellular involvement in 
pigmentation is clear when intracellular pigmentation is seen in cells which have little or 
no collagenous matrices associated with them, such as the pigmentation seen in the acinar 
cells in Chapter 8 (Fig. 8.6).
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The ultrastructural analysis of the in vitro cultures in this thesis represents the first 
observations of pigment deposition in in vitro cultures by TEM. The in vitro model used 
and examined in this thesis will prove invaluable in gaining an insight into the 
pigmentation process. This is emphasised even more given that based on the results in 
chapter 5, where pigmented cartilage matrix appears impervious to enzymatic 
degradation (Fig 5.4 & 5.5). This stresses that any therapeutic intervention needs to be 
targeted at the point prior to, or as close as possible to the earliest detection of 
pigmentation, before significant pigment can alter the biochemical and mechanical 
properties of cartilage sufficiently to cause observable pathology.
The results in chapter 5 demonstrate a novel advance in the understanding of the 
progression of ochronotic osteoarthropathy and may provide useful for understanding 
more common arthropathies in the wider population. The early histological observations 
seen in Fig. 5.8 show the earliest observed commencement of ochronosis. This is seen in 
the calcified cartilage, associated with individual cells and their matrices. Across 
examination of other tissues, pigment was never seen at the articular surfaces without it 
also being present in proximity to the subchondral boundary. This suggests that whatever 
factors have a role in the pigmentation process are associated with the cells in the 
calcified cartilage region in these tissues. In Chapter 5 it has been described that 
subchondral bone and calcified cartilage are important in the pathology of OA. Calcified 
cartilage has often been neglected in the study of joint degeneration in OA, but it is 
clearly the tissue through which loads are distributed from the hyaline articular cartilage 
to the underlying subchondral bone (Ferguson, 2003). The observations in Chapter 5
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show a novel subchondral phenotype, with complete resorption of the subchondral and 
calcified cartilage plates. There are, however, many reports highlighting a role for 
subchondral bone in the pathogenesis of OA (Karsdal, 2008). It has been suggested that 
the structural integrity of articular cartilage is reliant on normal subchondral bone 
turnover, intact chondrocyte function and normal biomechanical stresses (Karsdal, 2008, 
Felson, 2004, Hayami, 2004). AKU has already been documented as mimicking or 
causing premature OA (Balint, 2000, Lagier, 2006). This demonstrates that AKU may, in 
part, be useful for studying OA, given the extreme phenotype that it demonstrates. 
Perhaps in this instance the ochronotic pigment that is deposited may be a marker of 
tissue damage. Studies are underway to examine the deposition of HGA pigment in 
osteoarthritic tissues. The subchondral phenotype observed in the advanced ochronotic 
samples suggest that bisphosphonates may be worthy of reconsideration as a therapeutic 
strategy, although they would not directly prevent ochronotic pigment deposition, they 
may prolong the life of the joint, particularly if they are timed prior to any significant 
pigmentation of the overlying cartilage.
The observation of novel microanatomical structures; excrescences in both AKU and OA 
samples provides further evidence that the exceptional phenotype observed in AKU may 
be an extreme OA phenotype. The overlap of the presence of these structures in both 
sample sets suggests that any pathogenic mechanism(s) that are involved in the 
deposition of these abnormal structures may be present in both disorders. This indicates 
that the formation of these structures is not related to the presence of HGA in the tissues 
of AKU patients. One similarity in the two tissues is the abnormal loading that is present
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across these tissues. The mineralised tissues underlying the pigmented cartilage are 
probably subject to regional unloading which results in focal removal of the subchondral 
plate. The spread of pigmentation results in a wider unloading phenomenon. It is also 
possible that following resorption of the mineralised material from beneath the 
ochronotic cartilage as seen in Figs. 5.5 - 5.7, that should deposition of new bone be 
induced that it is not possible for the osteoclasts to prepare a surface for the new bone to 
be deposited on, given that the pigmented cartilage matrix appears impervious to 
degradation. It appears that the subchondral phenotype in AKU is at the opposite end of 
the spectrum to that seen in OA, but as described above, thickening of the subchondral 
bone plate would be difficult to achieve if there is little or no subchondral bone or 
calcified cartilage to anchor new tissues to following removal due unloading of the bone 
in response to the pigmentation of the overlying cartilage. Within these samples it is 
interesting to observed trabeculae which are incompletely formed. Without a middle 
meeting point these structures offer no strucutural significance, although they may still 
maintain their homoeostatic function as a calcium store.
It is not possible to offer evidence to demonstrate why the excrescences are caused but 
further work is underway in order to determine the formation and functional significance 
of these structures. There is the possibility that these structures also form in the non- 
pathological ageing process whereby natural alterations and slow down in the body result 
in the formation of these structures. The relationship with adipocytes on these structures 
is also extremely interesting and warrants further investigation. The role of these cells as
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bone lining cells has been suggested previously and the involvement of adipocytes in 
matrix templating and formation is interesting observation.
The observation of the first detection of ochronosis in a mouse model is a highly 
significant feature of this thesis. The understanding of many diseases and their 
pathogenesis has been vastly increased by the use of murine models. It was originally 
believed that mice do not demonstrate ochronosis, even with efficient urinary excretion 
of HGA. Whilst HGD -/- mice do excrete high levels of HGA in their urine, they do not 
appear to suffer from any of the adult symptoms seen in humans. Numerous hypotheses 
have been suggested as a reason for this, including life span, endogenous production of 
ASC and differences in the biomechanics of the joint. These hypotheses appear not to be 
completely true given that the observations in chapter 6 demonstrate pigmentation in 
FAH-/-, HGD +/- animals. The observations in these animals raise interesting questions 
about what factors in these animals are promoting deposition in the kidneys and joint 
tissues. Given the macroscopic observations in the kidneys and the histological 
deposition in the knees and kidneys there must be factors that are promoting deposition in 
these tissues, which are not present in the HGD -/- mice. The kidneys and the cells of 
these mice are subject to abnormal stresses from the presence of succinylacetone in 
tissues that have not reverted to the alkaptonuric phenotype. This compound has 
carcinogenic and mutagenic properties and the focal stresses may be in part contributory 
to the deposition of ochronotic pigment in the renal tissues of these animals. It may also 
be that this model is a complex way of inducing renal failure, the results of which are 
contributory to induce pigmentation in these animals. In humans pigmentation has been 
observed in kidney stones from patients with AKU (Melis, 1994), although there is no
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evidence to describe pigmentation associated with renal cells or their matrices. In the 
FAH-/-, HGD +/- mouse, it maybe that the absence of the FAH enzyme and the 
subsequent succinylacetone build up affects the renal performance, causing promotion of 
deposition of ochronotic pigment in these tissues. This may be similar to the changes 
seen in ageing in human kidneys. This is demonstrated in part by the observations of 
renal insufficiency in a patient with AKU, whose renal function was l/3rd that of his 
siblings, resulting in an elevated plasma HGA level compared to his alkaptonuric siblings 
(Introne, 2002).
In these mice with ochronosis, the observations of pigmentation in the joints is a highly 
relevant observation into understanding the pathogenesis of the disorder and will prove 
valuable in screening therapeutic agents. Whilst these animals did not show full depth 
cartilage pigmentation, synonymous with that seen in advanced ochronosis in humans, 
they do show identical initiation of pigmentation, which would be the ideal time to target 
treatment(s) to preventing further deposition. This model would be useful to observe 
what, if any, other pathological changes in the joints of these animals maybe inducing 
pigmentation in and around certain cells and if the instigators are the same as those seen 
in the human condition.
The novel observations of chapters 8 & 9 show previously unpublished presentations of 
ochronosis in tissues of patients with AKU. The rarity of the disease means that the 
opportunity to observe these tissues from patients with AKU is uncommon. The 
deposition in the cells of the submandibular gland and the possible association with the
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calculus is very interesting and suggests that the ochronotic pigment that is deposited in 
patient tissues is not a homogenous compound, but is able to recruit other proteins or 
molecules, or is in fact itself recruited to deposit in these areas. The importance of 
calcium in the deposition in these tissues warrants further investigation.
Both the cases in chapters 8 & 9 reinforce the question of the role of inflammation and 
underlying pathology in the deposition of ochronotic pigment in certain tissues. Both 
cases showed inflammation, and it may be the role of inflammatory cells and their 
secretions that in part are responsible for inducing pigmentation in these tissues. 
Interestingly, particularly in chapter 8, the tissues observed showed no notable deposition 
associated with the collagen fibres in the matrix, supporting the theory that pigmentation 
occurs in cells prior to matrix, or at the very least can occur independently of 
pigmentation in the matrix.
In summary these studies reported here provide novel findings which represent 
advancements in the understanding of the process of ochronosis and subsequent 
arthropathy in AKU. Whilst they do not complete the picture of what is happening in the 
disorder, they provide more evidence and knowledge for which new therapeutic strategies 
for treating this rare condition could be targeted.
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